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 Polyomaviruses are small, DNA tumor viruses that establish persistent infections 
in their natural hosts. Several members of the virus family are associated with human 
pathologies such as Progressive Multifocal Leukoencephalopathy (PML), trichodysplasia 
spinulosa and Merkel cell carcinoma. Polyomaviruses are one of the first virus family 
known to encode miRNAs. These polyomaviral miRNAs are located antisense to the 
early transcripts and hence, mediate the autoregulation of the viral early proteins, the T 
antigens. There are two major questions in the field of polyomaviral miRNAs – What is 
the biological significance of this miRNA-mediated autoregulation of the early 
transcripts? Are there other biological significant targets for these polyomaviral 
miRNAs? 
 This work addressed these two questions through an evolutionary approach. First, 
examination of SV40 and JCV variants indicated the high conservation of the miRNAs 
and their autoregulatory functions. Second, miRNA-mediated autoregulation of the early 
transcripts is conserved in a newly discovered, evolutionarily divergent viruses, the 
Bandicoot papillomatosis and Carcinomatosis viruses (BPCVs). Third, by inspecting 
 x 
divergent members of the polyomavirus family, we have shown that some non-human 
polyomaviruses encode miRNAs, with the function to autoregulate the early transcripts 
conserved. The conservation of miRNAs both among variants of individual member and 
across divergent members of the polyomavirus family implies importance. More 
importantly, a conserved function of autoregulating the early transcript further 
emphasized the biological relevance of the miRNAs in polyomavirus biology. Yet, the 
lack of replicative differences between miRNA-expressing and miRNA-null SV40 strains 
during lytic infections suggests a role for the polyomaviral miRNAs under a different 
setting, perhaps in the establishment of persistent infection of their natural hosts. 
This work represents an evolutionary study of polyomaviral miRNAs that has 
demonstrated the conserved nature of miRNA-mediated autoregulation of the early 
transcripts among various members of the polyomavirus and polyoma-like virus families. 
These results have implicated a potential role for the polyomaviral miRNAs in the 
establishment of persistent infection and raised the possibility of using the JCV miRNAs 
as potential biomarkers as a non-invasive form of diagnostic for PML.
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CHAPTER 1 Introduction 
1.1 Prologue 
“The gift that keeps on giving” may be the perfect description for 
polyomaviruses. Since the discovery of the first two members of Polyomaviridae, murine 
polyomavirus (Polyoma or muPyV) and Simian Virus 40 (SV40, Gross, 1953; Sweet and 
Hilleman, 1960), immense contributions to many faucets of the eukaryotic molecular 
biology and tumor biology have resulted from the intensive studies on these two viruses. 
But these contributions will not the end of what we can learn from these viruses. 
Polyomaviruses again stepped into the spotlight when it became one the first virus 
families known to encode microRNAs (miRNAs, Sullivan et al., 2005). This introductory 
chapter focuses on the discovery of polyomavirus miRNAs and their biological 
significance towards the polyomavirus lifecycle.  
 
1.2 MicroRNAs 
 MicroRNAs (miRNAs) are a class of eukaryotic small RNA molecules (~22nt) 
that play important regulatory roles in multiple biological processes that are of great 
relevance to virology (reviewed in Grundhoff and Sullivan, 2011; Kincaid and Sullivan, 
2012). The biogenesis of miRNAs have been reviewed in depth (see Bartel, 2009; 
Carthew and Sontheimer, 2009; Kim et al., 2009). Briefly, miRNAs are first transcribed 
as a longer primary transcript (pri-miRNA) containing the hairpin precursor known as the 
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precursor miRNA (pre-miRNA). The pre-miRNA hairpin is a small RNA structure of 
approximately 65nt in length, consisting of a terminal loop, a double-stranded RNA stem 
that encompass the miRNA duplex and flanking single-stranded RNA (Denli et al., 2004; 
Gregory et al., 2004; Han et al., 2004; Landthaler et al., 2004; Lee et al., 2003; Zhang and 
Zeng, 2010). The pre-miRNA hairpin structures are processed and liberated by Drosha, 
an endonuclease of the RNase III family (Lee et al., 2003; Zeng and Cullen, 2005; Zeng 
et al., 2004), as part of a larger complex known as the Microprocessor complex (Denli et 
al., 2004; Gregory et al., 204; Han et al., 2006). The pre-miRNA is then exported from 
the nucleus to the cytoplasm by exportin 5 in a GTP dependent process (Bohnsack, 2004; 
Lund et al., 2004; Yi et al., 2003). Dicer, another member of the RNase III endonuclease 
family, cleaves the terminal loop of the pre-miRNA in the cytoplasm, generating a short 
RNA duplex with 2 nucleotides (nt) overhangs at the 3’ end (Bernstein et al., 2001; 
Grishok et al., 2001; Hutvagner et al., 2001; Ketting et al., 2001). The short RNA duplex 
is then loaded into the RNA-induced silencing complex (RISC), with one strand of the 
duplex, the guide strand, preferentially retained over the less abundant strand of the 
duplex, also known as the star (*) strand or the passenger strand. The mature derivative 
miRNA near the 5’ and 3’ are also known as the 5p and 3p miRNAs respectively (Bartel, 
2009). Nucleotides 2 to 8 of the mature miRNA (numbered from the 5’ end), referred to 
as the seed region, are especially important in mRNA recognition with the 
complimentary binding sites being conserved in the target mRNA. miRNA binding sites 
are usually situated in the 3’ untranslated region (3’ UTR) of the target transcripts 
(Doench and Sharp, 2004; Grimson et al., 2007; Lewis et al., 2005; Lim et al., 2005; 
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Nielsen et al., 2007). When bound by miRNAs, the target transcripts display impaired 
translation (Humphreys et al., 2005; Pillai et al., 2005), which is usually followed by an 
increase in turnover rates (Bagga et al., 2005; Bazzini et al., 2012; Behm-Ansmant et al., 
2006; Giraldez et al., 2006). In addition to translational repression, some plant and viral 
miRNAs can bind the target transcripts with perfect complementarity throughout the 
entirety of the miRNA, directing endonucleolytic cleavage, resulting in robust decrease in 
the steady-state levels of those targeted transcripts (Llave et al., 2002). The 
endonucleolytic cleavage is initiated within the complementary region between the 
miRNA and the target transcript (Elbashir et al., 2001; Hammond et al., 2001; Martinez 
et al., 2002; Nykänen et al., 2001; Schwarz et al., 2004), mediated by the Argonaute 
protein 2 (AGO2), the core component of RISC (Liu et al., 2004; Meister et al., 2004; 
Rand et al., 2004). The latter mode of regulation, however, is rare for most animal 
miRNAs (Shin et al., 2010; Yekta et al., 2004a).   
 In 2004, the first viral miRNA was discovered in Epstein-Barr virus (EBV), a 
member of the herpesvirus family (Pfeffer et al., 2004). To date, virus-encoded miRNAs 
have been identified from several different families, including the herpes-, retro- and 
anellovirus families (Grundhoff et al., 2006; Kincaid et al., 2012, 2013; Pfeffer et al., 
2004). Over 300 viral miRNAs have been identified, yet only a small fraction have well-
understood functions. As small, non-immunogenic molecules that do not occupy 
significant genomic space, viral miRNAs have garnered great interest as potential 
effectors of pathogenesis and immune evasion. The main focus of this dissertation is the 
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discovery and characterization of a specific group of viral miRNAs, the polyomaviral 
miRNAs. 
1.3 Polyomaviruses 
Polyomaviruses are small (~50nm in diameter, Liddington et al., 1991; Rayment 
et al., 1982), non-enveloped virus with a circular, double-stranded DNA genome of 
approximately 5000 base pairs (bp). Historically, polyomaviruses are first considered as 
part of the papopaviridae, with the named derived from three of the members of the 
family – rabbit papillomavirus, murine polyomavirus and SV40, originally known as 
vacuolating virus. Extensive studies since then reveal that SV40 and muPyV are different 
from the papillomaviruses. Hence, the Polyomaviridae are now considered an 
independent virus family (Cole, 1996). 
 
1.3.1 History of Polyomaviruses discovery   
The first polyomavirus, muPyV, was discovered in 1953 by Ludwig Gross from 
his study on the transmission of murine leukemia virus (MLV, Gross, 1953), followed by 
SV40, subsequently was identified from a screen for viruses in rhesus macaque kidney 
cell cultures used for the production of poliovirus vaccine (Sweet and Hilleman, 1960). 
The first two human polyomaviruses discovered were JC virus (JCV) and BK virus 
(BKV). JCV was isolated from the brain tissue extract obtained from a patient with 
Progressive Multifocal Leukoencephalopathy (PML), a rare neurodegenerative disease 
caused by JCV lytic infection of oligodendrocytes, BKV was isolated from the urine of 
 5 
an immunosuppressed renal transplant patient. Both JCV and BKV were named after the 
initials of their respective patients in which the viruses were first described (Gardner et 
al., 1971; Padgett et al., 1971). More than 30 years later, following the advent of next 
generation sequencing techniques, discovery of new human polyomaviruses came at a 
blistering pace (Allander et al., 2007; Buck et al., 2012; Feng et al., 2008; Gaynor et al., 
2007; van der Meijden et al., 2010; Schowalter et al., 2010; Scuda et al., 2013; Siebrasse 
et al., 2012; Yu et al., 2012). To date, there are twelve known human polyomaviruses, 
with at least four of them associated with human pathologies: Merkel Cell polyomavirus 
(MCV), trichodysplasia spinulosa polyomavirus (TSV), BKV and JCV (Feng et al., 2008; 
Gardner et al., 1971; van der Meijden et al., 2010; Padgett et al., 1971). Most 
polyomaviruses are known to establish lifelong persistent infection in their native hosts, 
albeit through mechanisms that are not yet fully understood. However, in the laboratory 
settings, polyomaviruses can undergo lytic infection of cell cultures, leading to the 
ultimate destruction of the cells.   
 
1.3.2 Genetic make-up of Polyomaviruses 
 The polyomavirus genome can be divided into three regions: the non-coding 
control region (NCCR), the early and the late regions (Figure 1.1). The essential elements 
that control the genome replication and viral transcription, the origin of replication (ori) 
and the early and late promoters, are encompassed within the NCCR. The early and late 
promoters together drive a divergent transcriptional unit. The early transcripts encode the 
tumor (T) antigens whereas the late transcripts encode three structural capsid proteins, 
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VP1, VP2 and VP3. In addition to the capsid proteins, a forth late protein has been 
recently reported for SV40, VP4, and is suggested to function as a pore to disrupt cellular 
membranes for virion release during the lytic replication (Daniels et al., 2007; Giorda et 
al., 2012; Raghava et al., 2011, 2013). Importantly, individual members of the 
polyomavirus family have alternative repertoires of proteins, such as the agnoprotein in 





Figure 1.1 General Features of Polyomavirus genome.  
The polyomavirus genome can be divided into 3 regions – The non-coding control region 
(NCCR), the early and the late regions. The NCCR contains essential regulatory elements 
that controls DNA replication, promoters and enhancers for the early and late transcripts. 
The arrangement of these elements drives a divergent transcriptional unit, with the early 
transcripts denoted in red, represented in a anti-clockwise orientation and the late 
transcripts denoted in green, represented in a clockwise orientation. The early transcripts 
encode the tumor (T) antigens and the late transcripts encode the structural proteins, VPs.
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1.3.3 Non-coding control region (NCCR) 
 The non-coding control region (NCCR) contains the ori, the early and late 
promoters and enhancers. The SV40 NCCR is one of the best studied among the various 
polyomaviruses and will be the focus here. Two of the most important sequence elements 
within the NCCR are the 72bp pair repeat elements that function as enhancers for the 
SV40 early promoter (reviewed in Jones et al., 1988) and the set of three 21bp repeat 
sequences that is part of the early promoter (Benoist and Chambon, 1981; Everett et al., 
1983; Fromm and Berg, 1982; Hartzell et al., 1983). Based on the combination of these 
repeat elements in the NCCR, variants of SV40 can be classified into 3 different types – 
Archetype, nonarchetype and protoarchetype. The majority of the SV40 variants isolated 
from wild monkeys contain a single 72bp enhancer element and all three 21bp repeat 
sequences in their NCCR and are designated as the archetypes (Forsman et al., 2004; 
Ilyinskii et al., 1992; Lednicky et al., 1998). On the other hand, serial passage of 
archetypal SV40 variants in tissue culture usually leads to a duplication of the 72bp 
enhancer element and is designated as nonarchetypes. The most famous example of 
nonarchetype SV40 is the commonly used laboratory strain 776 (Lednicky and Butel, 
1997; Lednicky et al., 1995a, 1997; O’Neill et al., 2003). The third type of NCCR, the 
protoarchetype, is rarely described in literature and is defined as having a single 72bp 
enhancer element but lacking one of the 21bp repeat sequences, found to arise de novo 
within immunocompromised monkeys (Lednicky et al., 1998; Newman et al., 1998). 
Significantly, the laboratory adapted nonarchetypal SV40 strains can replicate to a higher 
level than the archetypal and protoarchetypal strains in both tissue culture and in vivo 
 9 
infections of Syrian golden hamsters (Lednicky and Butel, 2001; Lednicky et al., 1995b; 
Zhang et al., 2014).  
  
1.3.4 Tumor antigens 
 The tumor (T) antigens are a set of early polyomaviral proteins whose expressions 
are driven by the early promoter when the virus genome enters the nucleus. A single early 
primary transcript is differentially spliced to generate different T antigens (Courtneidge et 
al., 1991; Fu and Manley, 1987; Noble et al., 1987; Riley et al., 1997; Treisman et al., 
1981). Different polyomaviruses possess different splice variants of T antigens (Bollag et 
al., 2006; Carter et al., 2013; Houben et al., 2010; Shuda et al., 2008; Zerrahn et al., 
1993), but three of the best understood early proteins are the large, middle and small T 
antigens. Despite the vast amount of studies done, the sections below will only briefly 
cover some of the functions for each T antigen. 
 
1.3.4.1 Large T antigen 
 The term – “the most amazing molecule in the universe” was coined by Dr. James 
Pipas to describe large T antigen. Indeed, large T antigen is a multi-domain, multi-
enzymatic and multi-functional protein that contributes at various steps in the 
polyomavirus infection. Most of the functions described here are focused on the large T 
antigen of SV40. The large T antigen can be sub-divided into 4 separate domains – the 
ori-binding domain (OBD), the zinc (Zn)- binding domain, the ATPase domain and the J 
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domain (reviewed in An et al., 2012). During lytic SV40 replication, the large T antigen 
is the primary player that coordinates viral DNA replication by binding to the ori. The 
multimeric form of SV40 large T antigen, through the helicase domain, unwinds the 
double-stranded DNA to initiate the DNA replication process (Smelkova and Borowiec, 
1997, 1998). Acting as the helicase component, large T antigen is part of a larger, multi-
protein DNA replication complex consisting of host cell machineries (Dornreiter et al., 
1990, 1992; Huang et al., 1998; Melendy and Stillman, 1993; Weisshart et al., 1998).  
 The T antigens were named as such due to their transforming activity in multiple 
cell types in various host (reviewed in Ahuja et al., 2005). The SV40 large T antigen 
binds to the tumor suppressor retinoblastoma protein (pRb), a molecular brake that 
controls cell proliferation by associating with the E2F family of transcription factor 
(Bagchi et al., 1991; Chellappan et al., 1991). Following large T antigen binding to the 
hypophosphorylated form of pRb, E2F is relieved from its association with pRb. The 
release of E2F allows the activation of E2F-regulated genes, resulting in cell cycle 
progression from G0 to S phase. A subset of the E2F-regulated genes is absolutely 
required for polyomaviral DNA replication (Chellappan et al., 1992). This pRb binding 
motif is highly conserved among many different members of the polyomavirus family, 
including MCV, the first human polyomavirus known to cause cancer in human (Dyson 
et al., 1990; Feng et al., 2008; Houben et al., 2012). Abnormal upregulation of E2F-
regulated genes trigger a cellular defense mechanism via p53, another tumor suppressor. 
Large T antigen, however, is able to counter this cellular response by binding p53 (Lane 
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and Crawford, 1979; Linzer and Levine, 1979), inhibiting tumor suppressing function of 
p53 as well. 
 In summary, the large T antigen of SV40 alone has been shown to be sufficient to 
induce cellular transformation in multiple cell types of various host, by binding to two 
tumor suppressors, pRb and p53. By binding to these two tumor suppressors, large T 
antigen is able to drive cell proliferation.  
 
1.3.4.2 Middle T antigen 
 The middle T antigen, a plasma membrane protein (Ballmer-Hofer and Benjamin, 
1985; Ito et al., 1977), is encoded by the muPyV and closely related viruses (Courtneidge 
et al., 1991; Delmas et al., 1985). Better known for its oncogenic activity, the middle T 
antigen is also important for the lytic life cycle of muPyV, acting as a switch from early 
to late transcription (Chen and Fluck, 2001; Chen et al., 2006, 1995). The oncogenic 
property of the middle T antigen comes from its ability to associate with many celluar 
protein tyrosine kinases involved in a series of signaling cascades. The association of 
middle T antigen with these tyrosine kinases results in constitutive activation of the cell 
cycle (reviewd in Fluck and Schaffhausen, 2009; Gottlieb and Villarreal, 2001). 
   
1.3.4.3 Small T antigen 
 The small T antigen, sharing almost the entire sequence with the middle T 
antigen, can associate with protein phosphatase 2A (PP2A, Pallas et al., 1990), thereby 
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inhibiting the protein’s phosphatase activity (Yang et al., 1991). This inhibition sends 
down a signaling cascade resulting in cell cycle activation (Porrás et al., 1999). In a lytic 
setting, the role of the small T antigen remains uncertain.  
 
1.3.5 Lytic replication 
 The lytic life cycle of polyomavirus has been well demonstrated by the prototypic 
member of the family, SV40 (reviewed by Cole, 1996). Briefly, upon infection of a cell 
and entry into the nucleus, the early promoter drives the expression of the T antigens, 
whose primary roles in a lytic replication is to promote the synthesis of viral DNA 
(reviewed in Cole, 1996). Multimeric large T antigen complexes can then bind the ori to 
mediate viral DNA replication. At the onset of viral genome replication, the late promoter 
is activated and drives the expression of the structural proteins. Accumulation of the 
structural proteins leads to the assembly of mature virus particles, followed by the 
eventual lysis of the infected cells and release of the progeny virions. In the laboratory 
setting, lytic infections of African green monkey kidney cells result in the development of 
cytopathic effect (CPE), characterized by cytoplasmic vacuolization, nuclear swelling 
and eventual lysis of the infected cells (Diderholm, 1963; Miyamura, 1976; Miyamura 
and Kitahara, 1975) 
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1.3.6 Persistent infection  
 One of the earliest reports on SV40 persistence in rhesus macaques came from 
Ashkenazi and Melnick, where they demonstrated that exposure to SV40 occurs early in 
life, with periodic episodes of transient viremia and viruria. Eventually, persistent 
reservoir of SV40 infections are established in the kidney and lymphoid tissues 
(Ashkenazi and Melnick, 1962). In addition to the observations made by Ashkenazi and 
Melnick, SV40 DNA could also be detected in the urine of immunocompetent macaques 
(Newman et al., 1998). The majority of studies on in vivo SV40 infections were done in 
SIV-infected immunocompromised monkeys, and SV40 was detected in the kidney, 
central nervous system, lymph nodes, liver and spleen (Lednicky et al., 1998; Newman et 
al., 1998; Simon et al., 1999). More recently, an SV40 infection study has been 
conducted in Syrian golden hamsters, a widely used model for studying SV40 infections 
and oncogenesis (Butel et al., 1972; Cicala et al., 1993; Diamandopoulos, 1973; McNees 
et al., 2009; Patel et al., 2009; Sroller et al., 2008; Swain et al., 2012; Vilchez et al., 
2004). In their study, Zhang et al. show that acute SV40 infections are observable in 
liver, kidney, spleen, lung and brain, with the kidney harboring the main reservoir of 
persistent infections (Zhang et al., 2014).  
Attempts at understanding SV40 persistent infections in the cell culture settings 
are very limited as well. Leonard Norkin’s work on SV40 infections of rhesus macaque 
monkey kidney epithelial cells (LLC-MK2) demonstrated that SV40 is capable of 
establishing persistent infections in these cells. Eventually the persistently infected cells 
reach the “stable carrier state” in which extensive SV40 replication and progeny release 
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is evident without the presence of CPE, persisting as long as 11 weeks post infection 
(Norkin, 1976, 1977). Besides the rhesus macaque kidney cells, various reports have 
demonstrated SV40’s ability to establish persistent infections in vastly different human 
cells lines such as the human glioblastoma, immortalized human fibroblast cell lines, 
lymphoblastoid B-cell lines and mesothelial cells (Dolcetti et al., 2003; Fahrbach et al., 
2008; Morelli et al., 2004; Norkin et al., 1985). However, the findings of Norkin (Norkin, 
1976, 1977) have been disputed by a separate group, shpwing lytic infection of primary 
rhesus kidney cells by SV40 that results in typical CPE, cell death, and progeny virion 
release comparable to infections of African green monkey cells (von der Weth and 
Deppert, 1992). Despite these studies on SV40 infections of rhesus macaque, under both 
whole animal and tissue culture settings, our understanding of the underlying mechanism 
for the establishment of SV40 persistent remains incomplete. Combined, persistent 
infection is a fascinating facet of the polyomavirus life cycle, one most akin to natural 
infections. Yet, our understanding of persistent infections remains rudimentary.  
  
1.4 Polyomavirus miRNAs discovery 
 The first two published examples of polyomaviral miRNAs are from SV40 and 
muPyV (Sullivan et al., 2005, 2009). However, hints of these two viruses expressing pre-
miRNAs were evident more than three decades ago, from work by Alwine and Khoury 
on SV40-associated small RNA (SAS-RNA (Alwine, 1982; Alwine and Khoury, 1980; 
Alwine et al., 1980)); and by Treisman and Kamen, and Fenton and Basilico on muPyV 
transcriptions (Fenton and Basilico, 1982; Treisman, 1981; Treisman and Kamen, 1981). 
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The discovery process for polyomaviral miRNAs first starts with pre-miRNA hairpin 
candidates prediction using the v-miR algorithm (Seo et al., 2008, 2009; Sullivan et al., 
2005, 2009; Cox et al., in prep). The candidate hairpins are then cloned into a 
heterologous expression vector driven by the cytomegalovirus (CMV) major immediate-
early promoter. The vectors are transfected into culture cells such as the human 
embryonic kidney 293T cells (HEK293T). Northern blot analysis is subsequently 
performed on the total RNA of the transfected cells. A signature northern blot result that 
indicates a particular pre-miRNA candidate is processed into mature miRNA would 
contain both the pre-miRNA signal in the size region between 70nt and 30nt, mature 
miRNAs in the region between 30nt and 10nt (Figure 1.2, McClure et al., 2011). This 
prediction approach, however, has at least one major drawback. The scoring of pre-
miRNA hairpin predictions is based on thermodynamic stability. Therefore, the longer 
the RNA sequence and hence the more thermodynamically stable the secondary structure 
is (lowest ΔG), the higher the v-miR score for that candidate will be, resulting in high 
false-positive predictions. Failure in v-miR prediction, however, is by no means an 
absolute indication that a particular member of polyomavirus is miRNA-null. With the 
availability of next generation small RNA sequencing, discovery of polyomaviral 
miRNAs can be performed, bypassing the need for v-miR predictions (Chen et al., 2011; 
Lin et al., 2010). After confirming the expression, it is essential to determine if the 
predicted viral miRNA is biologically active. The biological activity of the newly 
discovered polyomaviral miRNAs can then be demonstrated using a luciferase reporter 
system. This reporter-based assay allows for observing the downregulation of luciferase 
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signal when target sequences for the miRNAs are inserted downstream of the luciferase 




Figure 1.2 Discovery of Polyomaviral miRNAs.  
There are two general approaches to discovery novel polyomaviral miRNAs. The first 
approach (boxed in blue) involves v-miR prediction of candidate hairpins acroos the 
entire polyomaviral genome. The candidate hairpins are then cloned into heterologous 
expression vector (such as pcDNA3.1) and transfected into HEK293T. Total RNA from 
the transfected cells is then subjected to northern blot analysis to confirm the expression 
of the miRNA (boxed in green). A signature miRNA northern blot will indicate a pre-
miRNA signal between the 70nt and 30nt size markers, combined with signals from the 
5p, 3p or both miRNAs between the 30 and 10nt size markers. The second approach 
involves cloning the entire polyomaviral genome into the heterologous expression vector 
in both the late and early orientations (boxed in orange). The vectors are transfected into 
HEK293T. Small RNA fraction from the transfected cells is then subjected to next-
generation small RNA deep sequencing (Illumina or SOLiD sequencing platforms). The 
sequencing results are then confirmed by northern blot analysis as described. To test for 
functionality of the polyomaviral miRNAs, reporters are constructed by cloning the 
miRNA anti-sense sequence into the 3’ UTR of a Renilla luciferase open reading frame. 
A dual-luciferase assay is then conducted to test the candidate miRNAs’ activities on 
their respective anti-sense reporters.
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The small size of polyomaviral genome (~5kb) allows them to be genetically manipulated 
with relative ease. To study the relevance of the miRNAs on polyomaviral biology, a 
mutagenesis-based approach is usually employed to disrupt the hairpin structures, 
generating miRNA-null mutants (Bauman et al., 2011; Broekema and Imperiale, 2013; 
Sullivan et al., 2005, 2009). In addition to naturally circulating miRNA-null and miRNA 
variants, deletion mutants constructed from previous studies of polyomaviruses can also 
serve as useful tools for deciphering the biological roles of these polyomaviral miRNAs 
(Chen et al., 2013; Sullivan et al., 2009; Chen et al., in prep). It is highly likely that 
polyomaviral miRNAs have both viral and cellular targets, but deducing the biological 
significance of these targets will be a challenging task.  
  Polyomaviral miRNAs identified thus far are classified into two categories 
(Figure 1.3). The first category is the SV40-like, for which the miRNAs are located 
antisense to the C-terminus of the large T antigen open reading frame. The second is the 
muPyV-like, for which the miRNAs are also located antisense, but closer to the N-
terminus of the large T antigen open reading frame. The SV40-like category includes 
SV40, BKV and JCV whereas the muPyV-like category includes muPyV, MCV, 
PtsPyV2a, GggPyV1 and RacPyV. Since the polyomaviral miRNAs are all antisense, 
they maintain perfect sequence complementarity to the early transcripts. Polyomaviral 
miRNAs, therefore, are expected to mediate the endonucleolytic cleavage of the early 
transcripts, which has been demonstrated for SV40 and muPyV (Chen et al., 2013; 




Figure 1.3 Known polyomaviral miRNAs and their genomic locations. 
The polyomaviral miRNAs known thus far are all located antisense to the early 
transcripts. These miRNAs can be categorized into two different groups based on their 
genomic location. The first group, muPyV-like, includes the murine polyomavirus 
(muPyV), Merkel cell polyomavirus (MCV), Pan troglodyte verus polyomavirus 2a 
(PtsPyV2a), Gorilla gorilla gorilla polyomavirus 1 (GggPyV1) and raccoon 
polyomavirus (RacPyV) miRNAs, and are located closer to the N-terminus of the large T 
antigen. The second, group, SV40-like, includes the simian virus 40 (SV40), JC virus 
(JCV) and BK virus (BKV) miRNAs, and are located near the C-terminus of the large T 
antigen. 
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1.4.1 SV40 miRNAs   
 The first ever hint of polyomavirus-encoded miRNAs was described by Alwine 
and Khoury in 1980 as SV40-associated small RNA (SAS-RNA, Alwine and Khoury, 
1980; Alwine et al., 1980). SAS-RNA was characterized as a small RNA of 
approximately 65 nucleotides that was induced late during lytic infection. Surprisingly, 
the SAS-RNA was shown to share sequence homology with the 3’ end of the early viral 
mRNA as well. The function of SAS-RNA was not yet determined when it was first 
described, however, from the temporal expression and sequence homology within the 
SV40 genome, it was suggested that the SAS-RNA could play a possible role in 
controlling the gene expression of SV40 (Alwine, 1982; Alwine et al., 1980). The 
genomic location and sequence of the SAS-RNA were subsequently determined by 
Alwine and Khoury, mapping to nucleotide positions 2760 to 2825 of the SV40 776 
genome (the laboratory strain of SV40 is designated as 776). The combined works of 
Alwine and Khoury laid the foundation for the discovered miRNAs in SV40. Fast 
forward to 2005, a candidate miRNA with the highest scoring hairpin structure was 
predicted (v-miR prediction program (Grundhoff et al., 2006)) in the SV40 genome at 
around the same genomic location as the SAS-RNA. A series of northern blot analysis 
confirmed the hairpin candidate as a bona fide pre-miRNA, thereby revealing the true 
identity of SAS-RNA as the SV40 pre-miRNA, mapping to nucleotide positions 2794 to 
2851 of the genome, and is antisense to the T antigen transcripts. Just as described by 
Alwine and Khoury, the SV40 pre-miRNA and miRNAs accumulates at late times during 
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infection, with both the 5p and 3p miRNAs having perfect complementarity to the early 
transcripts (Sullivan et al., 2005).  
 Since both the 5p and 3p miRNAs are antisense to the early transcripts, it was 
predicted that the miRNAs would direct the endonucleolytic cleavage of the early 
transcripts (Chen et al., 2013; Sullivan et al., 2005). Indeed, the SV40 miRNAs were 
demonstrated to direct the cleavage of the early transcripts. Despite a decrease in T 
antigen expression (both large and small T antigens), the expression profile for both early 
proteins were still robust. Surprisingly, the decrease in T antigens production did not 
translate to a reduced virus yield for 776, when compared to a mutant SV40 incapable of 
expressing the miRNA (SV40 miRNA mutant (SM), (Sullivan et al., 2005)). Is the SV40 
miRNA mediated autoregulation of the T antigens a biologically relevant function during 
lytic replication, or is it a consequence of the genomic location of the SV40 miRNAs 
(antisense and therefore, perfectly complementary to the early transcripts). A hint of the 
answer to this question may have already been provided by Mother Nature, in the form of 
multiple SV40 variants circulating in the wild. A screen by Chen et al. of all 63 deposited 
fully sequenced isolates of SV40 for possible variations in their pre-miRNAs and 
derivative miRNAs revealed 17 unique classes of pre-miRNA primary sequence variants 
(Chapter II, Chen et al., 2013). A naturally circulating variant, strain RI257, identified 
from this study, displays an entirely different miRNA expression profile. The laboratory 
strain, 776, displays dominant expression of two different 3p derivative miRNAs, 
whereas for strain RI257, robust expression of both the 5p and the 3p miRNAs is evident, 
with the 5p miRNA as the more dominant derivative. More importantly, all the RI257 
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derived miRNAs possess different seed sequences than those from the strain 776 (Chen et 
al., 2013). As predicted from the altered seed repertoires, the strain 776 and RI257 
miRNAs target different repertoire of host transcripts. Despite having different seed 
sequences, the strain RI257 miRNAs still efficiently autoregulate the early transcripts to 
levels comparable to strain 776. This observation further highlights the likely biological 
importance of SV40 miRNA-mediated autoregulation of the T antigen transcripts, at the 
same time, tolerating substantial variability in their miRNA targetomes (Chen et al., 
2013). 
 The importance of miRNA-mediated autoregulation of T antigens is further 
highlighted when this mode of viral gene regulation is discovered in a fascinating group 
of recently described viruses, the Bandicoot Papillomatosis Carcinomatosis viruses 1 and 
2 (BPCV1 and 2, Chapter III (Chen et al., 2011). The BPCVs represent a group of 
naturally occurring hybrids between two different virus families, the Polyomaviridae and 
the Papillomaviridae. Since the genome of BPCVs are similar in size to known 
papillomaviruses and encode putative capsid proteins with similar nucleotide and amino 
acid sequences to the L1 and L2 capsid proteins of papillomaviruses (Woolford et al., 
2007), BPCV has been classified under the papillomavirus family. Despite their 
classification, the BPCVs maintained the same genomic organization of the 
Polyomavirus family and more importantly, the capacity to express the T antigen proteins 
(Bennett et al., 2008a; Woolford et al., 2007). BPCVs also encode miRNAs, albeit not 
antisense to the early transcripts, these BPCV miRNAs still direct the autoregulation of 
the early transcripts by binding to the 3’ UTR of the early transcripts, with near sequence 
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complementarity (20 out of 22nt). This discovery most likely represents the first example 
of miRNA-mediated autoregulation of the T antigen transcripts that is not through 
endonucleolytic cleavage but translational repression (Chen et al., 2011). The fact that the 
BPCV1 miRNAs are also found at abundant level in vivo further argues for a biologically 
significant role for the miRNAs, perhaps the autoregulation of the T antigen transcripts 
via the 3’ UTR (Chen et al., 2011). 
 The conserved nature of the miRNA-mediated autoregulation of the T antigen 
transcripts suggests biological importance. What, then, is the biological role of this 
regulation? One possibility is that the miRNA may function in maintaining persistent 
infection. In this model, the miRNA prevents excessive or untimely expression of the T 
antigens, thereby avoiding the persistent reservoir from entering the lytic replication 
cycle without induction and the subsequent clearance by the adaptive immune response. 
The best evidence for this is that the downregulation of T antigens expression during lytic 
infection leads to a reduction in the susceptibility to cytotoxic T lymphocytes (CTL)-
mediated lysis when compared to the miRNA-null mutant SV40 (SM) infection 
counterpart, emphasizing on the importance of modulating the expression of the 
immunogenic T antigens, possibly in immune evasion (Sullivan et al., 2005). In vivo 
evidence for the effect of SV40 miRNA on viral pathogenesis was demonstrated by 
Zhang et al., from their work on SV40 pathogenesis in Syrian Golden hamsters (M. 
auratus, Zhang et al., 2014) . The SV40 miRNAs were detected in both kidney and liver 
tissue, the two major sites of persistent infections in the infected hamsters. More 
importantly, there was an negative correlation between the expression level of the 
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miRNA and the viral loads in those tissues – that is, hamsters infected with SM harbored 
higher levels of viral DNA in the kidney and liver tissues than animals infected by the 
wild type viruses. This result, again, is congruent with the autoregulatory effect of the 
SV40 miRNAs on the T antigen transcripts since higher levels of T antigens in the SM 
infected cells could be expected to support enhanced viral DNA replication (Zhang et al., 
2014). 
 The conserved nature of the autoregulation of the T antigen transcripts in both 
SV40 and polyoma-like viruses leaves no doubt that regulating the level of T antigens, in 
order to establish persistent infection, is one of the main function. As we continue to 
explore the BKV, JCV, muPyV and MCV miRNAs in the following sections, the 
autoregulatory effect of the polyomaviral miRNAs will be further emphasized. Yet, it is 
by no means that we could rule out any possibility for the existence of cellular target(s) 
for the SV40 miRNAs. 
 
1.4.2 BKV and JCV miRNAs 
 Like the SV40 miRNA, the BKV and JCV miRNAs were identified from northern 
blot screening of potential pre-miRNA candidates obtained from the v-miR prediction 
program (Seo et al., 2008). The BKV and JCV encoded miRNAs show striking 
similarities with the SV40 miRNAs – 1. Located in the late orientation, 2. Genomic 
location, 3. Conserved function of T antigen transcripts autoregulation. 4. miRNA-
mediated cleavage of the T antigen transcripts. Despite having a 5p dominant miRNA 
expression profile and different seed sequences than the SV40 miRNAs, both the BKV 
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and JCV miRNAs lie antisense to the T antigen transcripts, suggesting the potential 
autoregulatory function of the human polyomaviral miRNAs. Indeed, from the results of 
both dual-luciferase reporter system and 5’ rapid amplification of cDNA ends (5’ RACE) 
from BKV and JCV miRNA expression vectors transfected cultured cells, Seo et al. 
concluded that the autoregulation of the T antigen transcripts is a conserved role of the 
BKV, JCV and SV40 miRNAs. Furthermore, the JCV miRNAs are found at robust levels 
in brain samples obtained from patients suffering from PML (Seo et al., 2008). However, 
the pathological implication of the in vivo detection of the JCV miRNAs remains 
unknown.  
It would be of no surprise for viral miRNAs to regulate transcripts of the infected 
cells. Due to the non-immunogenic nature of the miRNA, occupying minimal genomic 
space and the potential to target a vast array of cellular transcripts based on a short stretch 
of seed sequence (n=16384), miRNAs would be the perfect tools for viruses to evade the 
immune response. The most well known examples of viral miRNAs participating in 
immune evasion comes from members of the Herpesviridae (Cullen, 2013; Ramalingam 
et al., 2012). As for the polyomaviruses, the first reported cellular target for any 
polyomaviral miRNAs came from the study of the BKV and JCV miRNAs (Bauman et 
al., 2011). Bauman et al. first generated different lentiviral miRNA vectors each 
expressing the BKV 5p miRNA, JCV 5p miRNA and the BKV/JCV 3p miRNA, since the 
3p miRNA has 100% sequence identity between the two viruses. Using a combination of 
reporter system and fluorescence-assisted cell sorting (FACS) analysis, the authors 
determined UL16 binding protein 3 (ULBP3) to be a target for the BKV and JCV 3p 
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miRNAs. The ULBPs belong to a novel class of human, MHC class I-related cell surface 
proteins. The primary function of the ULBPs is to activate the natural killer (NK) cell, an 
important arm of the innate immune response that is responsible for the recognition and 
destruction of cells under stress, such as viral infections (Sutherland et al., 2002). Binding 
of ULBP3 by an NK cell surface receptor, NKG2D, stimulates NK cytotoxicity (Cosman 
et al., 2001). The results by Bauman et al. suggest an immune evasion effect for the BKV 
and JCV miRNAs-mediated downregulation of cellular ULBP3 level. Indeed, the 
expression of the JCV 3p miRNA in the JCV infected cells resulted in a reduction in NK-
mediated killing. Conversely, co-expression of a molecular sponge against the JCV 3p 
miRNA restored NK-mediated killing of the JCV infected cells (Bauman et al., 2011).  
The first phenotypic effect on the polyomaviral lifecycle by the viral miRNA 
came from the studies on BKV replication in cultured primary human renal proximal 
tubule epithelial (RPTE) cells, which is the natural cell culture model for BKV lytic 
replication (Broekema and Imperiale, 2013). Unlike the methodology employed in the 
construction of SM (SV40 miRNA mutant), Broekema and Imperiale constructed the 
BKV miRNA-null mutant by making just 3 surgical mutations designed to disrupt the 
BKV pre-miRNA hairpin structure, and thus, abolishing the mutant virus’ capacity to 
encode miRNAs. In agreement with previous works on SV40 and muPyV (Sullivan et al., 
20005, 2009), deletion of the BKV miRNA has no significant effect on the replication of 
BKV with a rearranged NCCR (analogous to nonarchetypal SV40). However, in the 
archetype NCCR background, the absence of the miRNA resulted in a 100-fold increase 
in early transcript production and a 50-fold increase in viral DNA replication. These 
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increases translated into decreased of progeny virions (Broekema and Imperiale, 2013). 
This study, in conjunction with the studies on SV40 and BPCV miRNAs, suggest a role 
for the polyomaviral miRNAs in maintaining persistent infections in their natural host. 
Expression of the polyomaviral miRNAs would curtail the level of T antigens in the 
infected cells, keeping them at a low enough level that would not support and sustain 
lytic infections (Chen et al., 2011, 2013). The idea of viruses using viral miRNAs to 
target its own transcripts to serve as a switch between persistent and lytic infections 
mirrors the switch between latent and lytic infections observed in some members of the 
herpesvirus family (Bellare and Ganem, 2009; Lei et al., 2010; Lu et al., 2010; Umbach 
et al., 2008). It is therefore, not surprising for the polyomaviruses to utilize its own 
miRNAs to regulate the T antigens, the essential components that drive the polyomavirus 
lytic life cycle. 
 
1.4.3 Murine Polyomavirus (muPyV) miRNAs 
The polyomaviral miRNAs described thus far (SV40, JCV and BKV) are 
conserved in terms of their genomic location, antisense to the C-terminus coding region 
of large T antigen. However, this is not the case for the miRNA encoded by the muPyV. 
Similar to the discovery of the SV40 miRNAs, the muPyV miRNAs were identified by 
the v-miR hairpin prediction algorithm (Sullivan et al., 2009). Despite still being in the 
late orientation and antisense to the early transcripts, the highest scoring candidate 
hairpin was found at a different genomic location that is much further downstream than 
the SV40 miRNA. This however, does not represent the first recorded description of the 
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muPyV pre-miRNA. In his thesis work and subsequent publication of the mapping of the 
muPyV late nuclear RNA, Richard Treisman provided the first description of the muPyV 
pre-miRNA (Treisman, 1981; Treisman and Kamen, 1981). Using the S1 nuclease 
protection assay, Treisman identified the 5’ and 3’ ends for a particular species of late 
muPyV small RNA that is consistent with the ends of the muPyV pre-miRNA hairpin. 
His discovery also suggested the necessary presence of an RNaseIII-liked enzyme 
necessary for the generation of those 5’ and 3’ ends. About a year later, in 1982, while 
studying the early transcriptional program during muPyV lytic infection of 3T3D mouse 
fibroblasts, Fenton and Basilico are able to detect a fragment of the early transcripts with 
a 5’ end that mapped antisense and in proximity to where Treisman and Kamen had 
found the late muPyV small RNA (Fenton and Basilico, 1982). The unusual characteristic 
of the muPyV early transcript fragments as reported is their accumulation late during 
muPyV lytic infections. Together, the observations from Treisman, Kamen, Fenton and 
Basilico, combined with what we now know on how polyomaviral miRNAs function, it 
was confirmed that the late muPyV small RNA is the muPyV miRNA, and the early 
transcript fragments are the product of the miRNA-mediated cleavage of the T antigen 
transcripts (Sullivan et al., 2009). Despite not being found in the same genomic location 
as the SV40, BKV and JCV miRNAs, the muPyV miRNAs are still antisense to the T 
antigen transcripts and therefore, miRNA-mediated cleavage of the early transcripts was 
again confirmed, through two independent methods – 1. Mapping of the early transcript 
cleavage site down to a single nucleotide resolution via the 5’ RACE, and 2. a 
corresponding decrease in T antigens expression level via immunoblot analysis.  
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muPyV is an evolutionarily distant member from SV40, BKV and JCV, yet, the 
same mode of miRNA-mediated autoregulation is conserved. This raises an important 
question: How does autoregulation of the T antigens by its own viral miRNAs contribute 
to polyomavirus biology? To address this question, Sullivan et al. infected C57BL/5J 
mice with both the wild type muPyV (PTA) and a mutant virus carrying a small deletion 
(21nt) within the pre-miRNA hairpin region, making it a miRNA-null mutant (PTA-
dl1013). Following by a systematic characterization of the infected animals, there were 
no significant differences between the two different groups. The CD8 T cell responses 
during acute and persistent phases of muPyV infection are comparable, interferon-γ (IFN-
γ) secretion, indicative of T cells functionality, viral clearance within the spleens and 
kidneys are not statistically different and the accumulation of viral DNA in the spleens 
and kidneys of neonatal mice are similar at various time points (Sullivan et al., 2009). 
This set of observations present a very interesting conundrum – is it possible for the 
miRNAs to serve no important biological function during in vivo muPyV infection? If so, 
why did the polyomaviral miRNA evolve to autoregulation the T antigens, a function 
conserved among diverse member of the family? As suggested by the authors, 
experimental protocols on laboratory animal infections are designed and optimized for 
convenience and efficiency, not scoped to mimic the natural routes of entry, nor spread of 
the virus among individuals. Therefore, phenotypic differences between having the 
miRNAs or not can be subtle. To fully tease out the contribution by the miRNAs will 
require long-term population studies focusing on the transmission, shedding and spread 
of the muPyV. 
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Similar to the SV40, BKV and JCV miRNAs, the muPyV miRNAs mediates the 
autoregulation of the early transcripts. However, the in vivo role of this autoregulation is 
not yet established.   
 
1.4.4 Merkel Cell Polyomavirus (MCV) miRNA 
On a historical time scale, the discovery of MCV, the first cancer-causing human 
polyomavirus, is young. Yet, its discovery returned the spotlight once again onto the field 
of polyomavirus biology. Utilizing a next-generation approach, known as digital 
transcriptome subtraction (DTS), which involves in silico subtraction of human cDNA 
sequences from the tumor cDNA sequences to isolate candidate viral sequences (Feng et 
al., 2007, 2008). MCV was found to be clonally integrated into the human genome of 
Merkel Cell Carcinoma (MCC), a rare, yet aggressive form of skin cancer that is usually 
associated with poor prognosis once diagnosed (Agelli and Clegg, 2003; Hodgson, 2005). 
A compilation of epidemiology data further supported the original notion of MCV being 
the etiological agent of MCC, as approximately 70 to 80% of MCC tumors are positive 
for MCV (Arora et al., 2012; Feng et al., 2008). The discovery of MCV miRNAs 
followed a similar trajectory as the discovery of SV40, muPyV, BKV and JCV miRNAs. 
Sequences were subjected to v-miR pre-miRNA hairpin prediction, and high-scoring 
candidates were cloned into a heterologous expression vector, followed by the subsequent 
transfection and screen for miRNA expression via northern blot analysis. The screen 
resulted in the confirmation of MCV miRNA mapping to a region of the genome that was 
previously shown to encode a pre-miRNA hairpin in muPyV (Seo et al., 2009). Being 
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located antisense to the T antigen transcripts, the MCV miRNA is predicted to cleave the 
early transcripts. However, due to the lack of a replication system, the function of the 
MCV miRNA could not be readily established. To circumvent this limitation, Seo et al. 
employed a luciferase-based reporter system to confirm that the MCV miRNA is indeed 
active at directing the inhibition of the reporter gene expression, thereby strongly 
suggesting that miRNA-mediated autoregulation of the T antigen transcripts is conserved 
in MCV (Seo et al., 2009). 
The in silico prediction and subsequent in vitro confirmation of MCV miRNAs, 
and the determination of its activity on the T antigen transcripts in vitro alone provide no 
evidence that the MCV miRNAs contribute to the MCV and MCC biology. Two different 
research groups have independently established partial MCV replication systems by 
transfecting MCV DNA into human embryonic kidney 293 (HEK293) cells and shown 
that both the small T and the large T antigens of MCV are essential for DNA replication 
(Feng et al., 2011; Kwun et al., 2009, 2013; Neumann et al., 2011). MCV was also found 
to express a bona fide middle T antigen-like alternative T antigen open reading frame 
(ALTO) during MCV DNA replication, albeit with functions that are not yet determined 
(Carter et al., 2013). It will be interesting to see if the MCV miRNA is made in these 
replication systems and if the miRNA-mediated autoregulation of the T antigen 
transcripts is observable (including ALTO). The MCV biology in MCC tumors, however, 
is fundamentally different from the laboratory replication systems. In the MCV-positive 
MCC tumors, the viral genomes are clonally integrated into the tumor genome. These 
integrated MCV genomes carry mutations that result in premature truncation of the large 
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T antigen, resulting in the expression of truncated large T antigens that lack the origin 
binding and helicase domains. Therefore, these large T antigens still maintain the 
capacity to bind to the retinoblastoma tumor suppressor protein (Rb) but the capacity to 
replicate the MCV genome is eliminated (Fischer et al., 2010; Shuda et al., 2008). 
However, the MCV miRNAs are still antisense, allowing for the potential autoregulation 
of the T antigen transcripts in MCC tumors, including ALTO. In order to determine if 
miRNA-mediated autoregulation of the early transcripts is relevant to MCC biology, the 
in vivo detection of the MCV miRNA will first have to be established. An initial small 
RNA sequencing screen of 7 MCC tumor samples (3 MCV-positive and 4 MCV-
negative) performed by Lee et al. showed that the MCV miRNA is detectable in 2 out of 
3 MCV-positive tumor samples but not in the 4 MCV-negative tumor samples. 
Additional screening of 51 MCC tumor samples via quantitative reverse-transcription 
PCR (qRT-PCR) for the MCV miRNA detected the viral miRNAs in 19 out of 38 MCV-
positive MCC tumors but in none of the 13 MCV-negative tumors. These data provide a 
positive correlation between MCV DNA positivity and detecting the MCV miRNAs (Lee 
et al., 2011). However, the MCV miRNAs identified in that report contains a shift in 2nt 
at the 5’ end of the miRNA over the entire 22nt mature sequence (Lee et al., 2011), when 
compared to miRNAs generated under transfection conditions (Seo et al., 2009). The 
authors suggest that a cellular context dependent factor might account for the difference 
in mature miRNA sequences between the in silico and the in vivo determinations of the 
miRNA (Lee et al., 2011). Another possible explanation, however, is the possible biases 
introduced during the small RNA library preparation. It has been well-documented that 
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different adapter sequences can introduce variations in the frequencies of 5’ end ligation 
of small RNA species with different sequences at the 5’ end (Jayaprakash et al., 2011). 
The bias introduced at the 5’ end ligation step will then be exacerbated at the PCR 
amplification step (Dabney and Meyer, 2012; Kanagawa, 2003; Sendler et al., 2011), 
resulting in a miRNA expression profile that is not reflective of the actual abundance of 
small RNA species in vivo. 
Both the truncated large and the small T antigens of MCV have been shown to be 
transforming proteins (Cheng et al., 2013; Shuda et al., 2011), making the detection of 
MCV miRNA in MCC tumors presents a very perplexing finding – What is the biological 
significance of detecting both the MCV T antigens and the miRNAs in the same tumor 
samples? Is MCV miRNA-mediated autoregulation of the T antigen transcripts 
functionally relevant to MCC tumor biology? In light of this question, a seed sequence 
identity search revealed that the MCV 5p miRNA shares 6 out of 7 seed sequence 
identity with the cellular miRNA, hsa-miR-7-1 (miR-7), potentially mimicking its 
function (Chapter V, Chen et al., in prep). Relevant to cancer biology, evidence that 
supports a tumor-suppressive role of miR-7 (Fang et al., 2012; Kefas et al., 2008; Okuda 
et al., 2013; Reddy et al., 2008; Saydam et al., 2011; Webster et al., 2009) while 
contradicting reports also suggest the opposite (Cheng et al., 2005; Chou et al., 2010). 
Regardless of its true function, the possibility for the MCV 5p miRNA to mimic a 
cellular miRNA introduces a second layer of complexity to the MCC tumor biology and 
the potential role of MCV miRNAs in tumorigenesis. 
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1.4.5 Other polyomaviral miRNAs 
Thus far, the capacity to encode miRNAs has only been described for SV40, 
BKV, JCV, muPyV and MCV (Chen et al., 2013; Seo et al., 2008, 2009; Sullivan et al., 
2005, 2009). Our lab has shown, through small RNA deep sequencing screening of the 
remaining 9 human polyomaviruses, that only human polyomavirus 12 (HPyV12) 
encodes miRNAs (Kincaid et al., in prep, Cox et al., in prep and unpublished data). 
HPyV12 was discovered by Korup et al., from the sampling of gastrointestinal tract fluid 
and liver samples (Korup et al., 2013). The miRNAs encoded by HPyV12 are also 
located at a genomic region very similar to the muPyV and MCV miRNAs. Being 
antisense to the early transcripts, our lab has also demonstrated, via luciferase reporter 
assay, that HPyV12 miRNAs could potentially autoregulate the early transcripts. Without 
a replication system, however, it remains unclear if this mode of autoregulation is 
observable in vivo and its implication to the HPyV12 biology (Cox et al., in prep). 
One of the ongoing works in our lab involves the determination of miRNA 
encoding capacity for all members of the polyomavirus family. We first looked into 3 
non-human polyomaviruses and one raccoon polyomavirus. Using a similar in silico 
approach in the discovery of MCV miRNAs (Seo et al., 2009), the genomes of Pan 
troglodyte verus polyomavirus 1a and 2a (PtsPyV1a and 2a), Gorilla gorilla gorilla 
polyomavirus 1 (GggPyV1) and raccoon polyomavirus (RacPyV) are first subjected to v-
miR prediction of candidate pre-miRNA hairpins. Transfection studies and northern blot 
analysis confirm the presence of miRNA for PtsPyV2a, GggPyV1 and RacPyV but not 
for PtsPyV1a (Chapter IV, Chen et al., in prep). Expectedly, all 3 miRNAs are shown to 
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be capable of autoregulating the early transcripts as demonstrated by a luciferase reporter 
system. Interestingly, RacPyV is found in 20 out of 20 raccoons diagnosed with olfactory 
tract/frontal lobe brain tumors, and the fact that the large T antigen protein is detectable 
in a subset of neoplastic cells from the tumors, strongly associates RacPyV as the 
etiological agent of raccoon brain tumors (Dela Cruz et al., 2013). Based on the genomic 
location of the miRNAs, RacPyV can be classified under the muPyV-like category 
(which includes MCV). Northern blot analysis of total RNA obtained from 4 raccoon 
brain tumor samples shows that 4 out of 4 are positive for the RacPyV miRNAs (Chen et 
al., in prep). Again, the biological implication of detecting both the miRNAs and the T 
antigens in the same tumor samples is yet to be determined. Similar to the MCV 5p 
miRNA, a minor derivative of the RacPyV 5p miRNA also shares 6 out of 7 seed 
sequence identity with miR-7 as well, but the implication of this finding on RacPyV 
replication and brain tumor biology is yet to be determined. 
 
1.5 Model 
 The combined findings of polyomaviral miRNAs are in line with the following 
model for polyomaviruses. First, during lytic replication, the role of miRNA-mediated 
autoregulation of the early transcripts serves to keep the expression of the T antigens at 
an optimum level. Most of the studies presented here involved the lytic life cycle of the 
polyomavirus, which demonstrated high degree of conservation of the autoregulatory 
function of the polyomaviral miRNAs. Second, polyomaviruses establish life-long, 
persistent infections of their hosts. Therefore, regulating the early transcripts could be one 
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of the mechanisms for the maintenance of persistence. The extent of miRNAs effects is 
generally described as subtle and “rheostatic” (Gottwein et al., 2007; Lim et al., 2005; 
Samols et al., 2007), thereby reducing the emphasis for the essentiality to solely target 
cellular transcripts by a single set of viral miRNAs. This is by no means negating the 
possibility of biologically significant cellular targets for these polyomaviral miRNAs. 
Since only about 25% or fewer viral miRNAs are likely to serve as mimics of host 
miRNAs (Grundhoff and Sullivan, 2011; Kincaid and Sullivan, 2012), the polyomaviral 
miRNAs might target a niche specific selected set of cellular mRNAs in combination 
with autoregulation of the T antigens, enforce in vivo establishment of polyomaviral 
persistent infections. 
 
1.6 Concluding remarks 
 The scope of this dissertation focuses on one central theme – the discovery and 
characterization of the polyomaviral miRNAs. Viral miRNAs is an exploding and 
fascinating field that will impact the way we understand different facets of biology, 
including virology and immune evasion. The discovery of polyomaviral miRNAs, in 
particular, has brought polyomavirus biology back into the limelight. Furthermore, their 
relatively simple genetic make-up and ease of laboratory manipulation makes 
polyomaviruses the perfect tool to better understand the roles of miRNAs in 
pathogenesis.  
 The first chapter has offered a detailed history on the discovery of all 
polyomaviral miRNA, starting with the SV40 miRNAs to the most recent work on non-
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human polyomaviral miRNAs. An in depth review of works done to elucidate the 
function of each polyomaviral miRNA are also included, pointing towards at least one 
major conserved function of the miRNA – autoregulation of the T antigen transcripts.  
 The second chapter takes the focus back to the SV40 miRNAs and its 
conservation among different variants of the member. Different miRNA expression 
profiles was shown for 2 different strains of SV40, potentially allowing the different 
variantss to tolerate substantially different “targetomes”, yet at the same time, conserving 
the autoregulatory function of the miRNAs. 
 The third chapter delves into an evolutionarily divergent class of emerging DNA 
virus, also known as the virological equivalent of the “bigfoot”, the Bandicoot 
Papillomatosis Carcinomatosis Viruses (BPCVs). This chapter details the discovery of 
miRNAs in a recombinant virus that is half-polyomavirus, half-papillomavirus, further 
emphasizing the importance of miRNA-mediated autoregulation of the T antigens.  
 The fourth chapter documents the identification of miRNA in other diverse, non-
human members of the polyomavirus, both primate and non-primate. The focus then 
shifts to an interesting and recently discovered member, the raccoon polyomavirus 
(RacPyV). It is of no surprise that the miRNA-mediated autoregulation of the T antigens 
to be conserved in RacPyV as well. We also hypothesize the possibility for the 5p 
miRNAs of both the RacPyV and MCV to mimic a cellular miRNA, miR-7. 
 The fifth chapter is refocus our attention back to the SV40 miRNAs. The 
identification of miRNA-null strains of SV40 in immunocompromised monkeys provided 
us with useful insight into the impact of the SV40 miRNA on natural infections, tying it 
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back to the conserved autoregulation of the T antigens by the polyomaviral miRNA and 
its possible roles in lytic and persistent infections. 
 The sixth chapter delves into addressing the possible role of the SV40 miRNAs in 
persistent infection, by pre-expressing the 776 miRNAs in African green monkey cells, 
followed by studying the effect of miRNAs on lytic replication and establishment of 
persistent infection. 
 The seventh chapter aims to address the possibility of detecting polyomaviral 
miRNAs as a diagnostic. Here we demonstrate the detection of JCV miRNAs in 
exosomes, extracellular vesicles secreted by cells, as a potential non-invasive and more 
accurate replacement for current diagnostic of PML. 
 The objective of this dissertation work is a straightforward one – to advance our 
knowledge on the polyomaviral miRNAs. Starting with the conservation of T antigen 
autoregulation by the miRNA in SV40 and polyoma-like viruses, to the discovery of 
novel miRNAs in diverse member of the polyomavirus family and studying the impact of 
the SV40 miRNA on both the lytic and persistent infections. This collection of work 
presented here only represents a small step towards unveiling our full understanding of 
polyomaviral miRNAs. For each miRNA found, new polyomaviruses are discovered; for 
each discovery made, more questions were raised. “The gift that keeps on giving” truly is 




CHAPTER 2 Divergent microRNA Targetomes of Closely-related 
Circulating Strains of a Polyomavirus 
 
2.1 INTRODUCTION 
miRNAs are a class of eukaryotic small RNA molecules that play a regulatory 
role in several biological processes relevant to virus infection including the immune 
response, apoptosis and tumorigenesis (Kincaid and Sullivan, 2012). Virus-encoded 
miRNAs identified from several different families, including the herpes, retro, and 
polyoma viruses, have generated much interest as potential effectors of pathogenesis. 
Over 300 viral miRNAs have been identified, yet only a small fraction have well-
understood functions (Boss et al., 2009; Gottwein and Cullen, 2008; Grundhoff and 
Sullivan, 2011; Tuddenham and Pfeffer, 2011). Unlike host miRNAs, most viral miRNAs 
are not well conserved and only ~25% or less are likely to serve as mimics or “analogs” 
of host miRNAs (Grundhoff and Sullivan, 2011; Kincaid and Sullivan, 2012).  
 
Chen, C.J., Cox, J.E., Kincaid, R.P., Martinez, A., and Sullivan, C.S. (2013). Divergent 
MicroRNA targetomes of closely related circulating strains of a polyomavirus. J. Virol. 
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R.P.K., G.J.S., M.D.B., and C.S.S. wrote the manuscript 
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As such, identifying the most relevant targets of viral miRNAs is not straightforward. A 
valuable approach towards understanding the functions of viral miRNAs relies on high-
throughput target transcript identification (Dölken et al., 2010a; Gottwein et al., 2011; 
Grey et al., 2010; Haecker et al., 2012; Plaisance-Bonstaff and Renne, 2011; Riley et al., 
2012; Skalsky et al., 2012; Ziegelbauer et al., 2008). However, it is unlikely that all of 
these identified targets are relevant to the virus infectious cycle, thus limiting the utility 
of such approaches as stand-alone platforms for determining viral miRNA function. Here, 
we take advantage of natural variations in miRNA gene products from closely related 
virus strains, with the assumption that important miRNA target transcripts will be 
preserved throughout evolution.   
miRNAs are ~22 nucleotides long (reviewed in Bartel, 2009), and are derived 
from primary transcripts (pri-miRNA) containing hairpin precursor molecules (pre-
miRNA) (Carthew and Sontheimer, 2009; Kim et al., 2009). The pri-miRNA is cleaved 
by the double-stranded RNA-specific endonuclease Drosha to liberate the pre-miRNA 
(Lee et al., 2003; Zeng and Cullen, 2005; Zeng et al., 2004) that is then exported to the 
cytoplasm (Bohnsack, 2004; Lund et al., 2004; Yi et al., 2003). There, Dicer further 
cleaves the pre-miRNA (Bernstein et al., 2001; Hutvagner et al., 2001), and typically a 
single-stranded 22mer, enriched from one arm of the hairpin, is more abundantly retained 
in the RNA induced silencing complex (RISC). The other less abundant strand is 
sometimes referred to as the “star” strand or “passenger” strand (Bartel, 2009). The 5’ 
end of the 22mer, referred to as the “seed” region (nucleotides 2-8), is especially 
important for mRNA target binding and typically binds with perfect complementarity to 
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the 3’ untranslated (UTR) region of the target transcript (Lim et al., 2005). Most miRNA-
targeted transcripts display impaired translation followed by subsequent increased 
turnover (Bazzini et al., 2012), which can manifest as an overall decreased steady-state 
level of the targets (Lim et al., 2005; Samols et al., 2007). In addition, although rare for 
most animal miRNAs, some plant and viral miRNAs can bind with perfect 
complementarity (all ~22 nucleotides) to their targets and direct “siRNA-like” cleavage 
resulting in robust decreases in the steady state levels of the targeted transcripts. 
The polyomaviruses are a family of small, circular, double-stranded DNA circular 
genome viruses. Most polyomaviruses are thought to take up lifelong infections of their 
hosts, albeit the mechanisms for how this occurs are poorly understood. In addition, 
polyomaviruses can undergo robust lytic infection. There are currently 12 known human 
polyomaviruses, of which at least four: Merkel Cell Polyomavirus (MCPyV), 
Trichodysplasia Spinulosa Polyomavirus (TSPyV), BK Virus (BKPyV), and JC Virus 
(JCPyV) are associated with serious disease in immunosuppressed humans (Dalianis and 
Hirsch, 2013; DeCaprio and Garcea, 2013; Feltkamp et al., 2012; Kazem et al., 2013; 
Spurgeon and Lambert, 2013). Simian Vacuolating Virus 40 (SV40), a prototypic 
polyomavirus, undergoes lytic infection in cultured African green monkey cells and as 
such has been a valuable laboratory model for polyomavirus infection (Cole, 1996). We 
have previously demonstrated that several members of the Polyomaviridae (SV40, BKV, 
JCV, Simian Agent 12 (SA12), murine polyomavirus (muPyV) and Merkel Cell 
Polyomavirus (MCPyV)) express miRNAs that lie antisense to the early transcripts and 
possess the ability to cleave these transcripts via an siRNA-like mechanism (Cantalupo et 
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al., 2005; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009). The conserved nature of this 
mode of autoregulation amongst divergent polyomaviruses implies importance. However, 
at least three observations could suggest otherwise. First, the degree of regulation 
imparted by the miRNA is partial. That is, at least in the laboratory models of lytic 
infection(Sullivan et al., 2005, 2009), a high fraction (~50%) of intact early transcripts 
remains uncleaved by the viral miRNA-RISC (Sullivan et al., 2005, 2009). Second, a host 
target has been reported for the JCV star strand miRNA (Bauman et al., 2011). Third, our 
unpublished data suggest that at least some strains of polyomavirus likely do not encode 
miRNAs (Cox and Sullivan, unpublished). Therefore, it remains to be determined if 
autoregulation of the antisense early transcripts is truly important in the polyomaviral 
lifecycle. 
Here, we address the question of whether polyomaviral miRNA-mediated 
autoregulation of the early transcripts is a relevant activity, or rather results as an off 
consequence of the genomic location of the polyoma miRNAs (antisense and therefore 
necessarily perfectly complementary to the early transcripts). We screened all 63 
deposited fully-sequenced isolates of SV40 for possible variations in their pre-miRNAs 
and derivative miRNAs. We uncovered 17 different classes of pre-miRNA primary 
sequence variants, some of which result in different miRNA products. We identified a 
naturally-circulating variant virus (RI257) that generates derivative miRNAs– all 
possessing different seeds than the miRNA derivatives from the majority of SV40 
isolates. We show that, as would be predicted from the altered seed repertoires, the 
reference strain 776 miRNAs target a different repertoire of host transcripts than RI257. 
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However, strikingly, the RI257 miRNAs efficiently autoregulate early transcript levels to 
a similar degree as strain 776. These results underscore the likely importance of SV40 
miRNA-mediated autoregulation of viral gene expression. Furthermore, this work 






2.2.1 Identification of 17 classes of sequence variants in the SV40 pre-miRNA 
genomic region.  
Polyomaviruses are common human pathogens that can be associated with cancer 
and other serious diseases in immunosuppressed patients (Dalianis and Hirsch, 2013; 
DeCaprio and Garcea, 2013; Feltkamp et al., 2012; Kazem et al., 2013; Spurgeon and 
Lambert, 2013). We have previously identified several different animal and human 
polyomaviruses that produce miRNAs capable of autoregulating early viral gene 
expression (Cantalupo et al., 2005; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009). 
Whether this function is beneficial to polyomavirus biology remains unknown. The fact 
that this mode of gene regulation is conserved amongst diverse polyomaviruses implies 
importance. However, it is also possible that targeting numerous host transcripts is a key 
function of these miRNAs. Teasing out the relevant importance of these two non-
mutually-exclusive models is complicated by the fact that no variations in the miRNA 
seed sequences have been reported in different strains of the same virus. Such variants 
could allow prioritization of the most relevant targets since even single nucleotide 
changes in the seed can direct a different efficiency of activity and spectrum of target 
transcripts (van Dongen et al., 2008; Fedorov, 2006; Grimson et al., 2007; Jackson, 
2006). Presumably, only important targets, host or viral, will be preserved amongst the 
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variant viruses. Therefore, we first set out to identify isolates of the same virus species 
that give rise to variant derivative miRNAs.  
Our strategy to identify miRNA seed variants of the same species is outlined in 
Figure 2.1A. SV40 is one of the best-studied polyomaviruses with the full genomes of 63 
different isolates deposited in Genbank. Therefore, we focused on SV40. We first 
identified all deposited strains that possess nucleotide variation in the general pre-miRNA 
region of the genome. Because flanking regions can affect the processing of pre-miRNAs 
(Zeng and Cullen, 2005), we defined our region of interest as containing the predicted 
hairpin stem-loop structure plus an additional 10 nucleotides on either side of the hairpin 
(nucleotides 2764 – 2881 in the 776 reference strain). From the 63 isolates examined, we 
identified 17 different classes that contain at least a single nucleotide change in the pre-
miRNA and/or nearby flanking regions (Figure 2.1B). Most classes contained only one or 
two nucleotide substitutions, or larger duplications or insertions that were not predicted to 
dramatically alter the secondary structure of the pre-miRNAs. One notable exception was 
strain RI257 that contains 22 individual nucleotide changes (Figure 2.1B) but nonetheless 
preserves a high-scoring predicted pre-miRNA structure (VmiR analysis (Grundhoff, 
2006), data not shown). Thus, we identified 17 different classes of SV40 strains that 





Figure 2.1 Sequence alignment of 63 deposited SV40 genome sequences 
reveals 17 classes of variants in the pre-miRNA genomic region.  
(A) Experimental workflow for identification of unique pre-miRNA variants of SV40. 63 
fully sequenced SV40 genomes were aligned and this resulted in 17 classes of variants in 
the pre-miRNA genomic region. The 17 pre-miRNA genomic regions were synthesized 
and cloned into pcDNA3.1neo. 293T cells were transfected with the expression vectors. 
RNA was harvested for high-resolution northern blot analysis and next generation 
sequencing. (B) Sequence alignment of the 17 classes of variants in the pre-miRNA 
genomic region. Each class was numbered from 1 to 17, and the strain names were 
indicated as well (* indicates the strains that were mentioned in this study). Polymorphic 
bases are highlighted: A in red, T in green, C in purple and G in yellow. The pre-miRNA 
genomic region of 776 was used as the reference strain in the alignment process and the 
corresponding 776 pre-miRNA genomic location is numbered at the 5’ and 3’ end of the 
alignment. The 5p (black) and 3p (blue) miRNA derivatives are underlined and indicated 
by the arrows. 
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2.2.2 RI257: A variant SV40 strain with altered pre-miRNA processing and a different 
seed repertoire.  
As an initial screen for identifying derivative miRNA variants, we conducted 
high-resolution northern blot analysis (Koscianska et al., 2011) of the 17 different classes 
of SV40 pre-miRNA and miRNA derivatives. We synthesized the genomic regions 
encompassing each pre-miRNA sequence variant and engineered expression vectors for a 
single strain that was representative of each of the 17 classes of sequence variants (Figure 
2.1). We transfected cells, harvested total RNA, and conducted high-resolution 
denaturing polyacrylamide gel electrophoresis. Blots were then probed with radioactive 
oligonucleotides. These results showed that 14 of the 17 representative strains displayed a 
band pattern similar to the reference strain 776. Consistent with previous low-resolution 
northern analysis (Sullivan et al., 2005), multiple miRNA derivatives are observed for the 
776-like miRNAs. These include a preponderance of 3p arm derivatives that migrate 
predominantly as a doublet (Figure 2.2A, lanes 1-13 and 776). Additionally, a minor 
proportion of the total derivatives arises from the 5p arm and migrates as a doublet. This 
pattern is identical to what we observed for 776-infected cells (data not shown), 
demonstrating that the transfection assay gives rise to biologically-relevant processed 
miRNA products. Interestingly, 3 strains displayed an altered miRNA migration pattern. 
These include strains MC-028846B (Figure 2.2A, lane 14), K661 (Figure 2.2A, lane 15) 
and RI257, (Figure 2.2A, lane RI257). MC-028846B was discovered as a contaminant in 
a lot of poliovaccine manufactured in 1955 (Rizzo et al., 1999). Like 776, MC-028846B 
produces a predominant 3p derivative, however, unlike 776, it migrates as predominantly 
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a single band. Sequencing of the MC-028846B miRNA demonstrated a seed sequence 
that is identical to the faster migrating miRNA of 776 (Figure 2.2A, lane 14 and lane 776, 
and data not shown), and therefore we did not pursue this variant further. K661 (Forsman 
et al., 2004; Lednicky et al., 1998) appears to make very little detectable miRNA 
derivatives, which suggests that low-miRNA-producing strains, or even null strains, can 
arise in some contexts. As such, K661 will be the subject of a separate publication and is 
not further discussed here. Of all the strains, RI257 is unique in that it produces an 
abundant, slow-migrating 5p derivative as well as a single 3p derivative (Figure 2.2A, top 
panel, lane "RI257"). We quantified the relative distribution of 5p and 3p derivatives 
relative to the pre-miRNA for each strain (Figure 2.2B and data not shown. The 
quantification was performed on the representative Northern blot image shown in Figure 
2.2A). The vast majority of total miRNA derivatives arise from the 3p arm for all strains 
except RI257. Strikingly, although RI257 produces about ~43% of total viral miRNAs 
from the 3P arm, the majority of derivatives (~57%) arise from the 5p arm. Given the 





Figure 2.2 Strain RI257 produces a pre-miRNA variant whose predominant 
derivative switches to the 5p miRNA arm.  
(A) High-resolution Northern blot analysis reveals RI257 produces a pre-miRNA variant 
whose predominant derivative switches to the 5p miRNA. 293T cells were transfected 
with expression vectors of the 17 classes of pre-miRNA variants. Total RNA was 
harvested for high-resolution Northern blot analysis. The top panel represents the 5p 
probe and the bottom panel represents the 3p probe. The strains mentioned in this study 
are indicated by the strain names, otherwise, they were labeled with their corresponding 
numbers from Figure 2.1. The bands corresponding to the pre-miRNA (white 
arrowheads) or the 5p (black arrowhead) and 3p miRNAs (gray arrowhead) are indicated. 
As a loading control, ethidium bromide-stained low-molecular-weight RNA is shown in 
the bottom panel. (B) Graphical representation of the switch in predominant derivatives 
to the 5p miRNA for RI257. The band signals from the high-resolution Northern blot 
analysis were quantified and plotted in a bar graph format. The x-axis indicates the 776 
and RI257 strains and the y-axis indicates the expression of the 5p (black bars) and 3p 
miRNAs (gray bars) as a percentage (%) of the sum of the band signals from both the 5p 
and the 3p miRNAs.  
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   The aberrant slow migration and the “switch” to 5p dominance of the RI257 
miRNA derivatives suggests the possibility that RI257 gives rise to different miRNA 
seeds. To test this in an infectious context, we first had to engineer a virus that makes the 
RI257 miRNA derivatives. To study the effects of varying only the pre-miRNA region, 
we generated a recombinant virus in the genetic background of the reference strain 776 
with the pre-miRNA region replaced by the corresponding genomic region of RI257. We 
named this recombinant virus “RI257-MIR”. RI257-MIR produces high titer stocks and 
displays growth kinetics highly similar to 776 (data not shown). Northern blot analysis 
confirmed identical banding patterns for the miRNA derivatives from the infected cells as 
was observed in the transfected cells (data not shown). We infected cells with RI257-
MIR or 776 and harvested total RNA at 40 hpi. Next, the RNA was size-fractionated to 
isolate RNAs that encompass the pre-miRNA and miRNA size classes. We generated 
cDNA libraries from these small RNAs and conducted next generation deep sequencing 
(Figure 2.3). We note that read counts from next generation sequencing are not 
necessarily linearly quantifiable due to intrinsic biases in small RNA library generation 
(Hafner et al., 2011; Jayaprakash et al., 2011; Linsen et al., 2009; Sorefan et al., 2012; 
Sun et al., 2011; Willenbrock et al., 2009). Nonetheless, consistent with the Northern blot 
analysis, the sequencing reads demonstrated 2 major products for RI257 (a 5p and 3p 
derivative) and two major products for 776 (two different 3p derivatives). This analysis 
demonstrated that the two major miRNA derivatives from RI257 (the 5p and 3p 
derivatives) both possess seeds that differ from 776 (Figure 2.3). As would be predicted 
from its aberrant migration in the northern blot analysis (Figure 2.2A), the RI257 5p 
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miRNA seed differs substantially from its 776 5p counterpart, with 3 of the 7 nucleotides 
altered. 776 produces two 3p derivatives, one that is 21 nucleotides long and more 
abundant (776-3pS) and one that is 22 nucleotides long (776-3pL). The RI257 3p 
derivative seed differs most substantially from the most abundant 776-3pS, with 5 of the 
7 nucleotides altered and by 1 nucleotide from the less abundant 776-3pL seed. Thus, in 
addition to the altered ratios of 5p and 3p derivatives, RI257 also produces miRNA 






Figure 2.3 Strain RI257 miRNAs have a unique seed composition compared to 
other SV40 isolates produces a 5p dominant arm and possess a novel seed. 
Coverage plot of the deep sequencing reads from 776 and RI257-MIR infected BSC-40. 
The number of reads that mapped to the 776 (A) and RI257 (B) genomes are plotted on 
the y-axes. The x-axes indicate either the 776 or the RI257 genomic position. For better 
visualization of peak separation, an enlarged inset containing the pre-miRNA region 
(200bp, gray dotted lines) is shown (top panels). The start counts of each miRNA are 
indicated by the black bars and the coverage is represented by the gray filled area. The 
776 strain produces 2 dominant 3p arms (black, dashed arrows) but RI257 produces 
robust amount of both the 5p (black, solid arrow) and 3p (black, dashed arrow) arms, 
with a 5p dominance. The miRNA sequences are indicated above the plots, with the seed 
sequences represented in bold and underlined.
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2.2.3 SV40 strains RI257 and 776 possess divergent miRNA targetomes. 
Previous studies demonstrate that even a single nucleotide change in a miRNA 
seed region can dramatically alter which transcripts are targeted (Baek et al., 2008; 
Bartel, 2009; Hafner et al., 2010; Lewis et al., 2005; Selbach et al., 2008). Therefore, we 
sought to determine if, as would be predicted, that the RI257 miRNAs possess a different 
target repertoire. BSC-40 African green monkey kidney epithelial cells were infected 
with a control miRNA null mutant virus “SM” (Sullivan et al., 2005), RI257-MIR, or 776 
and total RNA was harvested at 44hpi. Biotinylated cRNA was generated from total RNA 
and microarray expression analysis was conducted. Lim et al. previously demonstrated 
that a sizable fraction of miRNA target transcripts display subtle decreases in steady state 
levels upon expression of the miRNA (Lim et al., 2005). It has been estimated that ~60% 
of miRNA regulation occurs through perfect seed complementarity binding to the target 
and many of these interactions map to the 3’ UTR (Bartel, 2009; Zisoulis et al., 2010). 
The African green monkey genome is not yet released, however, a sampling of 10 
different orthologs shows that the 3’ portion of these genes share ~94% identity with 
human and rhesus macaque genes (Spindel et al., 2005). Since the African green monkey 
3'UTRome is not yet annotated, we utilized the human annotation of 3’ UTRs (Genome 
Reference Consortium Human Build 37 patch release 10 (GRCh37.p10)(Flicek et al., 
2012)). We identified likely target transcripts as those that were reduced by 40% or more 
at the steady state level (reduced transcripts). Plotting the number of individual reduced 
transcripts whose 3’ UTRs contain one or more copies of each possible heptamer (of 
16384 total) identified a clear “signature” of seed complementarity, thus confirming the 
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validity of using the human 3' UTR annotations. Transcripts containing the 776-3pL and 
776-3pS seed complements were the first and second, respectively, most represented in 
776-infected cells (n =22 of 117 total). Conversely, transcripts containing the RI257-5p 
and RI257-3p were the first and second, respectively, most represented in RI257-infected 
cells (n =26 of 409). This result is consistent with the increased abundance of RI257 5p 
derivatives relative to 776. Additionally, this analysis showed that the specific miRNA 
seed complement heptamers from the relevant infecting virus exceed all other possible 
16384 heptamers (n= 15-17 transcripts per relevant complementary heptamer versus the 
overall median of 4 or less transcripts for all heptamers), arguing that our approach is 
truly identifying some bona fide targets of these viral miRNAs. 
We next determined if the miRNA target transcripts are different between the 
RI257 and 776-infected cells. Only 3 out of 26 total putative RI257 target transcripts 
overlap with the 22 putative 776 target targets (Figure 2.4A). From this analysis, 
consistent with what would be predicted from having different seed repertoires, we 
conclude that a sizable fraction of host transcripts targeted by viral miRNAs from the 
RI257 and 776 strains are different.  
To test whether similar results would be obtained in a different cellular context, 
we utilized human embryonic kidney cells (HEK293T). Cells were co-transfected with a 
plasmid expressing the relevant miRNA and plasmid expressing EGFP to mark 
transfected cells. Cells were sorted based on EGFP levels to enrich for transfected cells. 
We harvested total RNA from these cells and analyzed a portion via northern blot, and 
subjected the remainder to microarray expression analysis. Northern blot analysis 
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confirmed enrichment for miRNA-expressing cells (data not shown). When comparing 
either RI257 or 776 miRNA-transfected cells to the negative control BPCV1 miRNA-
transfected cells, we observed a distinct “seed complement” signature of “top hits” in 
host mRNAs specific to each viral miRNA at the > 40% reduction cutoff (Figure 2.4B). 
This analysis reveals just 1 of 24 total putative RI257 targets overlap with 1 of 19 total 
putative 776 targets. Consistent with the infection data (Figure 2.4A), these data suggest 




Figure 2.4 Different miRNA target repertoires for SV40 strains 776 and RI257. 
(A) BSC-40 cells were infected with 776 (top panel) or RI257-MIR (bottom panel), total 
RNA from 44hpi were reverse transcribed to cDNA and subjected to microarray analysis. 
All possible combinations of heptameric sequences are plotted on the x-axis, the number 
of transcripts containing each corresponding seed complements is plotted on the y-axis. 
The number of transcripts containing the 776-3pL (red), 776-3pS (purple), RI257-5p 
(green) and RI257-3p (blue) seed complements are indicated. The sum of numbers of 
transcripts downregulated by 40% or more is indicated by “n”. The white arrowhead 
marks the enriched peak for each plot. The median number of transcripts for each 
heptamer is indicated by the dashed line (776=2.29, RI257=2.498). (B) 293T cells were 
transfected with 776 (top panel) or RI257 miRNAs (bottom panel) expression vectors, 
total RNA from 48 hours post transfected cells were subjected to the same microarray 
analysis as described above. 
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Combined, our microarray analysis identified only 4 host transcripts that are 
possibly regulated by both the 776 and RI257 miRNAs. Luciferase reporter analysis 
showed that only the 3' UTR of one of these, DUSP8, is regulated by both the 776 and 
RI257 miRNAs (Figure 2.5D). Because all four of these 3' UTRs have an above average 
length (2081nt versus an average of 800 nucleotides for all annotated human 3' UTRs 
(Mignone et al., 2002), see Tables S3 and S4), it is possible that our target identification 
assay is biased towards false positives for longer 3' UTRs. Irrespective, our DUSP8 3' 
reporter results suggest that a minority of host targets can be shared in common between 
the RI257 and 776 miRNAs.  
We considered the possibility that the RI257 and 776 miRNAs have different 
targets but effect the same pathways. However, functional classification of gene lists 
from both our transfection and infection studies (DAVID Bioinformatics Resources 6.7 
(Huang et al., 2008, 2009)) did not reveal any significant common functional groups 
(data not shown). We note that our approach likely underestimates the repertoire of 
possible targets. To minimize false positives, we applied a high stringency cutoff (40% 
reduction) and furthermore, our approach would miss those targets whose binding is not 
dependent on perfect seed complementarity docking in the 3’UTR. Therefore, it remains 
possible that some important shared host transcripts or pathways are targeted by both 
RI257 and 776 miRNAs. Nonetheless, our data clearly suggest that many host transcripts 
are uniquely targeted by 776 or RI257. 
We next determined if some of the putative RI257-specific and 776-specific 
targets are indeed directly and specifically regulated via their 3' UTRs by each respective 
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miRNA. We generated 3’ UTR reporter constructs for five of the candidate targets 
identified from the transfection study (two 776-specific and three RI257-specific). As 
expected, none of the five reporters were regulated by both the 776 and RI257 miRNAs 
(Tables S3 and S4). One of the 776 targets, archain 1 (ARCN1), and all three of the 
RI257 targets (ACTN4, C1orf86 and C9orf140) scored positive for specific negative 
regulation (Tables S3 and S4 and data not shown). For two of the targets, ARCN1 and 
C9orf140, we also generated negative control mutant reporters altering two nucleotides in 
each of the seed complementary regions (Figure 2.5A). These mutant 3'UTR reporters 
were at least partially refractory to SV40 miRNA regulation, thereby demonstrating that 
this regulation is direct (Figure 2.5B, C). Importantly, the ARCN1 3' UTR reporter was 
only significantly regulated by the 776 miRNA and conversely the C9orf140 was only 
significantly negatively regulated by the RI257 miRNA (Figure 2.5B, C). These results 
demonstrate that closely related strains of the same virus can have different direct 





Figure 2.5 Luciferase reporter assays confirm unique 776 or RI257 miRNA 
host targets.  
(A) Diagram of the 3’ UTRs of ARCN1 (776 unique target) and C9orf140 (RI257 unique 
target). The vectors consist of a Renilla luciferase reporter upstream of a single copy of 
an approximately 1kB fragment of the 3’ UTR of ARCN1 or C9orf140 (WT). The seed 
complements in the 3’ UTRs are underlined and base pairings between the 3’ UTRs and 
the miRNAs are indicated by vertical lines. The nucleotide changes in the seed mutant 3’ 
UTR reporter (Mut) are indicated in bold and italicized. (B, C) The reporters from panel 
A were co-transfected with firefly luciferase expression vector individually into 293T 
cells, and the Renilla luciferase readings were normalized to the readings from the firefly 
luciferase (FF. Luc) and plotted (y-axis). The x-axis indicates the different Renilla 
luciferase (R. Luc) reporter constructs. The plasmids expressing either the 776 or the 
RI257 miRNAs are indicated by the gray and the black graphs respectively. As a negative 
control, empty expression vector was used and indicated by the white bars. (D) The 
Renilla luciferase reporter containing the 3’ UTRs from two of the predicted 776 and the 
RI257 miRNAs overlapping target transcripts, EID2B and DUSP8, were co-transfected 
with firefly luciferase expression vector individually into 293T cells. The bar graphs were 
constructed as in figures 2.5B and C. P values are computed using Student’s t test. “***” 
indicates P < 0.0001, “**” indicates P < 0.001, “*” indicates P < 0.05. 
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2.2.4 SV40 strain RI257 autoregulates early mRNA expression similar to strain 776.  
As is true with all known polyomaviral miRNAs, both 776 and RI257 miRNAs lie 
antisense to the early transcripts. Therefore, as has previously been shown for 776, the 
RI257 miRNAs would be predicted to negatively regulate the early transcripts via an 
“siRNA-like” cleavage mechanism to some degree. However, it has been shown that 
siRNAs with different seed compositions can have major differences in the efficiency 
with which their target transcripts are cleaved (Haley and Zamore, 2004; Harborth et al., 
2003; Holen et al., 2002; Reynolds et al., 2004; Schwarz et al., 2006). We determined the 
efficiency of miRNA-mediated cleavage of early transcripts in 776 versus RI257-MIR-
infected cells. BSC-40 African Green Monkey kidney epithelial cells were infected and 
total RNA was harvested. Next, northern blot analysis was performed and the proportion 
of miRNA-mediated 3’ early mRNA cleavage fragments relative to full-length early 
mRNA was determined. As previously demonstrated (Sullivan et al., 2005), the control 
miRNA mutant SM virus produced no detectable early mRNA cleavage fragments, while 
infection with 776 produced readily-detectable amounts (Figure 2.6A). Importantly, 
infection with RI257-MIR also resulted in early mRNA cleavage, suggesting that the 
RI257 miRNA mediates cleavage similar to the 776 miRNA. Quantification of the ratio 
of cleaved early mRNA fragment:full-length mRNA bands demonstrated that both the 
776 and RI257 miRNAs display robust activity with ~50% of total early mRNA being 
cleaved by 60hpi (Figure 2.6B). Thus, despite having different seeds, the 776 and RI257 





Figure 2.6 SV40 strain RI257 autoregulates early mRNA expression similar to 
the reference strain 776.  
(A) Northern blot analysis of early mRNA cleavage. BSC-40 cells were either mock 
infected, infected with 776, miRNA mutant virus SM, or RI257-MIR at an MOI of 10. 
Total RNA harvested from 12, 36 and 60hpi was subjected to Northern blot analysis. A 
pool of 5 probes were designed to recognize the 3’ cleavage fragment of the SV40 early 
mRNA. The uncleaved SV40 early mRNA is indicated by the black arrowhead, and the 
SV40 early cleavage fragment is indicated by the white arrowhead. The 3.0kb and 0.2kb 
RNA marker positions are marked on the left hand side of the blot. As a load control, the 
ethidium bromide-stained 5s rRNA band is shown in the bottom panel. (B) A graphical 
representation of the progression of SV40 early mRNA cleavage as a percentage. The 
band signals from the Northern blot analysis were quantified and plotted in a bar graph 
format. The x-axis indicates the hours post infection and the y-axis indicates the amount 
of early mRNA cleavage for 776 (triangle) and RI257-MIR (square) as a percentage (%) 
of the total amount of early mRNAs (both cleaved and uncleaved).  
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2.2.5 Unlike 776, RI257 autoregulates early mRNA expression through both 5p and 
3p miRNA-mediated cleavage.  
Previously, both the 5p and 3p 776 miRNAs were shown via RNase protection 
mapping to be able to direct cleavage of the early mRNAs (Sullivan et al., 2005). 
However, our results demonstrating that the majority of 776 miRNAs derive from the 3p 
arm of the pre-miRNA predict that this arm of the 776 miRNAs should be more active in 
directing this mode of autoregulation. Conversely, RI257 expresses robust level of both 
the 5p and 3p arms of the pre-miRNA (Figure 2.2A and 3). This might suggest that the 3p 
miRNA is not the only active arm, but rather that the 5p arm of the pre-miRNA is active 
as well. However, the efficiencies of miRNA/siRNA-mediated cleavage can vary 
depending on sequence composition (Haley and Zamore, 2004; Harborth et al., 2003; 
Holen et al., 2002; Reynolds et al., 2004; Schwarz et al., 2006). To determine if both the 
5p and 3p miRNAs direct cleavage of 776 and RI257 early mRNAs, a modified RACE 
protocol was utilized. This protocol enriches for and maps the 5’ ends of miRNA-
mediated cleavage fragments. Consistent with the previously published RNase protection 
assays (Sullivan et al., 2005), early cleavage fragments mapping opposite the miRNA at 
approximately the 10th nucleotide position (the “scissile phosphate” (Hornstein et al., 
2005; Yekta et al., 2004a) (previously shown to be a hallmark of miRNA-mediated 
cleavage (Barth et al., 2007; Seo et al., 2008; Sullivan et al., 2009)) showed that both the 
5p and 3p SV40 miRNAs are active in 776-infected cells, albeit the majority of clones 
(14/15) mapped opposite to the 3p miRNA derivatives (Figure 2.7A). In contrast, all 
clones (15/15) for RI257 map opposite the 5p miRNA. Because RACE could be subject 
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to inherent cloning biases, these results do not rule out that the RI257 3p miRNAs are 
active at directing early mRNA cleavage, but they do establish that the 5p miRNA of 
RI257 is effective at directing early mRNA cleavage. To assess these apparent 
differences between the 776 3p and RI257 5p-dominant effects in a more quantitative 
fashion, we developed a luciferase reporter assay (Figure 2.7B). For this assay, two 
reporters were created; one that can indicate cleavage mediated by the 776 and/or RI257 
5p miRNAs, and one that can indicate cleavage by the 776 and/or RI257 3p miRNAs. 
Co-transfection of these reporters with a negative control MCPyV miRNA showed no 
effect (Figure 2.7C). Similarly, co-transfection of either the 776 or RI257 miRNA 
expression vector had no effect on the negative control vector 3’ UTR reporter. However, 
co-transfection of either the RI257 or 776 miRNA-expressing vector demonstrated the 
ability to negatively regulate both the 5p and 3p reporters. Importantly, we observed a 
substantially greater effect for the 776 miRNA on the 3p reporter over the 5p reporter 
(90% reduction versus 35% reduction). Conversely, a greater effect for RI257 was 
observed on the 5p reporter over the 3p reporter (83% reduction versus a 76% reduction). 
Remarkably, these results demonstrate that although near-identical fractions of the 776 
and RI257 early mRNAs are cleaved in infected cells (Figure 2.7C), the individual 
cleavage events comprising this regulation are mediated more so by the 3p miRNA 






Figure 2.7 RI257 predominantly autoregulates early mRNA expression 
through 5p miRNA-mediated cleavage.  
(A) 5’ RACE analysis maps the cleavage of the early mRNA by the RI257 5p miRNA. 
The early transcript is indicated by the long black arrow (going from left to right), the 5p 
(black arrow) and 3p (gray arrow) miRNAs (going from right to left) are shown below 
the early transcript. The cleavage sites mediated by the 5p miRNA (black arrowheads) 
and the 3p miRNA (gray arrowheads) are shown above the early transcript. The cleavage 
position is indicated as “10th” and “11th” nucleotide position starting from the 5’ end of 
the miRNAs. The number of 5’ RACE clones that mapped to the respective cleavage 
sites are indicated beside the arrowheads. (B) Diagram of a luciferase reporter construct 
with the concatamerized 3’ UTR containing either two 5p miRNA binding sites or two 3p 
miRNA binding sites each from both 776 and RI257 (4 binding sites total per reporter). 
The vector consists of the same Renilla luciferase reporter as described in Figure 2.5. (C) 
RI257 autoregulates early mRNA expression predominantly through the 5p miRNA. The 
reporters from panel B were co-transfected with firefly luciferase expression vector 
individually into 293 cells, and the Renilla luciferase readings were normalized to the 
readings from the firefly luciferase (FF. Luc) and plotted (y-axis). The x-axis indicates 
the different Renilla luciferase (R. Luc) reporter constructs. The plasmids expressing 
either the 776 miRNAs (776) or the RI257 miRNAs (RI257) are indicated by the gray 
and black bars respectively. As a negative control, empty expression vector (empty) was 
used and indicated by the white bars. To show specificity of the 776 and the RI257 
miRNA on the reporters, a Renilla luciferase reporter construct carrying MCV miRNA 




There are over three hundred virus-encoded miRNAs that are known, each with 
the potential to regulate hundreds of transcripts (Cullen, 2011; Grundhoff and Sullivan, 
2011; Kincaid and Sullivan, 2012). Many miRNAs derive from viruses of relevance to 
human health, including those from the herpes and polyoma virus families. Additionally, 
considering recent studies demonstrating that experimentally derived RNA viruses 
(Langlois et al., 2011; Varble et al., 2010) and some natural retroviruses (Kincaid et al., 
2012) can generate robust miRNA levels, it seems likely that numerous additional viral 
miRNAs await discovery. Despite much progress in identifying new viral miRNAs, few 
have well understood functions. A major advance in understanding miRNA function 
occurred with the observation that some miRNA targets display subtle decreases in 
steady levels upon miRNA binding (Gottwein et al., 2007; Lim et al., 2005; Samols et al., 
2007) thereby making target identification amenable to high throughput detection 
methods. In addition, recent high throughput positive enrichment strategies either with 
(Gottwein et al., 2011; Haecker et al., 2012; Riley et al., 2012; Skalsky et al., 2012) or 
without crosslinking (Dölken et al., 2010a) have shown much success in identifying viral 
miRNA target transcripts associated with protein components of the silencing machinery. 
However, it remains unclear what fraction of these targets are important during the 
infectious cycle. 
Here we present data that further emphasize the importance of viral miRNA-
mediated autoregulation of polyomavirus early transcripts. Our approach is to identify 
closely related strains of viruses that possess different seed repertoires. Since the seed 
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region plays a major role in dictating target interactions, variants with different seed 
repertoires would be expected to have different miRNA targets. This approach assumes 
that targets (host or viral) preserved throughout evolution will be important; while the 
less relevant, or possibly “niche specific” targets will be unique to each strain. Using this 
approach for SV40, we identify a class of circulating variants, typified by RI257, which 
differ substantially from other classes of SV40 miRNAs. Unlike 776, in which the vast 
majority of miRNAs are derived from the 3p arm of the pre-miRNA, RI257 gives rise to 
abundant miRNAs detectable from both arms. In addition, both the 5p and 3p RI257 
miRNA derivatives possess different seed sequences than 776. We show that, as would 
be predicted by the different seeds, 776 and RI257 miRNAs have some targets unique to 
each respective virus. While this clearly demonstrates that some miRNA targets are 
unique to each strain, it remains to be addressed if these unique targets play any role in 
the polyomavirus lifecycle.  
As RI257 has been isolated independently in different geographical regions 
(Fagrouch et al., 2011), we conclude that RI257-like viruses are circulating in the wild. 
Thus, the different repertoires of host targets for 776 and RI257 miRNAs demonstrate 
that wild circulating strains of SV40 can tolerate different “targetomes” (Figure 2.4). 
These data suggest that some viral miRNA targets may be of little selective advantage to 
the virus. This is consistent with the notion that some viral miRNA targets could be 
neutral or even disadvantageous to the virus, as long as the sum total of regulation 
imparted by the targets is of sufficient benefit (Kincaid and Sullivan, 2012). Here, we 
present data only for some targets of SV40 in cultured cells, and it remains to be seen if 
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this applies in vivo or to viruses other than members of the Polyomaviridae. However, in 
light of our findings, a note of caution is warranted as to meaningfulness of viral miRNA 
targets identified via high throughput studies in the absence of secondary criteria.  
Our study reveals at least one important miRNA target common to both 776 and 
RI257– the early viral mRNAs. Strikingly, despite being mediated predominantly by 
different miRNA derivatives (the 5p miRNA for RI257 and the 3p for 776), and via 
different seed repertoires, the cleavage efficiency of the early mRNAs (~50%) is 
approximately equal for both strains (Figure 6B). This suggests evolutionary pressure to 
maintain a consistent level of this mode of autoregulation. This finding is especially 
noteworthy given the variance in cleavage efficiency that can be associated with siRNAs 
of different sequence (Haley and Zamore, 2004; Harborth et al., 2003; Holen et al., 2002; 
Reynolds et al., 2004; Schwarz et al., 2006). Our results do not rule out important roles 
for select host targets. On the contrary, we speculate that targeting select host transcripts 
may be an essential function of the polyomaviral miRNAs during persistent infection 
(discussed below, Figure 2.8). However, combined with previous studies on other 
polyomaviruses and polyoma-like viruses (Cantalupo et al., 2005; Chen et al., 2011; Seo 
et al., 2008, 2009; Sullivan et al., 2005, 2009), our findings underscore the likely 





 This work establishes that closely related viruses can tolerate different repertoires 
of miRNA targets. The reason why such similar viruses can have different miRNA 
targets is unknown. We propose at least two non-mutually exclusive explanations could 
account for this: First, although these viruses are closely related and fully infectious in 
the same host (Rhesus Macaques), it is possible that these viruses occupy different 
niches. In this scenario, miRNAs could be considered drivers of evolution (e.g., altered 
tissue tropism), perhaps even contributing to the process of viral speciation (Kincaid and 
Sullivan, 2012). Second, any particular individual miRNA target could be of no selective 
advantage to the virus, as long as the sum total of regulation imparted by the miRNA on 
other transcripts is advantageous (Kincaid and Sullivan, 2012). Both of these models may 
be relevant to other virus families in addition to the Polyomaviridae.  
Combined with previous published studies (Cantalupo et al., 2005; Chen et al., 
2011; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009), the findings from this study are 
consistent with the following model for polyomaviruses: First, the striking consistency 
between RI257 and 776 of the fraction of early transcripts that are subject to miRNA-
mediated cleavage implies that maintaining an optimal degree of this regulation provides 
a selective advantage. Since these results were obtained during lytic infection, we 
propose that one function of the SV40 miRNA could be to optimize the abundance of 
early mRNAs and/or early proteins during lytic infection (or at minimum to avoid 
excessive cleavage of the early transcripts). Second, a non-mutually exclusive model is 
for a role of the miRNA during persistent infection (Broekema and Imperiale, 2013; 
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Grundhoff and Sullivan, 2011; Kincaid and Sullivan, 2012). Although the mechanisms 
are poorly defined, SV40 and other polyomaviruses establish long-term persistent 
infections in vivo. Clearly, negatively regulating early gene transcripts could be a way to 
enforce persistence, akin to the role that has been proposed for some herpesviral miRNAs 
(Dölken et al., 2010b; Kincaid and Sullivan, 2012; Murphy et al., 2008). Indeed, a recent 
report from Brokema and Imperiale for the BK human polyomavirus is consistent with 
this notion (Broekema and Imperiale, 2013). Furthermore, considering the robust changes 
in host gene expression associated with lytic infection (Chandriani and Ganem, 2007; 
Ebrahimi, 2003; Marcinowski et al., 2012; Marquitz et al., 2012; Poole et al., 2002) 
compared to the generally more subtle degree of regulation imparted by miRNAs, it 
seems likely that viral miRNA regulation of select host targets may be most relevant 
during persistent infection. In this model, viral miRNA targeting of the early transcripts 
and select host transcripts plays a role in promoting and/or reinforcing persistent 
infection. This could occur analogous to some herpesviral miRNAs, in which host targets 
are associated with increased cell viability, immune evasion and indirectly negatively 
regulating viral lytic genes (Kincaid and Sullivan, 2012; Lei et al., 2010; Murphy et al., 
2008). Clearly, such models await future testing in relevant persistent models of 
polyomavirus infection.  
In conclusion, a surprising degree of plasticity in miRNA targets can be tolerated 
by closely related viruses, yet at the same time, the capacity to regulate common viral 
transcripts is maintained. This work not only advances our understanding of the 
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Figure 2.8 Model for the roles of SV40 miRNAs during different replication cycles.  
During lytic infection, the SV40 miRNAs serve to optimize the level of early viral transcripts and/or early viral proteins in the 
infected cells (left panel). In another non-mutually exclusive model, the SV40 miRNAs could aid in the establishment and or 
maintenance of persistent infection, by negatively regulating both the early viral transcripts and select host transcripts.
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2.5 MATERIALS AND METHODS 
 
2.5.1 SV40 sequence analysis and alignment.  
63 unique SV40 complete genome sequences were aligned based on a ~120bp 
region encompassing the pre-miRNA, using the Geneious software (Biomatters, New 
Zealand).  
 
2.5.2 Cell culture and RNA isolation.  
Human embryonic kidney (HEK) cells 293 and 293T, African green monkey 
kidney epithelial cells BSC-40, and African green monkey kidney fibroblast cells COS-7, 
were obtained from the American Type Culture Collection (Manassa, VA). All cells were 
maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine 
serum (Life Technologies, New York). Total RNA was harvested using an in-house PIG-
B solution as described previously (Chen et al., 2011; Lin et al., 2010; Seo et al., 2008; 
Weber et al., 1998).  
 
2.5.3 Vector construction, transfection, and High-resolution northern blot analysis.  
All DNA vector constructs were confirmed by sequence analysis through the 
Institute of Cellular and Molecular Biology Sequencing Facility at the University of 
Texas at Austin. The primers used in the construction of the 17 representative SV40 
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microRNA expression vectors are listed. Briefly, the primers are annealed and filled-in 
using Phusion High-Fidelity DNA Polymerase (New England BioLabs, Massachusetts) 
according to the manufacturer’s protocol. The PCR products are cloned into the 
KpnI/XhoI sites of the pcDNA3.1neo expression vector. 
293T cells were plated in 6-well plates and transfected using the Lipofectamine 2000 
transfection reagent (Life Technologies) according to the manufacturer’s instruction. 
293T cells were also transfected with empty pcDNA3.1neo vector as a negative control. 
Total RNA was harvested at 48 hours post-transfection and subjected to a modified 
version of high-resolution Northern blot analysis (Koscianska et al., 2011). Briefly, 30 
micrograms of total RNA was separated on a Tris-borate-EDTA-Urea-15% 
polyacrylamide gel. The bromophenol blue marker was allowed to migrate 30cm along 
the length of the gel. The RNA was transferred into an Amersham Hybond N+ membrane 
(GE Healthcare, Pennsylvania) and probed for miRNA as previously described 
(Grundhoff, 2006). Quantification of the band signals was performed using the Quantity 
One software (Bio-Rad, California) The probe sequences used were as follows: 776-5p 
probe, CAAGGCTCATTTCAGGC; Ri257-5p probe, CAACGCACATTTCAGTC; MC-
028846B-5p probe, CAAAGCTCATTTCAGGC; SV40-3p probe, 
CTCAGGGCATGAAACAGGC.  
 
2.5.4 Construction of the RI257-MIR virus.  
To generate the RI257-MIR chimeric virus, overlapping PCR was used to 
generate 2 fragments joined together via a linker, using Phusion High-Fidelity DNA 
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Polymerase (New England BioLabs). The resulting fragment was inserted into the 
NheI/BstXI sites of the pSVB3 vector, to generate pRI257-MIR. The RI257-MIR 
chimeric virus was produced as described previously (Kraus and Mertz, 2001). Briefly, 
pRI257-MIR was digested with BamHI, followed by intramolecular ligation of the viral 
DNA. The ligation reaction was transfected into BSC-40 and amplified. The primers used 
were as follows: Liner primer: 
GACTGTGAAGATTCGGGGGACTGAAATGTGCGTTGTGATTGTGAGTCAACGC
CTGTTTCATGCCCTGAGTCTTCTAGGTTGTC; Fragment 1 forward primer, 
TATCGTCCATTCCGACAG; Fragment 1 reverse primer, 
CACATTTCAGTCCCCCGAATCTTCACAGTCTGTTTATGATCACAATCAACCAT
ATCACATTTGTAAAGGTTTTACTTGCTTTAAAAAACC; Fragment 2 forward 
primer, 
TGTTTCATGCCCTGAGTCTTCTAGGTTGTCATTCCCCGCCTGTTTTTCCTGCAC
ATTTTCCTCCTCAGCATCATCATCACTGTTTCTTAG; Fragment 2 reverse primer, 
ACTGCAAACAATGGCCTG.    
 
2.5.5 5’ rapid amplification of cDNA ends (RACE) analysis to map the cleavage site of 
early transcripts.  
BSC-40 cells were seeded in T25 tissue culture flask and infected with 776 or the 
RI257-MIR virus at an MOI of 10 as described (SV40 protocol book). Total RNA was 
harvested at 60 hours post infection (hpi) as described above. The total RNA was further 
purified using the Oligotex mRNA Mini Kit (Qiagen, California) according to the 
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manufacturer’s protocol. 5’ RACE was performed using FirstChoice RLM-RACE Kit 
(Life Technologies) according to manufacturer’s protocol. Reverse transcription reaction 
was performed using SuperScript III (Life Technologies) according to the manufacturer’s 
protocol. The reverse transcribed cDNA was subjected to RNaseH (Life Technologies) 
treatment at 37°C for 20 minutes. 1 microliter of the reverse transcription product was 
used as the template for the first round of nested PCR using Taq DNA Polymerase (New 
England BioLabs). 1 microliter of the first round PCR reaction was then used in the 
second round of nested PCR using Taq DNA Polymerase. The PCR products from both 
rounds were TA cloned into pCR2.1-TOPO using the TOPO TA Cloning Kit (Life 
Technologies) according to the manufacturer’s protocol. A combined 15 clones from 
each infection sample were sequence analyzed through he Institute of Cellular and 
Molecular Biology Sequencing Facility at the University of Texas at Austin. The primers 
used were as follows: reverse transcription primer, 
GCTTTATTTGTAACCATTATAAGCTGCAATAAACAAGT; 5’ RACE first round 
PCR forward primer, GCTGATGGCGATGAATGAACACTG; 5' RACE first round 
reverse primer, TAACAACAACAATTGCATTCATTTTATGTTTCAGGTTC; 5’ RACE 
second round PCR forward primer, 
CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATG; 5’ RACE second round PCR 
reverse primer, AGGGGGAGGTGTGGGAGGTTTTTTAAAGCAAGTAAAAC.     
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2.5.6 Luciferase assays.  
The cellular 3’ UTR reporters were constructed by cloning fragments of the 
corresponding genomic regions of the targets from 293T genomic DNA using the primers 
listed. Briefly, the PCR products are generated using KOD Hot Start DNA Polymerase 
(EMD Millipore, Massachusetts) according to the manufacturer’s protocol, and cloned 
into the pcDNA3.1dsRluc vector, which expressed a destabilized version of Renilla 
luciferase. The ARCN1 seed mutant reporter contains engineered point mutations at the 
fourth and fifth nucleotides complementary to the 5’ end of the 776-3pL miRNA. The 
C9orf140 seed mutant reporter contains engineered point mutations at the second and 
third nucleotides complementary to the 5’ end of the RI257-5p miRNA. The seed mutant 
reporters were constructed by using the corresponding wild type reporter as template for 
site-directed mutagenesis using PfuUltra II Fusion HS DNA Polymerase (Agilent 
Technologies, California), according to the manufacturer’s protocol. 293T cells were 
plated in 24-well plates and transfected using the TurboFect transfection reagent (Thermo 
Scientific, Pennsylvania) according to the manufacturer’s protocol. Cells were 
transfectetd with the reporter and the miRNA expression vector. 293T cells were also 
transfected with the empty reporter as a negative control. The pcDNA3.1Luc2CP vector 
was also cotransfected to normalize for transfection efficiency. Cells were collected 24 
hours posttransfection and analyzed with the Dual-Luciferase reporter assay system 
(Promega, Wisconsin) according to the manufacturer’s instruction. The luciferase 
readings were collected using a Luminoskan Ascent microplate luminometer (Thermo 
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Scientific). Results from the Renilla luciferase were normalized to the firefly luciferase 
readings, and the ratios were plotted as a bar graph to the empty vector control.  
The 776/RI257 5p miRNA perfect-match reporter contains 2 miRNA binding 
sites that are perfectly complementary to the 776-5p miRNA and 2 miRNA binding sites 
that are perfectly complementary to the RI257-5p miRNA. The 776/RI257 3p miRNA 
perfect-match reporter is likewise, except with perfect-match to the 3p miRNAs. The 
reporters were generated by first annealing synthesized oligonucleotides carrying the 
miRNA sites, followed by PCR amplification and addition of restriction sites at both 
ends, using Phusion High-Fidelity DNA Polymerase (New England BioLabs). The PCR 
products were cloned into the pcDNA3.1dsRluc vector via the XhoI/XbaI sites. The dual-
luciferase assay was performed in 293 cells as described above. 293 cells were also 
transfected with the reporters along with the MCV miRNA expression vector as a 
negative control. As a second negative control, the MCV miRNA reporter containing 
binding sites that are perfectly complementary tot the MCV miRNA was transfected as 
well. The primers used were as follows: 5p reporter forward oligonucleotide, 
CCCAAGGCTCATTTCAGGCCCCTCAGTCCTGTCCCCAAGGCTCATTTCAGGCC
CCTCAGTCCTGTGATCACAACGC; 5p reporter reverse oligonucleotide, 
GATTCGGGGGACTGAAATGTGCGTTGTGATGAGGATTCGGGGGACTGAAATG
TGCGTTGTGATCACAGGACTGTGG; 5p reporter forward primer, 
ATCGCTCGAGCCCAAGGCTCATTTCAGGCCCCTCAGTCCTGTC; 5p reporter 
reverse primer, 




AACAGGCATTGAGTGGAAGACTCAG; 3p reporter reverse oligonucleotide, 
GTCAACGCCTGTTTCATGCCCTGAGTCTTCGAGGTCAACGCCTGTTTCATGCC
CTGAGTCTTCCACTCAATGCCTG; 3p reporter forward primer, 
ATCGCTCGCGGGAAGACTCAGGGCATGAAACAGGCATTGAGTC, 3p reporter 
reverse primer, ATCGTCTAGAGTCAACGCCTGTTTCATGCCCTGAGTCTTCGAG.    
 
2.5.7 SV40 infections.  
BSC-40 cells were seeded in 6-well plates. The cells were infected with either 
776, a miRNA null mutant “SM” (Sullivan et al., 2005)  and the RI257-MIR virus at an 
MOI of 10 when the cells were freshly confluent. The media from the plates were 
aspirated and 500μL of virus inoculum was used per well. The plates were rocked back-
and-forth every 15 minutes for 2 hours at 37°C (Tremblay et al., 2001). The virus 
inoculum was replaced with DMEM with 2%FBS. The titers of all 3 viruses are ~1.0 x 
108 pfu/mL. The viruses were titered using a modified version of the protocol (Drayman 
et al., 2010). Briefly, BSC-40 cells were seeded in 6-well plates and infected with serially 
diluted 776, SM or RI257-MIR as described above. The infected cells were collected by 
trypsinization and fixed in 4% paraformaldehyde in PBS for 20 minutes at 37°C. The 
fixed cells were then permeabilized using 3%BSA in PBS with 0.1% Triton-X-100 at 
room temperature for 10 minutes. The cells were washed with PBS and stained for large 
T antigen using the pAb416 antibodies (kindly provided by Dr. Jim Pipas, University of 
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Pittsburgh) for 1 hour at room temperature. The cells were then washed 3 times with 
PBS, followed by secondary antibody incubation with AlexaFluor 488 goat anti-mouse 
(Life Technologies) for 1 hour at room temperature. The cells were washed 3 times with 
PBS and analyzed using a BD LSRFortessa Cell Analyzer (BD Biosciences, California).     
 
2.5.8 Small RNA library generation and computational analysis of sequencing reads.  
BSC-40 cells were seeded in T75 tissue culture flask and infected with either 776 
or RI257-MIR at an MOI of 10 as described above. Total RNA from 776 and RI257-MIR 
infected BSC-40 was harvested at 40hpi. 200 micrograms of total RNA was gel 
fractionated to isolate small RNAs. The small RNAs from 776 infection was subjected to 
SOLiD sequencing as previously described (Chen et al., 2011; Lin et al., 2010). The 
small RNAs from RI257-MIR infection was subjected to Illumina sequencing as 
described (Burgos et al., 2013).  
 
2.5.9 Fluorescence-activated cell sorting and microarray analysis.  
293T cells were seeded in 10cm dishes and transfected with either empty 
pcDNA3.1neo vector, BPCV1 miRNA expression vector, 776 miRNA expression vector 
or RI257 miRNA expression vector using X-tremeGENE 9 transfection reagent (Roche, 
Indiana). pEGFP vector that expresses an enhanced version of the green fluorescent 
protein (GFP) were co-transfected as a transfection control. Cells were trypsinized at 48 
hours posttransfection and sorted based on the GFP signal. Cell sorting was performed by 
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the Institute of Cellular and Molecular Biology FACS facility at the University of Texas 
at Austin. Total RNA was harvested from the GFP-positive sorted fraction. 10 
micrograms of the total RNA was treated with DNase (Qiagen) followed by purification 
using the RNeasy MinElute Cleanup Kit (Qiagen) according to the manufacturer’s 
instructions. RNA integrity was verified on a 1.0% denaturing MOPS-formaldehyde-
agarose gel electrophoresis. The purified RNA was used as a template to make biotin 
labeled cRNA using an Illumina TotalPrep RNA Amplification Kit (Ambion) according 
to the manufacturer's guidelines. Labeled cRNA was precipitated overnight with 
isopropanol and sodium acetate. Biotinylated cRNA is hybridized to Illumina HumanHT-
12 v4.0 microArray chips at the KECK Institute (Yale University) according to Illumina's 
protocols. Quality control and data analysis were carried out according to the instructions 
provided by Illumina. 
BSC-40 cells were seeded in T25 tissue culture flask and infected with 776 or the 
RI257-MIR virus at an MOI of 10 as described above. Total RNA was harvested at 
44hpi. RNA purification and microarray analysis were performed as described above. 
DAVID functional annotation clustering analysis was performed at the highest stringency 
setting using the online-based software (DAVID Bioinformatics Resources 6.7 (Huang et 
al., 2008, 2009)).  
 
2.5.10 Northern blot analysis of cleavage fragments of early transcripts.  
BSC-40 cells were seeded in T25 tissue culture flask and infected with 776 or the 
RI257-MIR virus at an MOI of 10 as described above. Total RNA was harvested at 12, 
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36 and 60hpi as described above. 2 micrograms of total RNA was subjected to 1.25% 
denaturing MOPS-formaldehyde-agarose gel electrophoresis as described (Molecular 
Cloning manual, third edition chapter 7). The RNA was transferred onto Nytran SPC 
nylon transfer membrane (Whatman, New Jersey) using the TurboBlotter System 
(Whatman) according to the manufacturer’s instructions. The membrane was probed for 
the cleavage fragment of viral early transcripts in ExpressHyb hybridization solution 
(Clontech, California) at 45°C. Quantification of the band signals was performed using 
the Quantity One software (Bio-Rad). The probe sequences used were as follows: SV40 
Early 3p cleavage probe 1, 
GAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATT; probe 2, 
GCTTTATTTGTAACCATTATAAGCTGCAATAAACAAGT; probe 3, 
TAACAACAACAATTGCATTCATTTTATGTTTCAGGTTC; probe 4, 
AGGGGGAGGTGTGGGAGGTTTTTTAAAGCAAGTAAAAC; probe 5, 
CTCTACAAATGTGGTATGGCTGATTATGATCATGAACA. 
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CHAPTER 3 Insights into Polyomaviridae microRNA function 




microRNAs (miRNAs) are small, approximately 22 nucleotide regulatory RNA 
molecules that have been shown to play an important role in numerous fields, including 
virology and immunology (reviewed in Bartel, 2009; Boss and Renne, 2010; Sullivan, 
2008; Taganov et al., 2007). Virus-encoded miRNAs have been identified that target viral 
or host transcripts (Skalsky and Cullen, 2010; Sullivan and Cullen, 2009).  In some cases, 
mutant viruses defective for miRNA production have been shown to have altered 
activities of obvious relevance to virus infection.  
 
 
Chen, C.J., Kincaid, R.P., Seo, G.J., Bennett, M.D., and Sullivan, C.S. (2011). Insights 
into Polyomaviridae MicroRNA Function Derived from Study of the Bandicoot 
Papillomatosis Carcinomatosis Viruses. J. Virol. 85, 4487–4500. 
C.J.C., J.E.C., and C.S.S. conceived the project, C.J.C., J.E.C., and A.M. performed the 
experiments, C.J.C., J.E.C., R.P.K., and C.S.S. analyzed the data, and C.J.C., J.E.C., and 
C.S.S. wrote the manuscript.  
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Some activities associated with virus-encoded miRNAs include evasion of the innate 
immune response (Stern-Ginossar et al., 2007) and controlling the switch from latent to 
lytic infection (Lei et al., 2010; Lu et al., 2010). Thus, miRNAs represent a strategy used 
by several different virus families for optimizing their infectious life cycle. 
miRNA biogenesis has been reviewed in depth see (Carthew and Sontheimer, 
2009; Kim, 2005). In brief, miRNAs are derived from longer primary transcripts (pri-
miRNAs) that contain a hairpin structure called a precursor miRNA (pre-miRNA). The 
nuclear endonuclease Drosha “liberates” the hairpin pre-miRNA (Lee et al., 2003; Zeng 
et al., 2004), which is then exported to the cytoplasm and further processed into the 22 
nucleotide form by the Dicer endonuclease (Bernstein et al., 2001; Hutvagner et al., 
2001). This final miRNA product is stabilized within the cytoplasmic multi-protein RNA 
induced silencing complex (RISC) (Hammond et al., 2000). RISC-bound miRNAs 
associate with mRNA target transcripts, typically by binding to the 3’ untranslated (UTR) 
region with imperfect complementarity (Bartel, 2009). This results in inhibition of 
protein production and the indirect nucleolytic turnover of the targeted transcripts. 
However, though rare in animals, miRNAs encoded by plants and some viruses can also 
bind to target mRNAs with perfect complementarity and direct a specific, RISC-mediated 
endonucleolytic cleavage of that targeted transcript. Typically, this cleavage occurs in the 
coding portion of the transcript. In this mode, miRNAs act via a mechanism that is 
indistinguishable from small interfering RNA (siRNA)-directed transcript cleavage 
(Carthew and Sontheimer, 2009).  
 86 
Polyomaviruses are small, non-enveloped viruses that contain double-stranded 
circular DNA genomes of approximately 5 kilobase pairs (kb), and have been identified 
from various avian and placental mammalian hosts (reviewed in Cole, 1996; Imperiale 
and Major, 2007). We have previously shown that several members of the 
Polyomaviridae, including three human pathogens, encode miRNAs that lie antisense to 
and with perfect complementarity to the early transcripts (Cantalupo et al., 2005; Seo et 
al., 2008, 2009; Sullivan et al., 2005, 2009). The early transcripts give rise to the tumor 
antigen proteins (T antigens). These immunogenic proteins perform various cell cycle 
regulatory and other functions to initiate and carry out viral genome replication. We have 
identified miRNAs from human host viruses: JC virus (JCV) (Seo et al., 2008), BK virus 
(BKV) (Seo et al., 2008), and Merkel cell carcinoma-associated polyomavirus (MCV) 
(Seo et al., 2009); old world monkey host viruses: SA12 (Cantalupo et al., 2005) and 
simian virus 40 (SV40) (Sullivan et al., 2005), as well as the murine polyomavirus 
(muPyV) (Sullivan et al., 2009). In all cases, these miRNAs lie antisense to the early 
transcripts, albeit their position within the genome can vary by thousands of nucleotides. 
Analysis of early transcripts and proteins, as well as chimeric reporters, confirm that 
these miRNAs can direct siRNA-like cleavage of the early T antigen proteins.  This can 
result in a reduction in early protein levels in cell culture models of lytic infection 
(Sullivan et al., 2005, 2009), and thus represents a form of viral autoregulation of gene 
expression.  
The fact that such evolutionarily divergent members of the Polyomaviridae all 
encode autoregulatory miRNAs underscores the likely importance of this mode of gene 
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expression control. However, there are several observations that make the importance of 
this regulation unclear. First, it is possible that some polyomaviruses might not encode 
miRNAs. For example, computational prediction using the Vmir software package 
(Cantalupo et al., 2005; Grundhoff et al., 2006; Sullivan and Grundhoff, 2007) fails to 
identify strong pre-miRNA candidates from the WU virus (unpublished observations). 
Second, the degree of negative regulation imparted on the early gene products is only 
partial; abundant early protein levels are detectable at late times of lytic infection with 
wild type virus, and inhibition of these miRNAs leads to only minor (a few fold or less) 
increases in early protein levels (Seo et al., 2008; Sullivan et al., 2005, 2009). Third, lytic 
infection of cultured cells with mutant SV40 or muPyV viruses (that are defective for 
miRNA production), shows similar kinetics and virus yields when compared to infection 
with wild type viruses (Sullivan et al., 2005, 2009). Finally, acute in vivo infection of 
mice with the miRNA mutant muPyV shows virus yields that are similar to wild type 
virus (Sullivan et al., 2009). In summary, the conserved autoregulatory activity of the 
polyomavirus miRNAs implies importance, however, numerous observations (as 
discussed above) make the degree and context of this importance unresolved.    
To better understand polyoma virus miRNA function, we sought to determine if 
an evolutionarily distant group of viruses that retain some features of the Polyomaviridae 
might also encode miRNAs and employ similar modes of gene regulation. Bandicoot 
papillomatosis carcinomatosis virus types 1 and 2 (BPCV1 and BPCV2) comprise a 
fascinating group of marsupial viruses that share distinct characteristics of both the 
Polyomaviridae and Papillomaviridae (Bennett et al., 2008a; Woolford et al., 2007).  The 
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BPCV viruses encode T antigen early proteins, and have a genomic organization similar 
to polyomaviruses. Like all polyomaviruses, the BPCV genomes consist of an origin 
flanked with promoters of opposing orientation that encode for either the early regulatory 
or late structural gene products. However, the size of the BPCV genome and the genes 
encoding the late proteins (L1 and L2), are most similar to the papillomaviruses. It has 
been theorized that the BPCVs are derived from an ancient co-infection recombination 
event between a polyomavirus and papillomavirus (Bennett et al., 2010). 
Bandicoots comprise a genus of small to medium-sized omnivorous marsupials. 
BPCV1 infects western barred bandicoots (Perameles bougainville), an endangered 
species whose only remaining natural range is on Bernier and Dorre Islands in Western 
Australia.  Infection with BPCV1 is associated with an often fatal papillomatosis and 
carcinomatosis disease that is endemic amongst the western barred bandicoots and has 
therefore hindered repopulation efforts (Woolford et al., 2009). BPCV2 is a related virus 
that was isolated from a papillomatous lesion from a southern brown bandicoot (Isoodon 
obesulus) (Bennett et al., 2008a). BPCV1 and 2 display the hallmarks of a common 
evolutionary ancestor, possessing similar genomic organizations and gene products, and 
are ~85% identical at the nucleotide sequence. Here, we show that both BPCV1 and 2 
encode evolutionarily conserved miRNAs that bind to and negatively regulate transcripts 
containing the 3’ UTR of the large T antigen transcripts. This novel mechanism of T 
antigen regulation lends strong support to the importance of miRNA- mediated 





3.2.1 Discovery of a BPCV1-encoded miRNA. 
To identify miRNAs encoded by BPCV1, we sub-cloned the entire viral genome 
downstream of a heterologous CMV promoter. Two different vectors were created, each 
designed to drive expression of transcripts from either the early or late orientations 
(pBPCV1-Early and pBPCV1-Late) (Fig. 1A). Next, we transfected human embryonic 
kidney cells (293T) with either vector, and then isolated total RNA. The RNA was size-
fractionated to isolate small RNAs (between ~10 – 70 nucleotides in length), which were 
then subjected to next generation sequencing via the massively parallel SOLiD platform. 
Analysis of the pBPCV1-Early and pBPCV1-Late sequencing results showed 39,390 and 
82,208 reads, respectively, that mapped perfectly to the BPCV1 genome. Surprisingly, 
the vast majority of the reads from both the pBPCV1-Early and pBPCV1-Late-
transfected samples mapped to a single 22 nucleotide RNA encoded in the late 
(papilloma-like) orientation at nucleotides 4963 – 4984. This region of the genome lies 
within the second non-coding region (NCR2) that is located in between the 3’ ends of the 
T antigens and L1/L2. (Fig. 1B). Although the distribution of reads from both samples 
was surprisingly similar, we confirmed that the sequencing reads were obtained from 
correct transfection events, since we were able to isolate a few reads that spanned the 
junctions of the plasmid vector backbone and the viral genome (data not shown). The 
relative abundance and size of this small RNA suggested it as a good candidate miRNA. 
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We then analyzed the genomic region surrounding this abundant 22 nucleotide 
RNA and predicted the secondary structure (Fig. 1C). This analysis revealed a predicted 
hairpin structure that possesses features common to many pre-miRNAs including a low 
∆G of -41.20kcal/mol, and a long stem portion (>30 nucleotides) with few large 
asymmetrical bulges. The abundant 22 nucleotide RNA maps to the top portion of the 3 
prime arm of the stem portion of the predicted hairpin (Fig. 1C, indicated in bold). These 
results suggest that the abundant 22 nucleotide RNA could be a miRNA derived from this 
hairpin pre-miRNA. Upon closer inspection of the sequencing reads, we observed 
additional evidence consistent with miRNA production. First, we observed an enrichment 
in 35mer reads (the maximum read length of our library) starting at position 4934 – 4936 
with the highest number of reads in both samples at position 4934. These full-length 
reads are consistent with being derived from the 5’ end of the predicted pre-miRNA 
hairpin structure. Second, we observed a small number of 21 – 23 nucleotide reads with 
5’ start sites co-terminal with the full length reads that mapped to the 5’ arm of the 
predicted hairpin stem, consistent with it being a passenger strand derivative of a putative 
pre-miRNA (typically, processing of a pre-miRNA yields one abundant derivative, the 
“guide strand miRNA”, and a less abundant derivative from the other arm of the stem 
called the “*star strand” or “passenger strand” miRNA). Combined, these results strongly 
suggested that we had identified a pre-miRNA (and its derivatives) that are encoded by 
BPCV1.  
To confirm the authenticity of this candidate miRNA, we conducted Northern blot 
analysis using several different probes (diagrammed in Fig. 1C). When probing with a 
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radiolabeled oligonucleotide that is perfectly complementary to the abundant 22 
nucleotide RNA, we observe a prominent band migrating at 22 nucleotides (Fig. 1F). In 
addition, we see a fainter band migrating at approximately 60 nucleotides that is 
consistent with a pre-miRNA (Fig. 1F). Next, we probed for the other, less abundant 
strand and observed a banding pattern completely consistent with it being a passenger 
strand RNA. Note that there are bands present at ~22 nucleotides and ~60 nucleotides, 
but that the ratio of the smaller band to the larger band is much lower than when probing 
for the guide strand derivative (Fig. 1D). We utilized two negative control probes, one 
designed to recognize the loop portion of the pre-miRNA (which should not be processed 
into a stable, smaller ~22 nt RNA), and one designed to a flanking region just outside the 
predicted hairpin region. As expected, the “loop” probe detected a band consistent with 
the pre-miRNA but did not detect any bands migrating at ~22 nucleotides (Fig. 1E). The 
negative control “flank” probe did not detect any specific bands (Fig. 1G). These results 
strongly suggest that the ~22 and ~60 nucleotide bands we detect are not due to non-
specific degradation or siRNA generation, since in either of these scenarios flanking 
genomic regions should also produce detectable small RNAs. Thus, we conclude we have 
identified a bona fide BPCV1-encoded miRNA, and according to the conventions of 






Figure 3.1 BPCV1 encodes a microRNA.  
(A) The BPCV1 genome was cloned into a heterologous expression vector in either the 
early or the late orientations. pBPCV1-Early and pBPCV1-Late were transfected and 48 
hours post transfection, small RNAs were size fractionated and subjected to ABI SOLiD 
sequencing.  Corresponding reads were mapped to the BPCV1 genome. Arrow indicates 
the SalI restriction site used to sub-clone the viral genome (B) Coverage plot of deep 
sequencing reads. The frequency of reads that mapped to the BPCV1 genome from the 
early and late expression vectors are plotted (log2 scale) on the y-axis. The x-axis 
indicates BPCV1 genomic position. Each graph is divided into an early orientation (top, 
rightward arrow) and a late orientation (bottom, leftward arrow) as indicated on the right 
side of the figure. The coverage plot revealed abundant reads in both the early and the 
late expression vector samples. The majority of the reads mapped a 22-nt RNA in the late 
orientation, nucleotide position 4963 – 4984, located in the second non-coding region 
(NCR2). The gray angled arrowheads indicate the high-scoring peaks (C) Predicted 
secondary structure of the BPCV1 pre-miRNA and the associated probes designed to 
verify the deep sequencing reads. The 3p miRNA is shown in bold. (D – G) Northern blot 
analysis confirms the expression of BPCV1-miR-B1. Probes were designed to recognize 
the 5p miRNA (D), terminal loop (E) and 3p miRNA (F). An additional downstream 
flanking probe (flank, not diagrammed in figure C) was used as a negative control (G). 
Both the 5p and the 3p miRNAs were readily detectable, with the 3p miRNA the most 
abundant. As a loading control, ethidium bromide-stained low-molecular weight RNA is 
shown in the bottom panels. The bands corresponding to the pre-miRNA (gray 
arrowhead) or the 5p and 3p miRNAs (black arrowhead) are indicated.  
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3.2.2 Evolutionary conservation of the BPCV1 miRNA 
BPCV2 is the only other known virus closely related to BPCV1, possessing ~85% 
nucleotide identity and a similar genomic organization. An alignment of both genomes 
shows that the region spanning the pre-miRNA shares 89.5% (153 / 171 nucleotide) 
identity (data not shown). These data imply a high likelihood that BPCV2 would encode 
a miRNA homologous to BPCV1-miR-B1. To test this notion, we first utilized a 
bioinformatic approach using the Vmir miRNA prediction software (Grundhoff et al., 
2006; Sullivan and Grundhoff, 2007; Sullivan et al., 2005). This analysis showed the 
BPCV1-pre-miR-B1 scored as the fifth highest candidate in the late orientation and the 
eleventh highest scoring overall candidate (Fig. 2A, top panel and data not shown). 
Interestingly, this analysis showed that an analogous region of the genome in BPCV2 
predicted a candidate pre-miRNA that scored even higher as the best candidate in the late 
orientation and the second best overall candidate (Fig. 2B, top panel, and data not 
shown). Notably, this predicted hairpin encompasses a 22 nucleotide stretch that is 100% 
conserved with the BPCV1 miRNA (Fig. 2 A, B, bottom panels, indicated in bold). To 
test if this high-scoring candidate miRNA is actually made by transcripts derived from 
the BPCV2 genome, we sub-cloned the entire BPCV2 NCR2 behind a chimeric 
promoter, transfected cells, and harvested total RNA. Northern blot analysis of this RNA 
confirms that BPCV2 encodes a homologous miRNA to BPCV1 (Fig. 2C). Accordingly, 






Figure 3.2 BPCV miRNAs are evolutionarily conserved.   
(A and B) Vmir predictions for BPCV1 and BPCV2 pre-miRNAs. The top panels show 
the Vmir predicted pre-miRNA candidates from BPCV1 and BPCV2. The y-axis 
indicates the Vmir scores of the candidate pre-miRNAs. The x-axis indicates the genomic 
position for BPCV1 and BPCV2 respectively. Candidate pre-miRNAs of the late 
orientation for both BPCV1 and BPCV2 are indicated by triangles. The verified BPCV1-
miR-B1 and BPCV2-miR-B1 are marked with a circle. The secondary structure 
predictions for BPCV1 and BPCV2 pre-miRNAs are shown below each Vmir plot. The 
sequences of 3p miRNAs are indicated in bold. (C) Northern blot analysis confirms 
BPCV2 encodes a miRNA. The analysis was performed as described in the figure legend 
for Figure 3.1. 
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3.2.3 Biogenesis of BPCV1-miR-B1. 
 
As described above, we obtained numerous sequencing reads for BPCV1-miR-B1 
irrespective of whether the RNA was harvested from cells transfected with the early or 
the late orientation expression vectors. Furthermore, Northern blot analysis readily 
identifies the miRNA from both constructs (Fig. 1C). Our ability to detect the miRNA 
from the early orientation construct implies an intrinsic robust promoter activity is 
present in the late (papillomavirus) orientation of the BPCV genome that drives 
expression of BPCV1-miR-B1. Since both the BPCV miRNAs are found within NCR2, 
and this region is not predicted to encode any proteins (Bennett et al., 2008a; Woolford et 
al., 2007) we speculated that it may serve as a cassette that contains a promoter to drive 
expression of the primary transcripts that give rise to the BPCV miRNAs. To test this 
hypothesis, we first subjected the NCR2 sequences from both BPCV1 and BPCV2 to 
bioinformatic analysis (Reese, 2001) to identify candidate promoter regions (Table 1). 
The highest ranked candidate promoter regions for both BPCV1 (nt 4769-4818) and 
BPCV2 (nt 4745-4794) were found to be located in similar genomic locations, 
approximately 60 nucleotides upstream of each respective BPCV pre-miRNA. Both of 
these candidate promoters contain a putative TATA box (Table 1). A sequence alignment 
between the NCR2 of BPCV1 and BPCV2 revealed that despite having only 73.9% 
(Bennett et al., 2008a) sequence identity in this region, the pre-miRNA and putative 
promoter regions are highly conserved (~90%, 187 / 211 nucleotide) (Fig. 3A), implying 
a conserved function. To test for functional activity of these putative promoters, a series 
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of constructs was created (Fig. 3B). We first cloned the entire NCR2 of BPCV1, as well 
as various truncations/internal deletions of this region. We individually transfected each 
of these constructs and then conducted Northern blot analysis for BPCV1-miR-B1 3p 
miRNA. The construct containing the full length NCR2 (named “1” in Fig. 3B & C) 
expressed robust levels of the miRNA (Fig. 3C). However, the truncation construct 
pcDNA3.1-BPCV1-∆pro∆NCR2, that has eliminated the predicted promoter and all 
upstream sequences within NCR2 (nucleotides 3758 – 4808), showed a dramatic 
reduction in the expression of the miRNA (Fig. 3C). To rule out the possibility that this 
truncation mutation somehow compromised important features of the pre-miRNA, we 
generated a chimeric construct containing an SV40 early promoter upstream of this 
truncation (named “3” in Fig. 3B & C). This chimeric construct was able to rescue 
readily detectable levels of the miRNA. These data argue that all essential cis processing 
elements for the pre-miRNA lie within ~60 nucleotides of the base of the stem portion of 
the predicted hairpin pre-miRNA. To determine if removal of the predicted promoter 
region (nucleotides 4769 – 4808) was sufficient to dramatically reduce transcription, an 
internal deletion mutant that deleted just the predicted promoter (preserving the rest of 
the NCR) was created (pcDNA3.1-BPCV1-∆pro, named “4” in Fig. 3B & C). This 
mutant construct showed greatly reduced transcription on par with the large deletion 
mutation (pcDNA3.1-BPCV1-∆pro∆NCR2, named “2” in Fig. 3B & C). Combined, these 
data support the existence of a strong promoter in the BPCV1 genome that lies upstream 
of the pre-miRNA, with essential elements at nucleotides position 4769 – 4808. 
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Since there is a high degree of conservation of the BPCV1 miRNA promoter 
region with BPCV2 (Fig. 3A), we examined whether expression of the BPCV2 miRNA is 
driven by a similar promoter. We sub-cloned the entire BPCV2 NCR2, containing both 
the putative promoter region and pre-miRNA regions, into a vector that does not contain 
a mammalian promoter. This construct drove high expression of the BPCV2 miRNA to 
levels comparable to BPCV1 (Fig. 3D). We therefore, conclude that the NCR2 of BPCV1 
and BPCV2 each contain a robust transcription-inducing activity, making the BPCV1 and 
2 miRNAs some of the only viral miRNAs with well-defined miRNA-specific promoters. 
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Table 3.1 The predicted promoter sequences in BPCV1-NCR2 and BPCV2-NCR2.  
Sequences from both the BPCV1-NCR2 and BPCV2-NCR2 were subjected to promoter prediction via the Neural Network 
Promoter Prediction Program (Reese, 2001). The predictions were ranked according to their scores, from 0 to 1.00, with an 
arbitrary cutoff of 0.8. The start and the end columns indicate the genomic location of the predictions in BPCV1 and BPCV2, 
respectively. The nucleotides in bold indicate the predicted transcription start site. The row shaded in gray represents the 
region containing the promoter activity we identified in this study. The highest ranked predictions for both BPCV1 and 
BPCV2 were located at similar relative genomic locations (nucleotides 4969 – 4818 in BPCV1, 4745 – 4794 in BPCV2), ~60-
nt upstream of the BPCV pre-miRNAs. 
 
BPCV1-NCR2 
       Start End Score Rank   Predicted Promoter Sequence   
4769 4818 1.00 1 atgtgggcttataaaaggggctgcagaggtctgtagcttgtgcacactgt   
4554 4603 1.00 1 gcattctctatataaagctgcagcggccgtgccgcttttcgttgcagccg 
4546 4595 0.95 3 tgttatatgcattctctatataaagctgcagcggccgtgccgcttttcgt 
4663 4712 0.93 4 aaaataatttttaatagcctggatatctgccatgacagttaaatcagtag 
3852 3901 0.83 5 gggaaatgtataattttcaggcctacatcattatgcagttagtctgtgtg 
         BPCV2-NCR2 
       Start End Score Rank   Predicted Promoter Sequence   
4745 4794 0.99 1 tatgtgggtctataaaaggggctgcagaggtctgaaagctgtgcacactg 
4710 4759 0.93 2 tatcccctgcactaaaatatgggctgttcctaccgtatgtgggtctataa 
4929 4978 0.93 2 accgaaagtatataatactgtgcttgagagtgcgcggtaaataaacatta 
4525 4574 0.90 4 tttgtaagtatattaccgccgtatcggcttatacctctgcagccgctctg 





Figure 3.3 An evolutionarily conserved promoter in NCR2 drives the 
expression of the BPCV miRNAs.  
(A) Sequence alignment plot between BPCV1 and BPCV2 NCR2 revealed a highly 
conserved region upstream of BPCV1-miR-B1. The percentage identity between BPCV1 
and BPCV2 is calculated over a window of 20 nucleotides and is plotted on the y-axis. 
The x-axis represents the genomic position of the NCR2, with 1 being the first nucleotide 
immediately downstream of the large T antigen stop codon. Black horizontal bars 
represent BPCV1-miR-B1-3p and 5p miRNAs. The gray bar represents the position of 
the conserved promoter. (B) Deletion constructs used to map the NCR2 promoter activity. 
The construct, pcDNA3.1-BPCV1-NCR2, included flanking regions from both L1 and 
large T antigen genes. Various internal deletion or truncation constructs (as diagrammed) 
were assayed. The dotted lines represent the deleted region from the NCR2 and the 
dashed lines represents vector sequences. The column on the right indicates the 
expression of the miRNA relative to the FL construct, “+++” represent abundant miRNA 
expression, “++” represents intermediate miRNA expression, “–” represents no 
detectable miRNA expression. (C) Northern blot analysis from various NCR2 constructs 
identifies promoter activity at nucleotides 4769 – 4808. The 3p miRNA probe was used 
for the analysis. The loading control, shown in the bottom panels, is ethidium bromide-
stained low-molecular weight RNA. The miRNA band is indicated by the black 
arrowhead. (D) Northern blot analysis shows NCR2 promoter activity is conserved 
between BPCV1 and BPCV2. Analysis and labeling is as described in Figure 3.3C, 
above. The miRNA band is indicated by the black arrowhead. 
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3.2.4 miRNAs encoded by BPCV1 and BPCV2 negatively regulate transcripts 
containing the Large T antigen 3’ UTR via a manner distinct from all known 
polyomaviruses. 
Because all known Polyomaviridae miRNAs are encoded antisense to the early 
transcripts, we wondered if this might also be the case for the BPCV1 miRNA. Inspection 
of the genomic location of BPCV1-miR-B1 shows that the miRNA lies 85 nucleotides 
downstream from the large T antigen stop codon (nucleotides 5070 - 5072). Two 
different algorithms predict a strong polyadenylation recognition site at nucleotides 5023 
- 5038 in the early orientation (Cheng et al., 2006; Tabaska and Zhang, 1999, data not 
shown). If these predictions are correct, it would mean that the early transcripts would 
likely terminate before they reached the BPCV1 miRNA genomic location encoded on 
the opposite strand. This would render antisense miRNA-mediated cleavage of the early 
transcripts impossible. We therefore performed 3’ Rapid Amplification of cDNA Ends 
(3’ RACE) analysis on RNA harvested from cells transfected with pBPCV1-Early to map 
the 3’ end of the BPCV early transcripts. We sequenced PCR reactions as well as 
individual clones from the RACE reaction. The results were identical in both types of 
analyses– all sequencing reactions including the PCR reactions, as well as 9 out of 9 
individual clones, mapped to the same site. These analyses mapped a polyadenylation 
cleavage site between nucleotides 5008-5010 (since this region of the genome contains 
three Thymidines, it is unclear if the first three Thymidines mapped are derived from the 
genomic template or are added by the cellular polyadenylation machinery) (Figure 3.4A). 
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This site is consistent with the computationally-predicted polydenylation site (Cheng et 
al., 2006; Tabaska and Zhang, 1999), and lies greater than 20 nucleotides away from the 
BPCV1-miR-B1. As described in a later section, we were able to obtain RNA from a 
natural BPCV1 infection of a western barred bandicoot, and mapping of the 3’ end of the 
early transcripts from this source further confirms the polyadenylation cleavage site we 
mapped in RNA harvested from transfected cells (sequencing of the PCR reactions and 7 
out of 7 individual clones mapped a single location identical to the one mapped for the 
transfected samples, Figure 3.4A). Combined, these data demonstrate that unlike all 
known Polyomaviridae miRNAs, the BPCV1-miR-B1 is not encoded antisense to the 
early mRNAs, but rather lies in a separate downstream portion of the genome. Therefore, 
BPCV1-miR-B1 does not possess perfect complementarity to the early mRNAs and is 
less likely to direct siRNA-like, miRNA-mediated cleavage of these transcripts (Figure 
3.4B). 
During the course of analyzing the sequencing data, we noted that performing a 
local BLAST search (Altschul et al., 1997) of BPCV1-miR-B1 to the BPCV1 genome 
produced two significant “hits” at different locations within the genome. As expected, the 
one hit displayed a perfect 22 of 22 nucleotide match and mapped to BPCV1-miR-B1 
itself. Unexpectedly, the other hit displayed a 20 of 22 nucleotide match that mapped to 
the 3’ UTR of large T antigen (Figure 3.4A). Several reasons suggest this would be a 
likely target site for regulation by BPCV1-miR-B1. First, the portion of complementarity 
to the seed region (nucleotides 2-7, known to play an especially important role in miRNA 
target recognition) (Lim et al., 2005) is a perfect match (Figure 3.4C). Second, as 
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discussed in a later section, the BPCV1 T antigen 3’ UTR complementary region is 100 
% conserved (22 of 22 nucleotides) with the related BPCV2 early 3’ UTR, while the 
remaining portions of the 3’ UTRs share only 76.7% identity (33 of 43 nucleotides). This 
implies a conserved function in the putative miRNA target portion of early transcript 3’ 
UTRs. Third, miRNA target sites are thought be more active when located close to the 
ends of the 3’ UTR, but greater than 15 nucleotides from the stop codon (Grimson et al., 
2007), and the putative BPCV1-miR-B1 target site matches these criteria (close to both 
ends of the 3’ UTR– only ~20 nucleotides from the 3’ terminus of the early transcripts 
and 19 nucleotides downstream from the stop codon). Therefore, we set out to explore 





Figure 3.4 The BPCV1 pre-miRNA is not complementary to the early 
transcripts.  
(A) 3’ RACE analysis maps the polyadenylation cleavage site of early transcripts. The 
polyadenylation cleavage site is indicated by a black triangle. * and # indicate number of 
individual clones that that were mapped from the transfected or in vivo RNA samples, 
respectively. In both cases all of the clones mapped the same polyadenylation cleavage 
site. (B) Circular map of BPCV1 genome shows the genomic location of the BPCV 
miRNA and the miRNA complementary site. (C) Diagram showing the predicted base-
pairing interaction between the BPCV1 miRNA and the miRNA binding site in the 3’ 
UTR of the large T antigen transcript. The canonical Watson-Crick base pairings are 
represented by the thick vertical lines, the wobble pairing is indicated with a thin vertical 
line.
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To test the hypothesis that BPCV1-miR-B1 regulates early gene expression, we 
utilized Renilla luciferase reporter constructs containing the entire BPCV1 3’ UTR. In 
addition, we generated a negative control 3’ UTR containing a 2-nt point mutation in the 
miRNA seed region, a second negative control 3’ UTR containing a deletion of the entire 
predicted 22-nt binding region, or a positive control 3’ UTR containing an engineered 
binding site that is perfectly complementary to the BPCV1 miRNA (Figure 3.5A). Co-
transfection of a vector expressing BPCV1-miR-B1 with a reporter plasmid containing 
the entire BPCV1 early 3’ UTR results in a marked decrease in luciferase expression 
(Figure 3.5B). Notably, co-transfection of either a control vector that does not express 
any miRNA, or a control vector expressing an irrelevant miRNA, has little effect on the 
luciferase activity of the plasmid containing the wild type BPCV early 3’ UTR, thus 
implying specificity. Importantly, when we delete the entire putative miRNA target 
region, or more surgically, alter only two nucleotides within the seed complementary 
region, we observe no negative regulation. As expected, when we engineered a perfectly 
complementary reporter, we also observed BPCV1-miR-B1-specific negative regulation. 
Notably, the degree of regulation observed for this positive control reporter was similar to 
the natural large T antigen 3’ UTR reporter. These results strongly suggest that BPCV1-
miR-B1 can negatively regulate the BPCV1 early transcripts by binding to the 3’ UTR. 
Thus, although 3’ UTRs represent the most common locale of miRNA-mediated 
repression in animals, this is the first demonstration of such regulation for polyomavirus-
like transcripts. 
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The BPCV1 large T antigen 3’ UTR shares 84.6% identity (55 of 65 nucleotides) 
with BPCV2, however, the miRNA binding site is 100% conserved (22 of 22 
nucleotides) (Figure 3.5C). Therefore, we hypothesized that BPCV2 would undergo 
miRNA-mediated regulation of its early transcripts. To test this, we conducted identical 
experiments to those described in Figure 3.5A, except that we utilized a reporter vector 
that contains the entire BPCV2 large T antigen 3’ UTR and a BPCV2 miRNA-expressing 
vector (Figure 3.5D). Strikingly, these results mirrored precisely the trends we observed 
for BPCV1 (Figure 3.5E), and suggest that this novel form of miRNA-mediated 






Figure 3.5  Evolutionarily conserved negative regulation of the 3’ UTR of the 
early transcripts.  
(A) Diagram of luciferase reporter construct containing the entire 3’ UTR of large T 
antigen, as well as control constructs. The vectors consist of a Renilla luciferase reporter 
upstream of a single copy of the entire 3’ UTR of BPCV1 large T antigen (WT), a 
negative control 3’ UTR containing a 2-nt point mutation in the miRNA seed region (Pt), 
a negative control 3’ UTR containing a deletion of the predicted 22 nucleotide binding 
region (Del), or a positive control 3’ UTR containing an engineered perfectly 
complementary site to the BPCV1 miRNA (Perfect) at nucleotide positions 5043 and 
5050. Numbers at either end indicate the location of the BPCV1 nucleotides that were 
cloned. (B) The BPCV1 miRNA negatively regulates the 3’ UTR of large T antigen. The 
reporters from (A) were co-transfected individually into 293 cells and normalized to 
Firefly luciferase (FF. luc) and plotted (y-axis). The x-axis indicates the different Renilla 
luciferase (R. luc) reporter constructs. The plasmids expressing either vector alone, MCV 
miRNA, or BPCV1 miRNAs are indicated by the black, gray and white bar graphs 
respectively. P-values were computed using Student’s t-test. * indicates P < 0.05, ** 
indicates P < 0.01 and *** indicates P < 0.001. (C) The miRNA binding site is 100% 
conserved between the BPCV1 and BPCV2 3’ UTRs. Diagram depicting the level of 
conservation in miRNA and binding site between BPCV1 and BPCV2. The region 
between the pre-miRNA and the large T antigen stop codon was divided into various 
regions, showing the percent conservation between BPCV1 and BPCV2. The regions of 
100% conservation are shaded in gray. The BPCV 3p miRNA is indicated by the black 
bar and the miRNA binding region is indicated by the gray bar. The BPCV1 nucleotide 
positions 4869 – 5072 and the BPCV2 nucleotide positions 4846 – 5051 were used in this 
conservation analysis. (D) The BPCV2 3’ UTR is negatively regulated by the BPCV2 
miRNA. Similar reporters as described above in panel A were engineered for the BPCV2 
3’ UTR. (E) Luciferase assays for the BPCV2 large T antigen 3’ UTR reporters were 
performed as described above in panel B. 
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3.2.5 BPCV1-miR-B1 is expressed in vivo. 
 
Infection with BPCV1 is associated with papillomas and carcinomas in western 
barred bandicoots (Woolford et al., 2007). PCR detection and in situ hybridization 
analyses demonstrated that the virus is present in the majority of papillomatous and 
carcinomatous lesions tested (Bennett et al., 2008b; Woolford et al., 2007, 2009). 
Because the western barred bandicoot is an endangered species, obtaining tissue explants 
from infected animals is a challenge. We were able to obtain both lesional and a small 
amount of non-lesional tissue samples from a single infected animal that had to be 
euthanised for humane reasons due to complications arising from BPCV1-associated 
metastatic squamous cell carcinoma. We harvested total RNA from two different lesional 
regions on the same animal as well as non-lesional skin from a different portion of the 
animal. We were pleased to observe a robust signal showing a specific band from both 
lesional samples (Figure 3.6A). This band co-migrates with the BPCV1-miR-B1 band 
that is detected in the positive control RNA derived from BPCV plasmid-transfected cells 
(Figure 3.6A). Probing any of four different negative control samples, RNA from non-
lesional bandicoot skin (Figure 3.6C), HEK 293 cells (Figure 3.6A), HEK 293T cells 
(Figure 3.6A), or BSC40 African green monkey cells (Figure 3.6A), did not detect any 
specific bands. As a control to rule out that the band we detect from the lesional samples 
could be from random degradation of total RNA, we stripped the blot in Figure 3.6A and 
then re-probed with the terminal loop probe (as described in Figure 3.1C). If the band we 
detect is random degradation of a larger viral transcript, then other probes for RNA 
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sequences proximal to the BPCV1-miR-B1 should also provide a signal at ~22 
nucleotides. Probing with the terminal loop probe (recognizes an RNA sequence just 
proximal to the miRNA) did not detect any bands from the lesional samples (Figure 
3.6B). This result strongly argues that neither random degradation fragments nor siRNAs 
can account for the miRNA signal we detect migrating at  ~22 nucleotides, since both of 
these processes would be expected to generate Northern blot detectable bands throughout 
this region of the genome (and not just from one arm of the pre-miRNA precursor 
hairpin). It is worth noting that the terminal loop probe recognizes the pre-miRNA band 
in the positive control RNA sample but not in the lesional samples. Either of two 
explanations likely account for this: 1) more efficient processing of the pre-miRNA in 
vivo, or 2) a pre-miRNA nuclease activity that is active in the preparation of the in vivo 
samples. Irrespective, the fact that the loop probe recognizes the pre-miRNA from the 
positive control transfected sample, rules out any technical artifact that could account for 
its inability to detect bands from the lesional tissue. Together, these data demonstrate that 






Figure 3.6 BPCV1-miR-B1 is expressed in vivo.  
(A) Northern blot analysis scores positive for RNA harvested from either of 2 different 
bandicoot lesions. Negative control lanes are from human embryonic kidney cells (HEK) 
293, HEK 293T cells, and BSC40 African green monkey cells. RNA from cells 
transfected with BPCV1 miRNA-expressing plasmid is included as a positive control. 
The loading control, shown in the bottom panels, is ethidium bromide-stained low-
molecular weight RNA. The bands corresponding to the pre-miRNA (gray arrowhead) or 
the 5p and 3p miRNAs (black arrowhead) are indicated. (B) The signal detected from 
lesional tissue is not due to random degradation. The blot from panel A was stripped and 
re-probed with the terminal loop specific probe. The pre-miRNA band was detected from 
the transfected positive control sample confirming the activity of the probe. No signal 
was detected at 22 nucleotides from the lesional tissue, ruling out that the band detected 
in panel B was due to random degradation of transcripts spanning the pre-miRNA region 
of the genome. The pre-miRNA detected by the terminal loop is indicated by the gray 
arrowhead. (C) BPCV1-miR-B1 is expressed only in bandicoot lesions. Northern blot 
analysis of both non-lesional and lesional RNA samples indicates that BPCV1-miR-B1 
can only be detected in lesional tissue. The loading control, shown in the bottom panel, is 
Northern blot detection of the let-7a miRNA. The BPCV1-3p miRNA is indicated by the 




The discovery of new virus-encoded miRNAs and understanding their functions 
represents an exciting developing sub-field of virology. Here, we describe miRNAs from 
a fascinating group of recently described viruses, representing only the sixth virus 
family/group shown to encode miRNAs. BPCV1 and BPCV2 are remarkable because 
they represent natural hybrids of two different virus families, the Polyomaviridae and 
Papillomaviridae. Like the polyoma viruses, the BPCVs express T antigen proteins and 
have a genomic organization that consists of an origin of replication flanked by 
promoters that drive the regulatory T antigen transcripts in one direction around the 
circular genome, and drive the capsid transcripts in the other direction (Figure 3.7). 
However, unlike the polyomaviruses, the capsid proteins are clearly related to the 
papillomavirus capsid proteins L1 and L2. Furthermore, the size of the genome is ~7300 
base pairs, closer to the papillomaviruses (~7-8.5 kb) than the polyomaviruses (~5.2 kb). 
In contrast to the known polyomaviruses and most papillomaviruses, the BPCVs also 
contain a long untranslated region (NCR2) of ~1.3 kb, which we have shown serves as 





Figure 3.7 Model for miRNA-mediated viral gene regulation of Polyomaviridae 
and polyoma-like viruses.  
Both the polyoma and BPCV viruses encode miRNAs with the ability to negatively 
regulate the early T antigen transcripts. The mechanism of this regulation, however, 
differs between the polyoma and BPCV viruses. BPCV viruses encode a miRNA that is 
located in a non-coding portion of the genome and is not antisense nor fully 
complementary to the early transcripts. All polyomaviral miRNA that have so far been 
reported are found antisense and complementary to the early transcripts, albeit they are 
found in different regions of the genome. 
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We have demonstrated that the BPCV miRNAs can direct negative regulation of 
transcripts that contain the large T antigen 3’ UTR (Figure 3.5A, B). This suggests that 
similar to what has been observed in the polyoma (Seo et al., 2008, 2009; Sullivan et al., 
2005, 2009), herpes (Bellare and Ganem, 2009; Grey et al., 2010; Murphy et al., 2008; 
Umbach et al., 2008), and ascoviruses (Hussain et al., 2008), that BPCV miRNAs play a 
prominent role in the regulation of viral gene expression. This notion is supported by the 
observation that the BPCV large T antigens have a relatively small 3’ UTR at ~60 
nucleotides (Figure 3.4A), however 20 of 22 are perfectly complementary to the miRNA. 
Since one of the mismatched target nucleotides could bind as a GU wobble, this 
potentially leaves only a single unpaired nucleotide between miRNA and mRNA target 
site (Figure 3.4C)– significantly fewer than almost all known animal miRNA-target pairs. 
Adding further weight to the model that BPCV1-miR-mediated viral gene 
regulation is relevant during infection is the fact that 3’ UTR regulation we observe is 
evolutionarily conserved with BPCV2 (Figure 3.5D, E). Using the Vmir miRNA 
prediction software, we easily identified the pre-miRNA that gives rise to BPCV2-miR-1 
(Figure 3.2B). Interestingly, the BPCV2 pre-miRNA scores as a higher ranked candidate 
than BPCV1-miR-1 (overall rank 2 versus 11). We previously observed a similar 
phenomenon for two different strains of MCV (Seo et al., 2009). These observations have 
relevance to future attempts of using bioinformatics approaches for identifying new viral 
miRNAs. Rather than analyzing a single viral genome, future bioinformatics efforts 
might be better served if a series of closely related viruses, or even different isolates of 
the same virus, were compared to identify common regions of predicted pre-miRNAs. 
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Finally, the fact that we show the BPCV1 miRNA is abundantly expressed during 
infection in vivo (Figure 3.6) argues that the regulation of the T antigen 3’ UTR we 
observe in cultured cells likely occurs in at least some in vivo settings. 
We have determined that the function of the second non-coding region of the 
BPCVs includes encoding a promoter and template for the primary transcript that 
contains the pre-miRNA. We note that we cannot rule out additional promoters and 
transcripts may be used to generate this miRNA during some stages of infection. It is 
interesting to point out that both NCR2 regions of BPCV1 and BPCV2 contain a 
predicted large T antigen binding site consensus sequence of GAGGC (Bennett et al., 
2008a; Pomerantz and Hassell, 1984; Woolford et al., 2007). In addition, our observation 
that this promoter is robustly active in cells derived from placental mammals, suggests it 
is responsive to transcription factors that were present in the last common ancestor of 
placental and marsupial mammals. Of note, possible host transcription factor binding 
sites that are predicted in these NCR2 regions include p53, E2F1, p300, and NF-kappaB, 
(Messeguer et al., 2002, data not shown). These observations suggest that regulation of 
the expression of the BPCV miRNAs may be complex and affected by numerous trans 
factors of both host and viral origin. Future experiments are required to test this 
hypothesis. 
We have previously shown that six different polyoma viruses encode miRNAs 
that negatively regulate, or are predicted to negatively regulate T antigen transcripts. In 
all cases, despite some sequence differences, these miRNAs are encoded on the opposite 
strands and antisense to the T antigen transcripts (Cantalupo et al., 2005; Seo et al., 2008, 
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2009; Sullivan et al., 2005, 2009). This conserved mode of regulation implies 
importance, however, one could argue that since the degree of regulation imparted by 
these is only partial (Sullivan et al., 2005, 2009), the polyomaviral miRNA-mediated 
viral transcript regulation is a secondary consequence of the genomic location of these 
miRNAs. However, the results we present here strongly imply that some diverse viruses 
that have polyoma or polyoma-like genomic organizations are under evolutionary 
pressure to maintain miRNAs that regulate T antigen expression. Because unlike the 
polyomaviral miRNAs, the BPCV miRNAs are encoded in a different region of the 
genome (Figure 3.4), and possess an alternative mechanism of action (3’ UTR regulation 
versus antisense miRNA-mediated cleavage of the coding sequence); we conclude that 
the miRNA-mediated regulation of T antigen expression is selected for in diverse viruses. 
We stress that in no way does this rule out the possibility that important host targets exist 
for these miRNAs. Indeed, as has been shown for several members of Herpesviridae, 
viral miRNAs will target virus-encoded or host-encoded transcripts and sometimes a 
single miRNA can target both (Grey et al., 2007; Stern-Ginossar et al., 2007). 
What is the purpose of polyomaviral and BPCV miRNA-mediated regulation of T 
antigen transcripts? One possibility, is that similar to the many Herpesviridae miRNAs 
that play a role in latency, the polyomaviral and BPCV miRNAs may play a role in 
maintaining persistent infection. In this scenario, these miRNAs would prevent excessive 
or untimely expression of the T antigens, thereby avoiding the triggering of inappropriate 
lytic induction or clearance by the adaptive immune response. In this regard, it is 
interesting to note that a putative T antigen binding site exists in the NCR2 region of both 
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BPCV1 and BPCV2 (Bennett et al., 2008a; Pomerantz and Hassell, 1984; Woolford et 
al., 2007).  Thus, BPCV T antigen could play a role in either a positive or negative 
feedback loop regulating expression of the miRNA. Currently, persistence is a poorly 
understood facet of the polyomaviral life cycle. To further elucidate the role of virus 
encoded miRNAs in regulating persistent and/or lytic infections, future studies will 
require the development of appropriate in vivo models.  
Finally, our results identify the first 2 viruses that encode papillomavirus-like 
gene products that also encode a miRNA. A previous study of human papillomavirus type 
31 strongly suggested that at least some papillomaviruses are not likely to encode 
miRNAs (Cai et al., 2006). However, it is still formally possible that other 
papillomaviruses may encode miRNAs. Our results suggest that those papillomaviruses 
with multiple non-coding regions, such as the Felis domesticus papillomavirus type 1, 
belonging to the genus Lambdapapillomavirus (λ-PV) (Rector et al., 2007), would be 
attractive candidates to hunt for true papillomavirus-encoded miRNAs. 
In summary, we have shown that an interesting new group of viruses encode 
miRNAs, which has important implications for distantly related viruses– including some 
human pathogens. In the future, exciting questions will be addressed such as the role of 
polyomavirus and polyomavirus-like miRNAs in possibly targeting host transcripts and 
establishing or maintaining persistent infection. What is clear at this point is that viral 
miRNA-mediated regulation of viral transcripts is important for divergent viruses, 
including herpesviruses, polyomaviruses, and the BPCVs. 
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3.4 MATERIALS AND METHODS 
 
3.4.1 Ethics Statement 
The use of animals is noted as tissue samples, blood samples and cadavers 
collected at the Kanyana Wildlife rehabilitation centre and therefore a formal approval 
application is not necessary as determined by the Murdoch University Department of 
Environment and Conservation Animal Ethics Committee, 2006/08.  
 
3.4.2 Cell Culture and RNA isolation 
Human Embryonic Kidney cells 293 and 293T were obtained from American 
Type Culture Collection (Manassas, VA) and maintained in Dulbecco’s Modified Eagle’s 
Medium supplemented with 10% fetal bovine serum (Cellgro, VA). Total RNA was 
harvested using an in house PIG-B solution (2M guanidinium thiocyanate (EMD, NJ), 
20mM citrate buffer, pH 4.5, 5mM EDTA, (Fisher Scientific, NH), 0.25% Sarkosyl 
(Sigma Aldrich, MO), 48% saturated phenol, pH 4.5 (Amresco, OH), 2.1% isoamyl 
alcohol (Fisher Scientific), 0.5% β-mercaptoethanol (Sigma Aldrich), 0.1% 8-
hydroxyquinoline (EMD) and 0.0025% Coomassie blue (EMD)) as described (Lin et al., 
2010; Seo et al., 2008; Weber et al., 1998).  
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3.4.3 Vector construction, transfection and Northern blot analysis 
All DNA vector constructs were confirmed by sequence analysis through the 
Institute of Cellular and Molecular Biology Sequencing Facility at the University of 
Texas at Austin. The entire BPCV1 genome (kindly provided by Lucy Woolford, 
Murdoch University, Australia) was digested with restriction enzyme SalI (New England 
Biolabs, MA) and cloned into the XhoI site of the pcDNA3.1puro expression vector. The 
resulting BPCV1 expression vectors were named pBPCV1-Early and pBPCV1-Late. The 
plasmid pcDNA3.1-BPCV1-NCR2, which contains the entire BPCV1 non-coding region 
2 and partial large T antigen and L1 open reading frame, was generated by cloning an 
approximately 1500-bp PCR-amplified fragment of the BPCV1 genome into the 
BglII/XhoI sites of the pcDNA3.1neo expression vector, removing the CMV promoter in 
the process. The primers used were as follows: BPCV1 NCR2 forward primer, 
ATCGATCGAAGATCTGGAGAAAGTTCTTGTATCAGAGCAG, and BPCV1 NCR2 
reverse primer, TAGCTAGCTCTCGAGCCAAAGCTCATAAAGCAGAACTTG.  
The plasmid pcDNA3.1-BPCV1-∆pro, which has the putative promoter in NCR2 
replaced with a unique KpnI restriction site, was generated through a three way ligation 
between two PCR-amplified NCR2 fragments into the BglII/XhoI sites of the 
pcDNA3.1neo expression vector. The primers used were as follows: BPCV1 NCR2 KpnI 
reverse primer, ATCGATCGAGGTACCAGCTGGGAACATCCCCTAAC, paired with 
the BPCV1 NCR2 forward primer described above to generate the first fragment, and 
BPCV1 NCR2 KpnI forward primer, 
ATCGATCGAGGTACCTGCACACTGTGCACATGTATTG, paired with the BPCV1 
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NCR2 reverse primer described above to generate the second fragment. The plasmid 
pcDNA3.1-BPCV1-∆pro∆NCR2, which had the entire NCR2 deleted except for the 
BPCV1 pre-miRNA, was generated by digesting pcDNA3.1-BPCV1-NCR2-∆pro using 
KpnI and BglII. The digested vectors were blunt-ended using Klenow fragment (New 
England Biolabs) and 10mM dNTPs (Invitrogen, CA), at 37°C for 30 minutes. Following 
Klenow fragment fill-in, the vectors were gel purified (Fermentas, MD) and self-ligated 
using T4 DNA Ligase (New England Biolabs). All constructs were linerized by SalI 
restriction digest prior to transfection into 293 cells. The chimeric truncation construct 
containing an SV40 early promoter is the non-linerized form of pcDNA3.1-BPCV1-
∆pro∆NCR2.   
The plasmids pcDNA3.1-BPCV1-miR-B1 and pcDNA3.1-BPCV2-miR-B1, 
which express the BPCV1 miRNA and BPCV2 miRNA, respectively, were generated by 
cloning an ~400-bp PCR-amplified fragment of either the BPCV1 genome or the BPCV2 
genome into the KpnI/XhoI sites of the pcDNA3.1neo expression vector. The primers 
used were as follows: BPCV1-miR-B1 forward primer, 
ATCGATCGAGGTACCGGATGTTCCCAGCTTATGTG, and BPCV1-miR-B1 reverse 
primer, ATCGATCGACTCGAGGCAGAACTTGAACTGTTAGACTC; BPCV2-miR-
B1 forward primer, ATCGATCGAGGTACCGGCTGTTCCTACCGTATG, and BPCV2-
miR-B1 reverse primer, TAGCTAGCTCTCGAGTCAGAGCTTGAATTATTGGACTC. 
293T cells were plated in 6-wells plates and transfected using Lipofectamine 2000 
reagent (Invitrogen) according to the manufacturer’s instructions. 293T cells were also 
transfected with empty pcDNA3.1neo vector as a negative control. Total RNA was 
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harvested at 48 hours post transfection. Ten micrograms of total RNA was separated on a 
Tris-borate-EDTA-Urea-15% polyacrylamide gel. The gel was transferred onto an 
Amersham Hybond N+ membrane (GE Healthcare, IL) and probed for miRNA as 
previously described (Grundhoff et al., 2006). The probe sequences used were as follows: 
BPCV1 3p probe, GCGCACTCTCAAGCACAGTATT; BPCV1 5p probe, 
AAGTACTAAGCCTGAGAGTTCCCATGCGATTCAAAAGT; BPCV1 loop probe, 
TATTATACTTTCGGTTTATAAAGTACTA; BPCV1 downstream flank probe, 
GAGATTTTCAAATTATGTATCTGCAATTAATGCTGAGA   
 
3.4.4 Computational prediction of viral pre-miRNAs, promoters, and polyadenylation 
recognition sites  
A viral miRNA prediction algorithm, Vmir (Grundhoff et al., 2006; Sullivan and 
Grundhoff, 2007), was used to obtain candidate pre-miRNAs from the genomes of 
BPCV1 and BPCV2 (genome accession number NC_010107.1 and NC_010817 
respectively). The secondary structure of pre-miRNAs were predicted via the Mfold RNA 
folding prediction web server (Zuker, 2003). The intrinsic promoters for both BPCV1 and 
BPCV2 were predicted via the Berkeley Drosophila Genome Project web server 
(Messeguer et al., 2002; Reese, 2001). The non-coding region 2 from both BPCV1 and 
BPCV2 were analyzed in the late orientation, with a default minimum promoter cut off 
score of 0.80 (between 0 and 1.00). To predict polyadenylation recognition and/or 
cleavage site of the BPCV T antigen transcripts, two different algorithms were used 
(Cheng et al., 2006; Tabaska and Zhang, 1999). 
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3.4.5 Small RNA library generation and computational analysis of sequencing reads 
for SOLiD 
293T cells were plated in T75 flasks and transfected with either pBPCV1-Early or 
pBPCV1-Late, using Lipofectamine 2000 reagent as described above. Total RNA was 
harvested at 48 hours post-transfection as described above. One hundred and sixty 
micrograms of total RNA was gel-fractionated to isolate small RNAs. The gel fraction 
containing the ~10 – 70 nucleotides size ranges were excised. The excised gel fragment 
was cut into smaller pieces, and soaked in 30 milliliters of 1M NaCl (Ambion, TX) for 
~40 hours at 4°C, while under constant rotation using a LabQuake Shaker Rotisserie 
(Thermo Fisher Scientific). The supernatants were concentrated through centrifugation 
with the Vivaspin 15R concentrator (Sartorius, Germany) at 3000 x g for 30 minutes at 
4°C. The RNA was precipitated by adding an equal volume of isopropanol and one-tenth 
total volume of 3M sodium acetate, pH 5.2 (Fisher Scientific). One microliter of 
glycogen (20 microrgrams / microliter, Invitrogen) was also added to the precipitation 
mixture to aid in the visualization of the RNA pellet. RNA precipitation was done at -
20°C overnight. The RNA pellet was washed with ice-cold 100% ethanol and air-dried. 
The RNA was then dissolved in water and converted into cDNA libraries for SOLiD 
sequencing as previously described (Lin et al., 2010). The 3’ sequencing adapter 
sequence was trimmed from the color space reads using custom Python scripts and any 
sequences with ambiguous calls or less than 18 nucleotides in length after trimming were 
 127 
removed from further analysis.  The preprocessed reads were then mapped to the BPCV1 
genome (NCBI accession number NC_010107.1) using the SHRiMP2 software package 
(Rumble et al., 2009). Uniqueness of reads of interest were further analyzed using the 
BLAST algorithm and the “nr/nt” database (Altschul et al., 1997). Secondary structure 
predictions for regions with abundant reads were generated using the mfold server 
(Zuker, 2003). 5p start site counts and coverage relative to total number of preprocessed 
reads were calculated using custom Python scripts and visualized using the gnuplot 
software package. Only reads with full length perfect matches to the reference genome 
were considered during the generation of coverage plots.  
 
3.4.6 3’ RACE analysis to map the polyadenylation cleavage site of early transcripts  
293T cells were plated in 6-well plates and transfected with pBPCV1-Early, using 
Lipofectamine 2000 reagent as described above. Total RNA was harvested at 48 hours 
post-transfection as described above. 1 microgram of the total RNA was reverse 
transcribed using Superscript III (Invitrogen) according to the manufacturer’s 
instructions. 2 microliters of the reverse transcription product was PCR-amplified using 
Phusion High-Fidelity DNA Polymerase (Finnzymes, Finland) according to the 
manufacturer’s instructions. The PCR product was sequence analyzed through the 
Institute of Cellular and Molecular Biology Sequencing Facility at the University of 
Texas at Austin. In addition, the PCR products were TA-cloned into pCR2.1-TOPO and 
individual clones were sequenced. The primers used were as follows: 
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Reverse Transcription primer, GACTCGAGTCGACATCGTTTTTTTTTTTTTTTTT, 
PCR forward primer, GACTCGAGTCGACATCG, PCR reverse primer, 
CCACCTACAGTAACTGTGAGATG      
 
3.4.7 Luciferase assays 
The BPCV1-miR-B1 and BPCV2-miR-B1 reporters were constructed by cloning 
a ~90-bp fragment corresponding to the entire large T antigen 3’ UTR non-coding region 
into the pcDNA3.1dsRluc vector that expressed a destabilized version of Renilla 
luciferase (Seo et al., 2008), via the XhoI/XbaI sites. The inserts were generated by 
oligonucleotide synthesis. For all oligonucleotides used, see list below. The negative 
control 2 nucleotide seed-region-mutated reporters contain engineered point mutations at 
the second and third nucleotides complementary to the 5’ end of the BPCV 3p miRNA. 
The negative control deletion reporters contain internal deletions of the 3p miRNA 
binding site. The positive control perfect-match reporters contain a miRNA binding site 
that is perfectly complementary to the BPCV 3p miRNA. 293 cells were plated in 12-
well plates and transfected using FuGENE HD transfection reagent (Roche, Switzerland) 
according to the manufacturer’s instructions. Cells were transfected with the reporter and 
the miRNA expression vector. 293 cells were also transfected with the reporter along 
with either MCV miRNA expression vector or empty vector as negative controls. The 
pcDNA3.1Luc2CP vector was also co-transfected to normalize for transfection 
efficiency. Cells were collected 48 hours post transfection and analyzed with the Dual-
Luciferase Reporter Assay System (Promega, WI) according to the manufacturer’s 
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instructions. The luciferase readings were collected using a Luminoskan Ascent 
Microplate Luminometer (Thermo Fisher Scientific). Results from the miRNA Renilla 
luciferase were normalized to the firefly luciferase readings and the ratios were plotted as 
a bar graph relative to the empty vector control.    
 
The primers used were as follows:  
BPCV1 WT forward primer, 
AAACTCGAGCTGCTTGTTCTTTTCTGTGTGCACTCCCAAGCACAGTATTAAAT
AAACAGTGCT 
BPCV1 WT reverse primer, 
TTTTCTAGAGGTAAAAAAACATTAGACACGGGTTTAGAGCAGCACTGTTTATT
TAATACTGTG 
BPCV1 Perfect forward primer (paired with BPCV1 WT reverse primer), 
AAACTCGAGCTGCTTGTTCTTTTCTGTGCGCACTCTCAAGCACAGTATTAAAT
AAACAGTGCT 
BPCV1 Deletion forward primer,  
AAACTCGAGCTGCTTGTTCTTTTCTGTAAATAAACAGTGCTGCTCTA 
BPCV1 Deletion reverse primer, 
TTTTCTAGAGGTAAAAAAACATTAGACACGGGTTTAGAGCAGCACTGTTTATT
TACA 




BPCV1 Point mutant reverse primer, 
TTTTCTAGAGGTAAAAAAACATTAGACACGGGTTTAGAGCAGCACTGTTTATT
TATGACTGTG 
BPCV2 WT forward primer, 
ATGATGCTCGAGGCTGTCTTTTGCTGTCTGCGTGCACTCCCAAGCACAGTATT
AATAAACAGTGCT 
BPCV2 WT reverse primer, 
ATGATGTCTAGAGGTAAATAAACATTAGACACGGGTTTTGAGCAGCACTGTT
TATTAATACTGTGC 
BPCV2 Perfect forward primer (paired with BPCV2 WT reverse primer), 
ATGATGCTCGAGGCTGTCTTTTGCTGTCTGCGCGCACTCTCAAGCACAGTATT
AATAAACAGTGCTG 
BPCV2 Deletion forward primer, 
ATGATGCTCGAGGCTGTCTTTTGCTGTCTGCAATAAACAGTGCTGCTCAA 
BPCV2 Deletion reverse primer, 
ATGATGTCTAGAGGTAAATAAACATTAGACACGGGTTTTGAGCAGCACTGTT
TATTGCAG 








3.4.8 Bandicoot lesion extraction, RNA isolation and Northern blot analysis 
An adult western barred bandicoot (Perameles bougainville) severely affected by 
multicentric papillomas and squamous cell carcinomas associated with BPCV1 infection 
was euthanised for humane reasons. Cutaneous papillomas and non-lesional skin biopsies 
were collected into sterile tubes and rapidly frozen in liquid nitrogen. Skin samples were 
finely minced using sterile scalpel blades then 20mg of tissue was mixed with 350 µL of 
RTL:β-ME solution (1 milliliters buffer RTL (Qiagen) with 10 µL β-mercaptoethanol), 
and homogenized using a Heidolph DIAX 600 homogenizer (John Morris Scientific P/L, 
Bentley, Western Australia, Australia) for 5 minutes on the highest setting (24,000 min-1). 
The lysate was centrifuged at maximum speed in a microcentrifuge for three minutes and 
transferred to a fresh microcentrifuge tube. Ethanol (100%) was added to the cleared 
lysate to bring the final concentration up to 60% ethanol. Next, the samples were applied 
to an RNeasy (Qiagen) mini spin column to purify the total RNA according to the 
manufacturer’s instructions, except that after the final wash step, the samples were stored 
at approximately 4 degrees C for several days while still on the column. The final elution 
steps were conducted with one volume of nuclease free water and then repeated with one 
volume of nuclease free TE, pH7. 
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Northern blot analysis was done as described for transfected samples (see above). 
The blot was first probed with the 3p probe, stripped with boiling hot stripping buffer 
(0.1% sodium dodecyl sulfate in double-distilled water, J.T. Baker, NJ) and then probed 
with the control terminal loop probe. Due to the low amount of non-lesional RNA 
negative control sample that was available, a second Northern blot analysis was 
conducted using only 180 ng of non-lesional RNA sample and lesional sample 1. The 
blot was first probed with the 3p probe, stripped as described above, and then probed 




CHAPTER 4 Naturally Arising Strains of Polyomaviruses with 




microRNAs (miRNAs) are small regulatory molecules that play a role in numerous 
and diverse processes, including those highly relevant to viral infection (Kincaid and 
Sullivan, 2012). For example, both host and viral miRNAs have been implicated in the 
adaptive and innate immune responses, cell death, and tumorigenesis (Bartel, 2009; Boss 
and Renne, 2010; Sullivan, 2008; Taganov et al., 2007). miRNAs are generally derived 
from primary transcripts (pri-miRNAs) that are processed by the Microprocessor 
complex (comprised of the endonuclease Drosha and its binding partner DGCR8) that 
give rise to the ~65 nucleotide hairpin precursor miRNA (pre-miRNA) (Lee et al., 2003; 
Zeng and Cullen, 2005; Zeng et al., 2004). In general, miRNAs function as part of the 
RNA induced silencing complex (RISC), directing its repressive activity to target mRNA 
transcripts. There are over 300 known viral miRNAs, and despite increasing progress, the 
majority lack an in depth understanding of their functions. 
 
We have identified miRNAs encoded by diverse polyomaviruses (Cantalupo et al., 
2005; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009). Polyomaviruses have small 
circular DNA genomes and take up long-term persistent infections via incompletely-
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defined mechanisms. Although undoubtedly there exist important host targets, 
independent evolutionary-based rationales suggest that polyomaviruses and "polyoma-
like" viruses (i.e., BPCV1&2) utilize miRNAs to autoregulate early viral gene expression 
of the T antigen proteins (Chen et al., 2011). Despite being able to demonstrate 
autoregulatory activity of the polyomaviral miRNAs during lytic infection of cultured 
cells, the relevance of the polyomaviral miRNAs during natural infection remains 
unknown. 
 
Here we have utilized a comparative genomics strategy to determine the 
preservation of the miRNA allele amongst strains of diverse polyomaviruses. Our work 
demonstrates that loss of miRNA expression is rare. Those cases where null or 
hypomorphic strains are found occur in immunocompromised hosts and all preserve the 
amino acid coding potential of the overlapping large T antigen ORF. In depth 
characterization of K661, a Simian Virus 40 (SV40) miRNA hypomorphic strain, 
identifies a defect in the processing of the primary miRNA transcript (pri-miRNA). K661 
and a recombinant virus that rescues miRNA expression show only modest differences, if 
any, in virus growth in both immortalized and primary cells. Thus, the polyomaviral 
miRNAs are preserved in most natural settings but can be dispensable in certain cell 
culture and rare in vivo contexts. Combined, our work demonstrates that the functional 
importance of polyomaviral miRNAs is context dependent, consistent with an activity 





4.2.1 SV40 strain K661 is severely attenuated for miRNA expression. 
In order to better understand the functions of polyomaviral miRNAs, we 
attempted to identify conditions where polyomaviral strains null or hypomorphic for 
miRNA expression arise. As a starting point, we focused on SV40, for which we have 
previously used comparative genomics to examine the pre-miRNA loci from all 63 
strains deposited in Genbank (Chen et al., 2013). Our previous analysis identified 17 
different classes of SV40 strains that each had at least a single nucleotide change in the 
pre-miRNA genomic region. Of all different classes, only a single class, comprised of 
strains K661 (Figure. 4.1A – C) and I275, apparently fails to give rise to detectable 
miRNAs (Chen et al., 2013). We first set out to repeat these results. Plasmids containing 
a heterologous CMV promoter driving the K661 pre-miRNA genomic region were 
transfected into BSC-40 cells, and RNA was harvested and subjected to high-resolution 
denaturing polyacrylamide gel electrophoresis and Northern blot analysis (Chen et al., 
2013; Koscianska et al., 2011). This analysis confirmed that no bands consistent with 
either 5p or 3p derivative miRNAs are detectable from the K661 constructs. However, 
the 5p and 3p derivative miRNAs are readily detectable from the control plasmids 
encompassing the pre-miRNA regions from the reference "3-p-dominant" 776 and the 
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“5p-dominant” RI257 control strains ((Chen et al., 2013) and Figure 4.1D and E).  These 
results suggest that K661 has dramatically reduced miRNA expression.  
Because the above findings were derived from transfection-based studies, we next 
examined if similar results are obtained during infection. We infected BSC-40 cells with 
K661 virus (Lednicky et al., 1998) at a multiplicity of infection (MOI) of 10 PFU/cell , 
and conducted similar Northern blot analysis. Total RNA was harvested at 48 and 60 
hours post infection (hpi). This analysis confirmed the lack of detectable bands consistent 
with viral pre-miRNA and mature miRNA during K661 infection (Figure 4.2A and B, 
lanes ”K661”). Additional Northern blot analysis using the terminal loop, 5’ and 3’ 
flanking probes, which were designed to recognize the terminal loop of the pre-miRNA 
and regions upstream and downstream of the pre-miRNA location, respectively, did not 
reveal any potential derivative miRNAs located immediately upstream or downstream of 
the pre-miRNA region (data not shown). These results demonstrate that the K661 strain 
does not express a detectable level of miRNAs via Northern blot analysis during lytic 
infection. Importantly, miRNA bands are readily detectable from cells infected with 
control viruses, either the reference strain 776, which has a duplicated enhancer, or an 
archetype strain SVCPC, which similar to K661, has only a single copy of the enhancer 
(Figure 4.2A and B, lanes “776” and “SVCPC”). Combined with our previous results, 
these data demonstrate that K661 produces substantially less miRNAs than all other 
SV40 strains studied to date.  
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Next, we addressed whether there are any low abundance viral miRNAs generated 
during infection with K661. BSC-40 cells were infected at an MOI of 20 PFU/cell and 
total RNA was harvested at 40hpi. Small RNAs (~10-70 nucleotides long) were isolated, 
ligated to linkers, reverse transcribed, and subject to high throughput massively parallel 
sequencing. 1.9 million total reads were obtained. However, only 794 reads mapped to 
the K661 genome, of which, only 40 reads mapped to the pre-miRNA region of K661. 
This sample did however yield a prominent spike in the ~22 nucleotide size class of small 
RNAs mapping to the miRN repository miRBase, consistent with our libraries being 
enriched for miRNAs (Figure 4.3A). Importantly, infection with miRNA wildtype 776 
revealed an ~22 nucleotide peak mapping to the pre-miRNA region of the viral genome 
(Figure 4.3B). This peak was mostly absent in cells infected with K661. We note the lack 
of significant “miRNA-like” reads mapping to any other location of the K661 genome 
argues against the emergence of other possibly compensatory miRNA loci. These data 






Figure 4.1 SV40 strain K661 is severely attenuated for miRNA expression. 
(A) SV40 strain K661 represents one of the unique classes of variants in the pre-miRNA genomic region from a previously 
published sequence alignment of 63 fully sequenced SV40 genomes (Chen et al., 2013). Gaps in the alignment are indicated by 
“-“ and nucleotide substitution in the terminal loop is indicated by “*”. The corresponding nucleotide positions in the 776 
reference strain genome are labeled at the 5’ and 3’ ends of the sequence. The 5p (black) and 3p (gray) miRNA derivatives are 
underlined and indicated by the arrows. (B) Comparison of large T antigen amino acid sequence between 776 and K661. Gaps 
in the alignment are indicated by “-“. The large T antigen primary sequences are provided for both strain 776 and K661. (C) 
Predicted RNA secondary structures for 776 (top panel) and K661 (bottom panel). The genomic sequences from the alignment 
were subjected to mfold prediction of secondary hairpin structures. The 5p (black) and 3p (gray) miRNA derivatives are 
indicated. The genomic location of the three deleted guanosine residues is indicated by a black arrow. The nucleotide 
substitution in the terminal loop is indicated by “*”. (D and E) High-resolution Northern blot analysis reveals K661 strain as a 
miRNA-null variant of SV40. 293T cells were transfected with the K661, RI257 or the 776 miRNA expression vectors. Total 
RNA was harvested for high-resolution Northern blot analysis. The strain names are indicated at the top of both blots, and the 
blots were probed for either the (D) 5p or the (E) 3p derivative miRNAs. The bands corresponding to the pre-miRNA (white 
arrowhead), the 5p (black arrowhead) and the 3p (gray arrowhead) miRNA derivatives are indicated. As a loading control, 
ethidium bromide-stained low-molecular-weight RNA is shown in the bottom panel and indicated as “EtBr”. 
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Figure 4.2 SV40 strain K661 is severely attenuated for miRNA expression during 
infection.  
Northern blot analysis of SV40 miRNA expression during lytic infections. BSC-40 cells 
were either mock infected, infected with 776, K661, or SVCPC, an archetype SV40 strain 
at an MOI of 10. Total RNA harvested from 48 and 60hpi was subjected to Northern blot 
analysis. Probes designed to recognize the (A) K661 3p miRNA derivative region and the 
(B) K661 5p miRNA derivative region. The bands corresponding to the pre-miRNA 
(white arrowhead), 3p (gray arrowhead) and 5p miRNA (black arrowhead) miRNA 
derivatives are indicated. As a loading control, ethidium bromide-stained low-molecular-
weight RNA is shown in the bottom panel for each blot and indicated as “EtBr”.The 
K661 pri-miRNA is a poor Microprocessor substrate. 
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Figure 4.3 SV40 strain K661 is hypomorphic for miRNAs expression.  
Coverage plot of the deep sequencing reads from (A) K661 and (B) 776 infected BSC-40 
cells. The number of reads that mapped to the indicated viral genomes are represented by 
the black bars. The number of reads that mapped to the miRNA database, miRBase are 
represented by the white bars. The x-axis represents the length of the reads that mapped 




4.2.2 The K661 pri-miRNA is a poor Microprocessor substrate. 
 
K661 has a three nucleotide deletion mapping to the genomic region containing 
the 5p arm of the pre-miRNA. The nucleotide deletion still allows for preservation of the 
large T antigen amino acid coding potential which overlaps the pre-miRNA locus in the 
opposite orientation. To better understand why K661 has such reduced miRNA levels, we 
re-examined the Northern blot analysis. In addition to the absence of a miRNA band, 
these blots show no detectable pre-miRNA band (Figure 4.1D and E ), consistent with a 
defect in Microprocessor processing of the pri-miRNA. To test this hypothesis, we took 
advantage of a luciferase-based Microprocessor efficiency assay (Ref James’ latest 
(Kincaid et al., 2012; Lin and Sullivan, 2011)). We cloned the pre-miRNA genomic 
regions from either K661 or 776 into the 3’ UTR region of a destabilized Renilla 
luciferase reporter construct (R. luc, Figure 4.4A). As expected, co-transfection of these 
constructs with plasmids expressing Drosha and DGCR8 resulted specific reduction in 
luciferase signal (approximately 70%) consistent with cleavage of the R. luc reporter 
mRNAs by Microprocessor. Importantly, K661 pre-miRNA reporters retained most of 
their activity upon co-expression of exogenous Microprocessor, consistent with an 
ineffective processing (Figure 4.4B). Combined with the Northern blot analysis, these 
results suggest the K661 pri-miRNA is only weakly processed by Microprocessor, 
thereby accounting for at least part of the attenuation of miRNA expression. 
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4.2.3 Rescue of K661 pri-miRNA by restoring four nucleotides.  
K661 represents the only known pre-miRNA class with an internal deletion 
within the pre-miRNA stem region (Chen et al., 2013). To test if this internal deletion 
contributes to the inefficient processing of the K661 pre-miRNA hairpin, we inserted the 
three missing guanosine residues into the K661 heterologous expression vector and 
named the resulting construct “K661+3G”. Northern blot analysis demonstrated that this 
resulted in a partial but substantial rescue of miRNA expression (Figure 4.4C). To 
independently test this construct, we generated an R. luc Microprocessor reporter 
containing the K661+3G chimeric hairpin in its 3’ UTR. Unlike the K661 reporter, co-
transfection of Drosha and DGCR8 expressing plasmids with the K661+3G reporter 
resulted in ~40% reduction in Renilla luciferase activity (Figure 4.4B). The ~40% 
decrease observed, however, was less than the ~70% observed for the 776 pri-miRNA 
reporter. These results suggest that reinsertion of the three guanosine residues allows 
Drosha processing of the K661 pre-miRNA hairpin, but not to the same efficiency as the 
776 pre-miRNA hairpin. Thus, in addition to the three guanosine residues, other 
sequences and/or structural motifs in the K661 pri-miRNA also contribute to the 
decreased miRNA expression. Therefore, we made an additional change, converting the 
adenine located in the terminal loop of the K661 hairpin (Figure 4.1A) to a guanosine, as 
is found in the 776 reference strain, and named the resulting construct 
“K661+3G+776L”. Both Northern blot and reporter construct analyses indicated that 
replacing the three deleted guanosine residues and converting the terminal loop adenine 
to a guanosine residue was able to substantially rescue the K661 hairpin processing 
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(Figure 4.4B and C). These data define sequence changes in the K661 that can account 




Figure 4.4 Rescue of K661 pri-miRNA by restoring four missing nucleotides.  
(A) Diagram of the K661 and 776 hairpin luciferase reporter. The vectors consist of a 
Renilla luciferase reporter upstream of a single copy of the hairpin structures in the 3’ 
UTR as indicated. (B) The reporters from panel A were co-transfected with firefly 
luciferase expression vector individually into 293T cells, and the Renilla luciferase 
readings (R. Luc) were normalized to the firefly luciferase readings (FF. Luc) and plotted 
on the y-axis. Either the pcDNA3.1neo vector alone or pCK-Drosha-FLAG and pcDNA-
DGCR8-FLAG (1:1) were transfected along with the reporters as well, represented by the 
white and grey bars respectively. The x-axis indicates the different hairpin structures 
cloned into the 3’ UTR of the Renilla luciferase reporter construct. As a negative control, 
Renilla luciferase without 3’ UTR hairpin was used. P values were computed using 
Student’s t test. “*” indicates P < 0.005, “**” indicates P < 0.001, “N.S.” indicates no 
statistical significance. (C) High-resolution Northern blot analysis of K661 rescue 
miRNA expression vectors transfected 293T cells. 293T cells were transfected with 776, 
K661, K661+3G or K661+3G+776L miRNA expression vector. Total RNA was 
harvested and subjected to high-resolution Northern blot analysis. The blot was probed 
for the 3p miRNA derivative. The identities of the expression vectors are indicated at the 
top of the blot. The bands corresponding to the pre-miRNA (white arrowhead) and the 3p 
(gray arrowhead) miRNA derivatives are indicated. A longer exposure of the blot is 
provided in the middle panel to better visualize the 3p miRNA derivatives and indicated 
as “Dark”. As a loading control, ethidium bromide-stained low-molecular-weight RNA is 
shown in the bottom panel and indicated as “EtBr”. 
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4.2.4 Restoring miRNA expression does not result in substantial differences in virus 
growth of K661. 
Our previous cell culture studies with the non-archetype 776 strain failed to 
uncover major differences in virus growth between the wild type reference strain virus 
(776) and one engineered to not express the miRNA (“SM”) (Sullivan et al., 2005). 
However, Broekema and Imperiale recently demonstrated a phenotype for the related 
human polyomavirus BKPyV when it was engineered to lack miRNA expression and 
infections were performed in primary renal proximal epithelial tubule cells (Broekema 
and Imperiale, 2013). Because the phenotype observed by Brokema and Imperiale was 
dependent on the virus having non-rearranged enhancers, we wished to explore if K661 
(which unlike SM lacks a duplicated enhancer), might more readily display miRNA 
effects.  
 
We first engineered a recombinant K661 virus that makes the 776 miRNA 
derivatives by swapping nucleotide position 2770 to 2863 of the corresponding 776 pre-
miRNA region into K661. We named this recombinant virus “K661-776miR”. Northern 
blot analysis of RNA harvested from infected cells confirmed that K661-776miR 
expresses the miRNA (Figure 4.5A). Next we confirmed activity of the miRNA by 
demonstrating that cells infected with K661-776miR give rise to the 3’ early mRNA 
cleavage fragments that we previously have demonstrated are dependent on miRNA-
mediated cleavage (Figure 4.5A, (Chen et al., 2013; Sullivan et al., 2005)). These studies 
demonstrate that replacing nucleotide position 2770 to 2863 in an otherwise K661 genetic 
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background is fully competent to give rise to bioactive viral miRNAs and a replication 
competent chimeric virus. 
 
To determine if restoring the miRNA to K661 results in altered virus replication 
kinetics or yield, BSC-40 cells were infected at an MOI of 10 PFU/cell and media was 
harvested at various times post-infection. As measured by immune staining and flow 
cytometry for infected cells, single step replication cycle analysis of both K661 and 
K661-776miR infections revealed little to no differences (at most less than 1.6-fold 
increase) in the end-point titer for K661-776miR at 96hpi (Figure 4.5B). Besides having 
comparable end point titers, the single step replication cycle kinetics were also highly 
similar between the two viruses (Figure 4.5B). To test virus growth via an independent 
assay, we also determined the release of viral genomes into the supernatant. In agreement 
with our flow cytometry-based infectious assay, real time quantitative PCR (qPCR)-
based quantitation of viral genomes present in the extracellular supernatant did not detect 
any significant differences between K661 and K661-776miR (data not shown). For 
increased sensitivity, we next conducted a multi-step virus replication cycle analysis over 
a 15-day period. Cells were infected at an MOI of 0.01 PFU/cell and approximately every 
3 days post infection (dpi) media was collected. Similar to the single step replication 
cycle analysis, no robust differences in end point titer, replication kinetics, or 
extracellular viral genomes were observed between K661 and K661-776miR (Figure 
4.5C). Finally, we repeated the multiple step virus replication assays on primary rhesus 
kidney epithelial cells. Immunofluorescent microscopy analysis for large T antigen 
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confirmed that primary epithelial cells were readily infected with SV40 (data not shown).  
This analysis revealed that at most, only a subtle difference of less than 2-fold growth 
advantage is observed for K661 over K661-776miR (Figure 4.5D). Combined, these data 
argue that at least in cultured cells, restoring miRNA expression to the proto-archetype 




Figure 4.5 Restoring miRNA expression does not result in substantial differences in 
virus growth of K661.  
(A) K661-776miR is a replication competent chimeric virus. K661-776miR was 
generated by swapping the K661 pre-miRNA genomic region with the corresponding 
region in 776. BSC-40 cells were infected with either 776 (WT), K661 (K) or K661-
776miR (K7) at an MOI of 10 PFU/cell. Total RNA was harvested and subjected to 
Northern blot analysis. Uninfected BSC-40 cells were used as a negative control (M). 
The blot was probed for the early transcript cleavage fragment. The bands corresponding 
to the early transcript cleavage fragment (black arrowhead) is indicated. The same RNA 
samples were subjected to Northern blot detection of the 776 3p derivative miRNA 
(indicated as “776 miRNA”). As a loading control, ethidium bromide-stained 28s 
ribosomal RNA is shown in the bottom panel and indicated as “28s rRNA”. (B to D) 
Replication cycle analysis of K661 and K661-776miR. BSC-40 cells were infected with 
either K661 or K661-776miR at an MOI of either (B) 10 or (C) 0.01 PFU/cell. (D) 
Primary rhesus macaque kidney epithelial cells were infected with either K661 or K661-
776miR at an MOI of 0.01 PFU/cell. Supernatant was collected at the time points 
indicated, followed by three rounds of freeze-thaw cycles. The supernatant was titered via 
flow cytometry (Drayman et al., 2010). The titer was determined in terms of PFU/mL and 
plotted on the y-axis. The time points are plotted on the x-axis. The K661 infections are 
indicated as solid lines and the K661-776miR infections are indicated as dotted lines. 
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4.2.5 miRNA-null variants of JCV can arise in humans.  
To determine if other polyomaviruses give rise to strains that are 
null/hypomorphic for miRNA expression, we bioinformatically compared a combined 
3145 different strains of polyomaviral genomes deposited in Genbank. We examined 528 
JCV, 2325 BKV and 292 MCPyV strains. We specifically examined the pre-miRNA 
genomic region with an additional 30 nucleotides of flanking sequence on both sides of 
the precursor hairpin. First, we aligned each to the relevant reference genomes to identify 
those with nucleotide variations in the pre-miRNA genomic region. Those that shared 
93% or less sequence identity with the miRNA-positive reference strain were selected for 
further study. These were then subjected to mfold analysis to identify predicted structures 
inconsistent with the features of a typical pre-miRNA. Using these criteria, we did 
identify any potential miRNA-null strains of BKV or MCPyV, however, we identified 2 
candidates for further study, both strains of JCV (Table 4.1). JCV strain Seq 3-5 contains 
two point mutations in the terminal loop region and a six base pair duplication in the 3p 
mature miRNA, and JCV strain HWM contains a 18 base pair deletion on the 5p side of 
the hairpin including a large portion of the 5p arm of the pre-miRNA region (Figure 
4.6A). As with SV40 K661, these mutations do not alter the amino acid reading frame of 
the large T antigen (Figure 4.6B). Mfold secondary structural analysis predicted distorted 
secondary hairpin structures for both HWM and Seq-3-5, with both unlikely to serve as 
substrates for the Microprocessor (Figure 4.6C). HWM exhibits a shorter, truncated 
hairpin and Seq 3-5 contains an internal bulge that generates a kink in the hairpin 
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structure. We cloned these pre-miRNA and flanking genomic regions behind a 
heterologous promoter that we have previously established is sufficient to drive miRNA 
expression (Figure 4.1 and (Seo et al., 2008)). Although the positive control Mad-1 
reference strain produced readily detectable miRNAs, as predicted from the secondary 
structure analysis, the pre-miRNA genomic regions from both HWM and Seq 3-5 failed 
to produce any specific miRNA products that are detectable by Northern blot analysis 
(Figure 4.6D and E, lanes “Seq 3-5” and “HWM”). This suggests, that similar to SV40 
K661, JC viruses null or hypomorphic for miRNA expression can arise during in vivo 
infection of immunocompromised hosts.
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Table 4.1. SV40, JCV, BKV and MCPyV pre-miRNA sequences examined. 
















SV40 63 1 62 (98.4%) 1/1 
JCV 528 2 526 (99.6%) 2/2 
MCPy
V 292 0 292 (100%) - 





Figure 4.6 miRNA-null variants of JCV can arise in humans.  
(A) More than six hundred JCV pre-miRNA genomic sequences were subjected to sequence alignment (Kearse et al., 2012). 
Gaps in the alignment are indicated as “-“. The nucleotide position is indicated above the reference JCV strain, Mad-1, at both 
the 5’ and 3’ ends. The 5p (black) and 3p (gray) miRNA derivatives are underlined and indicated by the arrows. (B) The large 
T antigen amino acid sequences of strains Mad-1, Seq 3-5 and HWM are aligned. Gaps in the alignment are indicated as “-“. 
The amino acid position is indicated above strain Mad-1. (C) Predicted RNA secondary structures for Mad-1 (top panel), Seq 
3-5 (middle panel) and HWM (bottom panel). The genomic sequences from the alignment were subjected to mfold prediction 
of secondary hairpin structures. The 5p (black) and 3p (gray) miRNA derivatives are indicated for strain Mad-1. (D and E) 
Northern blot analysis reveals Seq 3-5 and HWM are miRNA-null JCV strains. 293T cells were transfected with the individual 
JCV strains miRNA expression vectors. A plasmid expressing the bovine leukemia virus (BLV) B1 miRNAs was co-
transfected into 293T cells as a transfection control ((Kincaid et al., 2012) indicated as “BLV-B1”). Total RNA was harvested 
for regular Northern blot analysis at 48 hours post transfection. The strain names are indicated at the top of each blot. The blots 
were probed using the HWM 3p probe, Seq 3-5 3p probe or the BLV-B1 3p probe. The bands corresponding to the JCV pre-
miRNA (white arrowhead) and the JCV 5p derivative miRNA (black arrowhead) are indicated. As a loading control, ethidium 





Diverse viruses, including members of the herpes, polyoma and retro virus families 
encode miRNAs, but an depth understanding of their functions remains a work in 
progress. Our previous work has established that at least 6 different polyomaviruses 
encode miRNAs that are all capable of autoregulating T antigen transcripts expression via 
RISC-mediated cleavage (Chen et al., 2013; Seo et al., 2008, 2009; Sullivan et al., 2005, 
2009). Furthermore, bandicoot papillomatosis viruses 1 & 2 (BPCV 1 & 2), hybrid 
polyomavirus-papilloma viruses, also encode miRNAs capable of regulating the T 
antigen transcripts, albeit this likely does not occur through RISC-mediated direct 
cleavage of the target transcripts (Chen et al., 2011). The conservation of miRNA-
mediated regulation of the T antigen transcripts in such diverse viruses implies that this is 
advantageous to the lifecycles of some polyoma and polyoma-like viruses. However, the 
exact component(s) of the virus lifecycle where miRNA-mediated autoregulation is 
relevant remains unclear. Here, we set out to identify polyomavirus variants that are 
null/attenuated for miRNA expression (and the conditions where they can arise) in an 
attempt to better understand miRNA function in the polyomavirus lifecycle. 
 
We bioinformatically screened over 3208 strains from 4 different polyomaviruses. 
From this, we identified only three virus strains, one SV40 and two JC viruses, that have 
lost the ability to code for miRNAs. Although we cannot rule out that our approach 
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missed additional strains hypomorphic for miRNA production, we can say with 
confidence that major aberrations to the pre-miRNA genomic region are only rarely 
observed (Table 4.1). How do variants attenuated for miRNA production arise? Two of 
the miRNA null/attenuated viruses we identified arose from small deletions in the pre-
miRNA region, and one from a small insertion. Interestingly, all three variants preserve 
the amino acid reading frame of the large T antigen (Figure 4.1 and 4.6), demonstrating 
that while loss of the miRNA expression may be tolerated in some circumstances, 
naturally arising large T antigen truncations are not detected. Our in depth 
characterization of SV40 K661 demonstrates that at least part of the defect in miRNA 
biogenesis is due to an inefficient early processing event of the pri-miRNA. Both 
Northern blot analysis and a luciferase-based Drosha-mediated cleavage assays suggest 
that the K661 pre-miRNA region is a poor substrate for Microprocessor (Figure 4.4). 
Structural predictions from the pre-miRNA regions of both JCV strains, Seq 3-5 and 
HWM, suggest that they are also poor Dicer substrates (Figure 4.6C). Thus, a picture 
emerges whereby rare occurrences of miRNA attenuated/null polyomaviruses can occur 
due to defects in Drosha processing, but preservation of the carboxy terminus of large T 
antigen remains essential.  
 
All three miRNA null/attenuated polyomaviruses that we identified were detected 
in severely immunocompromised hosts. Although immunocompromisation is clearly not 
sufficient to give rise to miRNA attenuated/null polyomaviruses (as the vast majority of 
deposited JCV strains are from immunocompromised patients suffering from Progressive 
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multifocal leukoencephalopathy (PML)), this nonetheless may be an informative 
observation given previous reports suggesting a possible link for the polyomaviral 
miRNAs in suppressing the immune response (Bauman and Mandelboim, 2011; Bauman 
et al., 2011). Previous studies in cell culture and in vivo failed to identify any defect in 
various polyomaviruses engineered to lack miRNA expression (Sullivan et al., 2005, 
2009), and in certain conditions such mutants actually display a replicative advantage 
(Broekema and Imperiale, 2013; Zhang et al., 2014). Nonetheless, the high degree of 
conservation of the polyomaviral miRNAs implies a fitness disadvantage for strains that 
lose the miRNA. Therefore an important challenge for the future is developing an in vivo 
model system where a fitness cost is observable for miRNA mutant viruses. In light of 
our findings, a likely fruitful pursuit in this arena is determining experimental conditions 
that better approximate natural infection and immune response. 
 
All three polyomaviral miRNA attenuated/null polyomaviruses that we have 
identified likely arose during infection of an immunocompromised host (Table 4.2). The 
JCV strain Seq 3-5 was detected in the cerebral spinal fluid (CSF) of a severely 
immunocompromised patient suffering from PML (Dang and Koralnik, 2006). Seq 3-5 
arose upon a six base pair insertion within the 3p arm of the pre-miRNA genomic region 
(Zheng et al., 2005). We reach this conclusion because the distinct enhancer region and 
other atypical identifying genomic features of Seq-3-5are observed in other JCV strains 
isolated from the same patient, yet these parental strains still preserve an in tact pre-
miRNA genomic region (Zheng et al., 2005). For SV40 K661, it seems likely that the 
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immunocompromised host where K661 was isolated from was de novo infected with this 
virus (Lednicky et al., 1998). We base this hypothesis on the observation that a very 
closely related SV40 strain, I275, was isolated from an older immunocompromised host 
rhesus macaque housed at the same primate center. The host, from which I275 was 
isolated, also contained highly similar SV40 strains with the same genomic “fingerprint” 
(same genetic features in the non-coding control region), except that they contained the 
pre-miRNA genomic region in tact (Newman et al., 1998). Thus, it seems that under 
some circumstances, SV40 viruses defective for miRNA production can be transmitted. 
In this example, it is important to note that out of the eight rhesus macaques hosts tested, 
only the host of K661 did not have a neutralizing antibody response to SV40 (Lednicky 
et al., 1998). Thus, we cannot rule out the possibility that transmission of miRNA 
defective K661 is an uncommon event due to atypical immunocompromisation of the 
recipient host. Although immunocompromisation is clearly not sufficient to give rise to 
miRNA attenuated/null polyomaviruses (as the vast majority of deposited JCV strains are 
from immunocompromised patients suffering from Progressive multifocal 
leukoencephalopathy (PML)), our findings may nonetheless be informative given 
previous reports suggesting a possible link for the polyomaviral miRNAs in suppressing 
the immune response (Bauman and Mandelboim, 2011; Bauman et al., 2011).  
 
In summary, we show that polyomaviruses defective for miRNA expression can 
infrequently arise during in vivo infection. Our results show that loss of the miRNA can 
be observed under conditions of immune suppression, consistent with a functional role 
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that is most important in hosts/model systems possessing an in tact immune response. As 
most polyomavirus-associated disease is thought to derive from dysregulation of 
persistent infection, testing such a model should advance our understanding of disease 




Table 4.2. Isolation of miRNA-null/attenuated strains of SV40 and JCV in 
immunocompromised host. 
Viruses Strains Host Detected Immunocompromisation 
SV40 K661 Rhesus macaque SIV-infected, SV40-
induced lesions in brain, 
lung, thymus, small 
intestine and kidney. No 
detectable level of SV40 
neutralizing antibody. 
SV40 I275 Rhesus macaque SIV-infected, minimal 
retroviral encephalitis. 
SV40-induced lesions. 
JCV HWM Human HIV-positive, PML 
lesions in the hemispheric 
white matter. 
JCV Seq 3-5 Human PML, quadriplegia and 
pseudobulbar paralysis  
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4.4 MATERIALS AND METHODS 
 
4.4.1 SV40 and JCV sequence analysis and alignment.  
63 unique SV40 complete and 656 genome sequences were aligned based on a ~ 
120bp region encompassing the pre-miRNA, using the Geneious software (Biomatters, 
New Zealand, (Kearse et al., 2012)). The genome accession numbers of the miRNA-
positive reference strains are as follows: SV40 (J02400.1), JCV (NC_001699), BKV 
(NC_001538), MCPyV (EU_375803). 
 
4.4.2 Cell culture and RNA isolation.  
Human embryonic kidney 293T cells (HEK293T), African green monkey kidney 
epithelial cells BSC-40 were obtained from the American Type Culture Collection 
(Manassas, VA). All cell cultures were maintained in Dulbecco’s modified Eagle’s 
medium supplemented with 10% fetal bovine serum (Life Technologies, Carlsbad, CA). 
Total RNA was harvested using an in-house PIG-B solution as described previously 
(Chen et al., 2011; Lin et al., 2010; Seo et al., 2008; Weber et al., 1998). 
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4.4.3 MiRNA expression vector construction, transfection, and Northern blot 
analysis.  
All DNA vector constructs were sequence verified through sequence analysis at 
the Institute of Cellar and Molecular Biology Sequencing Facility at the University of 
Texas at Austin. The primers used in the construction of 776, K661 and RI257 miRNA 
expression vectors have been listed previously (Chen et al., 2013). The primers used in 
the construction of K661+3G and seven unique JCV miRNA expression vectors are listed 
in Table 4.3. The construction of wild type JCV (Mad-1) miRNA expression vector has 
been described previously (Seo et al., 2008). Briefly, the primers are annealed and filled-
in using Phusion High-Fidelity DNA polymerase (New England BioLabs, Ipswich, MA) 
according to the manufacturer’s protocol. The PCR products are cloned into the 
KpnI/XhoI or the XhoI/XbaI sites of the pcDNA3.1 expression vector. 293T cells were 
plated in 6-wells plates and transfected with the expression vectors using the 
Lipofectamine 2000 transfection reagent (Life Technologies) according to the 
manufacturer’s instruction. As a negative control, cells were transfected with empty 
pcDNA3.1neo vector. Total RNA was harvested at 48 hours post-transfection. Total 
RNA from SV40 strain miRNA expression vectors transfected 293T cells were subjected 
to a modified version of high-resolution Northern blot analysis (Chen et al., 2013; 
Koscianska et al., 2011), and total RNA from JCV strain miRNA expression vectors 
transfected 293T cells were subjected to regular Northern blot analysis (Sullivan et al., 
2005). A plasmid expressing the bovine leukemia virus (BLV) B1 miRNAs was co-
transfected as a transfection control (Kincaid et al., 2012). Briefly, 30 micrograms of total 
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RNA (High-resolution) or 10 micrograms of total RNA (regular) was separated on a Tris-
borate-EDTA-Urea-15% denaturing polyacrylamided gel. The bromophenol blue marker 
was allowed to migrate 30cm (High-resolution) or 7cm (regular) along the length of the 
gel. The RNA was transferred onto a Hybond N+ membrane (GE Healthcare, Pittsburgh, 
PA). The probe sequences used are listed in Table 4.4. 
 
4.4.4 Construction of the K661-776miR virus.  
To generate the K661-776miR chimeric virus, PCR was used to amplify the 776 
pre-miRNA region (nucleotide position 2770 to 2863). Two sets of overlapping PCR 
were then performed to generate the resulting K661-776miR chimeric fragment. The 
K661 viral DNA was digested and cloned into the BamHI site of the pUC19 vector, 
generating pUC19-K661. The K661-776miR PCR fragment was digested and cloned into 
the BamHI/BstXI sites of the pUC19-K661 vector to generate pUC19-K661-776miR. 
The K661-776miR chimeric virus was produced as described previously (Kraus and 
Mertz, 2001). Briefly, pUC19-K661-776miR was digested with BamHI, followed by 
intramolecular ligation of the viral DNA. The ligation reaction was then transfected into 
BSC-40 and further amplified. The primers used are listed in Table 4.3. 
 
4.4.5 Luciferase Assays.  
The viral pre-miRNA hairpin 3’ UTR reporters were constructed by cloning the 
pre-miRNA region of each strain using the primers listed in Table 4.3. Briefly, the PCR 
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products are generated using Phusion High-Fidelity DNA polymerase (New England 
BioLabs) according to the manufacturers protocol, and cloned into the pcDNA3.1dsRluc 
vector, which expressed a destabilized version of Renilla luciferase. 293T cells were 
plated in 24-wells plates and transfected using the Turbofect transfection reagent 
(Thermo Scientific, Waltham, MA). In addition to the individual reporters, 293T cells 
were co-transfected with pCK-Drosha-FLAG and pcDNA-DGCR8-FLAG at a ratio of 
1:1. 293T cells were also transfected with the empty Renilla reporter construct as a 
negative control. The pcDNA3.1Luc2CP vector was also co-transfected to normalize for 
transfection efficiency. The transfected cells were collected and lysed at 24 hours post-
transfection and analyzed with the Dual-luciferase reporter assay system (Promega, 
Fitchburg, WI) according to the manufacturer’s instruction. The luciferase readings were 
collected via a Luminoskan Ascent microplate luminometer (Thermo Scientific). The 
readings from the Renilla luciferase were normalized to the readings from the firefly 
luciferase, and the ratios were plotted as a bar graph relative to the empty vector control. 
 
4.4.6 SV40 infections for single and multi-replication cycle analyses.  
BSC-40 cells were seeded in 6-wells plates. The cells were infected with either 
K661 or K661-776miR when the cells were freshly confluent. For single-replication 
cycle analysis, cells were infected at an MOI of 10, for multi-replication cycle analysis, 
cells were infected at an MOI of 0.01. 500 microliters of viral inoculum was used for 
each well after aspiration of the original media, with each infection performed in 
triplicates. The plates were rocked back-and-forth every 15 minutes for 2 hours at 37°C 
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(Tremblay et al., 2001). The viral inoculum was replaced with DMEM supplemented 
with 2% FBS. For multi-replication cycle analysis in primary rhesus macaque kidney 
epithelial cells (Diagnostic Hybrids, Athens, OH), cells were also infected at an MOI of 
0.01. 200 microliters of viral inoculum was used for each vial of cells and infection was 
performed as described above. For the single-replication cycle analysis, supernatant was 
collected and subjected to three rounds of freeze-thaw cycles every 24 hours post 
infection, from 24 to 96 hours post infection. For the multi-replication cycle analysis, 
supernatant was subjected to the same freeze-thaw cycles every 3 days post infection, 
from 3 to 15 days post infection (for BSC-40) or every 4 days post infection, from 4 to 16 
days post infection (for the primary rhesus macaque kidney epithelial cells).  
 
4.4.7 Titering of supernatant via flow cytometry.  
The supernatant was titered using a modified version of the protocol published 
(Chen et al., 2013; Drayman et al., 2010). Briefly, BSC-40 cells were seeded in 6-wells 
plate and infected with diluted supernatant as described above. The infected cells were 
harvested using cell dissociation buffer (Life Technologies). Cells were fixed, 
permeabilized and stained for large T antigen using the pAB416 antibody (kindly 
provided by Dr. Jim Pipas) as previously described (Chen et al., 2013). The cells were 
analyzed using a BD ACCURI C6 flow cytometer (BD Biosciences, San Jose, CA). The 
titer for the supernatant was determined from a standard curve generated using viral 
stocks with known titers. 
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4.4.8 Titering of supernatant via real time quantitative PCR (qPCR).  
The supernatant was also titered using a modified version of the protocol 
published (Murata et al., 2009). Briefly, the collected supernatant was diluted by a 
hundred fold in water. One microliter of the diluted supernatant was used in a twenty 
microliters qPCR reaction with ten microliters of 2X PerfeCTa® SYBR® Green FastMix® 
ROX master mix (Quanta Biosciences, Gaithersburg, MD), 0.2 microliters each of the 
forward and reverse primer at 10μM. The qPCR reactions were performed on a ViiATM 7 
Real-Time PCR system (Life Technologies). For the quantification of the absolute 
number of viral genome equivalence, a serial dilution of pUC19-K661 vector was 
included as well. 
 
4.4.9 Small RNA library and computational analysis of sequencing reads.  
BSC-40 cells were seeded in T75 tissue culture flask and infected with K661 at an 
MOI of 20 as described above. Total RNA from the infected cells was harvested at 40hpi. 
The small RNA fraction was gel fractionated as previously described and subjected to 
SOLiD next generation sequencing as previously described (Chen et al., 2013; Lin et al., 
2010). The next generation sequencing analysis of 776 infected BSC-40 was obtained 
from a previously published report (cite chen Sullivan 2013). 
4.4.10 Northern blot analysis of cleavage fragments of early transcripts. 
BSC-40 cells were seeded in 6-wells plates and infected with 776, K661 or K661-
776miR at an MOI of 10 as described above. Total RNA was harvested at 48 and 60hpi 
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as described above. 10 micrograms of total RNA was subjected to 1.5% denaturing 
MPOS-formaldehyde-agarose gel electrophoresis as described (Molecular cloning 
manual). The RNA was transferred onto Nytran SPC nylon transfer membrane (GE 
Healthcare Life Sciences, Pittsburgh, PA) using the TurboBlotter System (GE Healthcare 
Life Sciences) according to the manufacturer’s instructions. The membrane was probed 
for the cleavage fragment of viral early transcripts in ExpressHyb hybridization solution 
(Clontech) at 45°C. The probe sequences used are listed in Table 4.4. 
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Table 4.3 List of primers for the construction of miRNA expression vectors, K661-776miR chimeric virus and 3’ UTR 
hairpin reporter constructs. 
 
Construction of JCV miRNA expression vectors 
JCV HWM Long 
Forward CTTTACAGATGTGATAGGTGCAGTGTTCCTGTGTGTCTGCACCAGAGGCTTCTGAGACCTGAGATTCAGTGCTTGATCCATG 
JCV HWM Long 
Reverse GGGGAGACCCATTCTTGACTTTCCTAGAGAGGAAGATTCTGAAGCAGAAGACTCTGGACATGGATCAAGCACTGAATCTCAG 
JCV miR KpnI 
Forward ATCGATCGAGGTACCCTTTACAGATGTGATAGGTGCAGTGTTC 
JCV miR XhoI 
Reverse ATCGATCGACTCGAGGGGGAGACCCATTCTTGACTTTC 
SAM-12 Forward ACTGCTCGAGAGGTGCAGTTTTCCTGTGTGTCTGCACCAAAGGCTTCTGAAACCTGGGAAAAGCATTGTGATTGTGATTCAGT 
SAM-12 Reverse ACTGTCTAGAACTTTCCTAGAGAGGAAGATTCTGAAGCAGAAGACTCTGGACATGGATCAAGCACTGAATCACAATCACAATG 
Seq 3-5 Forward ACTGCTCGAGAAGTGCAGTGTTCCTGTGTGTCTGCACCAGAGGCTTCTGAGACCTGGGAAAAGCATTGTGACTGAGATTCAGTGCT 
Seq 3-5 Reverse ACTGTCTAGAACTTTCCTAGAGAGGAAGATTCTGAAGCAGAAGACTCTGGACATGGACATGGATCAAGCACTGAATCTCAGTCACA 
FC-1 Forward ACTGCTCGAGAAGTGCAGTGTTCCTGTGTGTCTGCACCAGAGGCTTCTGAGACCTGGGAATAGCATTGTGATTGAGATTCAGT 
FC-1 Reverse ACTGTCTAGAACTTTCCTAGAGAGGAAGATTCTGAAGCAGAAGACTCTGGACATGGATCAAGCACTGAATCTCAATCACAATG 
JAL Forward ACTGCTCGAGAAGTGCAGTGTTCCTGTGTGTCTGCACCAGAGGCTTCTGAGACCTGGGAAGAGCATTGTGATTGAGATTCAGT 
JAL Reverse ACTGTCTAGAACTTTCCTAGAGAGGAAGATTCTGAAGCAGAAGACTCTGGACATGGATCAAGCACTGAATCTCAATCACAATG 
FL-7 Forward ACTGCTCGAGAAGTGCAGTTTTCCTGTGTGTCTGCACCAGAGGCTTCTGAGACCTGGGAAAAGCATTGTGATTGTGATTCAGT 
FL-7 Reverse ACTGTCTAGAACTTTCCTAGAGAGGAAGATTCTGAAGCAGAAGACTCTGGACATGGATCAAGCACTGAATCACAATCACAATG 
MO-1 Forward ACTGCTCGAGAAGTGCAGTGTTCCTGTGTGTCTGCACCAGAGGCTTCTGAGACCTGGGAAAAGCATTGTGATTGAGATTCAGT 
MO-1 Reverse ACTGTCTAGAACTTTCCTAGAGAGGAAGATTCTGAAGCAGAAGACTCTGGACATGGATCAAGCACTGAATCTCAATCACAATG 
Construction of K661+3G miRNA expression vector 
K661+3G Forward GATGTGATATGGCTGATTATGATCATGAACAGACTGTGAGGACTGTGAGGGCTGAGGGGCCTGAAATGAGCCTTGAGACTGTGAATCAA 
K661+3G Reverse CAGCCAGGAAAATGCTGATAAAAATAGAACATGGAAGACTCAGGGCATGAAACAGGCATTGATTCACAGTCTCAAGGC 
Construction of K661-776miR 
776 miRNA Reverse AGAACATGGAAGACTCAGGGC 
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Table 4.3, cont.  
miRNA antisense GTCCTCACAGTCTGTTCATGATCA 
miRNA sense GCCCTGAGTCTTCCATGTTCT 
K661 BamHI Forward CTGGGGATCCAGACATGATAAGATA 
K661 BstXI Reverse AAAGATCCACTTGTGTGGGTTG 
Construction of pre-miRNA hairpin reporter constructs 
SV40 miR Forward ATCGATCGACTCGAGTTATGTTTCAGGTTCAGGGGG 
776 miR Reverse ATCGATCGATCTAGAGTGGCTATGGGAATTGGAG 
K661 miR Reverse ATCGATCGATCTAGAGTGGCTATGGGAGTTGGAG 
K661+3G Forward GCATCCTCGAGGATGTGATATGGCTGATTATGATC 
K661+3G Reverse GACTAGGCCCCAGCCAGGAAAATGCTGATAAAAATG 
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Table 4.4 List of probes used in the Northern blot analysis. 
 
Northern Blot Probes 
776 3p probe CTCAGGGCATGAAACAGGC 
JCV 5p probe CAATCACAATGCTTTTCCCAGGTCTCAGAAGCCTCT 
JCV 3p probe CAGAAGACTCTGGACATGGATCAAGCACTGAATCA 
JCV loop probe AGCACTGAATCACAATCACAAT 
JCV HWM 5p probe CTGAATCTCAGGTCTCAGAAGCCTCTGGTGCAGA 
JCV HWM 3p probe TCTGAAGCAGAAGACTCTGGACATGGATCAAGCA 
JCV HWM loop probe GAATCAAGCACTGAATCTCA 
SAM-12 5p probe CAATCATGCTTTTCCCAGGTTTCAGAAGCCTTTGGTGCAGA 
SAM-12 loop probe CACTGAATCACAATCACAATG 
SAM-12 5' flank probe TTGGTGCAGACACACAGGAAAACTGCACCT 
SAM-12 3' flank probe ACTTTCCTAGAGAGGAAGATTCTGAAGCAG 
Seq 3-5 5p probe CAGTCACAATGCTTTTCCCAGGTCTCAGAAGCCTCTGGTGCAGA 
Seq 3-5 3p probe TCTGAAGCAGAAGACTCTGGACATGGACATGGATCAAGCACTGAATCTC 
Seq 3-5 loop probe CACTGAATCTCAGTCACAATG 
Seq 3-5 5' flank probe CTGGTGCAGACACACAGGAACACTGCACTT 
Seq 3-5 3' flank probe ACTTTCCTAGAGAGGAAGATTCTGAAGCAG 
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CHAPTER 5 Conservation of Viral MicroRNAs Among Diverse, 




Multiple members of the polyomavirus family have been shown to encode viral 
miRNAs (Cantalupo et al., 2005; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009). 
Based on their genomic location, the polyomaviral miRNAs can be catergorized into two 
groups. The “SV40-like” category encompasses the Simian Virus 40 (SV40), Simian 
agent 12 (SA12), BK virus (BKV) and JC virus (JCV) miRNAs (Cantalupo et al., 2005; 
Seo et al., 2008; Sullivan et al., 2005), which are located antisense to the C-terminus of 
the large T antigen coding region. The “muPyV-like” category, on the other hand, 
contains the murine polyomavirus (muPyV) and Merkel Cell polyomavirus (MCV) 
miRNAs (Seo et al., 2009; Sullivan et al., 2009), which are also located antisense, but 
near the N-terminus of the large T antigen coding region. Regardless of their genomic 
location, these polyomaviral miRNAs have been demonstrated to have autoregulatory 
effect on the T antigen transcripts (Cantalupo et al., 2005; Seo et al., 2008, 2009; Sullivan 
et al., 2005, 2009). The conserved nature of this mode of autoregulation implies 
importance. However, it remains unclear as to how this miRNA-mediated autoregulation 
of the early transcripts contribute to polyomavirus biology. 
 172 
miRNAs are small (approximately 22nt) molecules with regulatory functions. 
miRNAs play important roles in multiple faucets of biology, in particular, immunology 
and virology (reviewed in (Bartel, 2009; Boss and Renne, 2010; Cullen, 2011, 2013; 
Grundhoff and Sullivan, 2011; Kincaid and Sullivan, 2012)). The biogenesis of miRNAs 
have been intensely reviewed (Carthew and Sontheimer, 2009; Kim et al., 2009; Winter 
et al., 2009). Briefly, miRNAs are transcribed first as a longer, pre-miRNA hairpin 
containing pre-cursor RNA molecule known as the primary-miRNA (pri-miRNA). The 
pre-miRNA hairpin structure is recognized and process by Drosha and DGCR8 as part of 
a multi-protein complex, known as the Microprocessor complex (Denli et al., 2004; 
Gregory et al., 2004; Lee et al., 2003; Zeng and Cullen, 2005; Zeng et al., 2004). The pre-
miRNA is then exported from the nucleus to the cytoplasm via Exportin 5 (Bohnsack, 
2004; Lund et al., 2004; Yi et al., 2003). In the cytoplasm, the pre-miRNA molecule 
undergoes a second processing step, mediated by Dicer, to remove the terminal loop, 
which results in a small RNA duplex (Bernstein et al., 2001; Grishok et al., 2001; 
Hutvagner et al., 2001; Ketting et al., 2001). The abundant strand of the duplex, known as 
the guide strand, is preferentially loaded into the RNA-induced silencing complex (RISC) 
(Gregory et al., 2005). The less abundant strand, sometimes referred to as the passenger 
or the “*” (star) strand (Bartel, 2009), is ultimately turned over. When the miRNA binds 
to its target transcripts with imperfect sequence complementarity, translational repression 
of the target transcripts occurs (Humphreys et al., 2005; Pillai et al., 2005), followed by 
an increase in turnover of those target transcripts (Bagga et al., 2005; Bazzini et al., 2012; 
Behm-Ansmant et al., 2006; Giraldez et al., 2006). Although rare, some plant, animal and 
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viral miRNAs can also bind with perfect sequence complementarity to their target 
transcripts, resulting in an endonucleolytic cleavage (Hornstein et al., 2005; Llave et al., 
2002; Shin et al., 2010). 
In this study, we set out to better understand the biological significance of 
miRNA-mediated autoregulation of the early transcripts. We have previously 
demonstrated that the miRNAs are highly conserved among different strains of SV40 and 
JCV. In addition, a circulating SV40 isolate, despite encoding miRNAs with substantially 
different seed repertoire, could still mediate the cleavage of the early viral transcripts. 
Furthermore, we have also shown that a similar mode of autoregulation of the T antigens 
occurs in a very different class of viruses, the polyoma-like Bandicoot Papillomatosis 
Carcinomatosis Viruses 1 and 2 (BPCV1 and 2), There, the BPCV miRNAs recognizes 
the 3’ UTR of the early transcripts (Chen et al., 2011). Combined, these results imply an 
evolutionary pressure to maintain the autoregulation of the early viral transcripts. 
Furthermore, since members of the “muPyV” like category can also encode the middle T 
antigen, it is possible for the polyomaviral miRNAs to have independently evolved. 
Therefore, we set out to determine if like the SV40-like viruses, the miRNA-mediated 
autoregulation of the early transcripts is also conserved in divergent polyomaviruses. 
Here, we make use of the recent boom in the discovery of new polyomaviruses, both 
human and non-human (Buck et al., 2012; Dela Cruz et al., 2013; Korup et al., 2013; 
Leendertz et al., 2011; Scuda et al., 2011, 2013; Siebrasse et al., 2012; Stevens et al., 
2013), combining an evolutionary and computational approach to determine if other 
evolutionarily distant polyomaviruses are capable of encoding miRNAs. We inspected 
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four recently discovered non-human polyomaviruses – the Pan troglodyte verus 
polyomaviruses 1a and 2a (PtsPyV1a and 2a), Gorilla gorilla gorilla polyomavirus 1 
(GggPyV1) (Leendertz et al., 2011) and the raccoon polyomavirus (RacPyV) (Dela Cruz 
et al., 2013), which are closely related to MCV, the first oncogenic human polyomavirus 
(Feng et al., 2008), and determine if they would also encode miRNAs. We demonstrated 
that three of the four polyomaviruses inspected indeed expressed miRNAs. More 
importantly, for RacPyV, which has been strongly suggested as the etiological agent of 
raccoon brain tumors, we were able to demonstrate the robust expression of the viral 






5.2.1 Computational prediction and verification of PtsPyV2a, GggPyV1 and RacPyV 
miRNAs.  
We have previously demonstrated that diverse members of the polyomavirus 
family encode miRNAs that autoregulate the early viral gene products (Cantalupo et al., 
2005; Chen et al., 2013; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009). The 
biological significance of this conserved mode of autoregulation, however, remains 
unclear. Thus far, the capacity to encode miRNAs has only been demonstrated for a few 
members of the polyomavirus family, to better understand the biological significance of 
autoregulation of the early transcripts, we sought to determine if other evolutionarily 
distant members of this virus family encode miRNAs as well. We inspected four recently 
discovered non-human polyomaviruses, two from West African chimpanzee (Pan 
troglodytes verus), one from western lowland gorilla (Gorilla gorilla gorilla), and one 
from North American raccoon (Procyon lotor). Phylogenetic analysis of these four 
viruses and six other polyomaviruses that are known to encode miRNAs indicates that 
Pan troglodyte verus polyomavirus 2a (PtsPyV2a) (Leendertz et al., 2011) and Gorilla 
gorilla gorilla polyomavirus 1 (GggPyV1) (Leendertz et al., 2011) are evolutionarily 
closest to MCV but distant from the two prototypic members of the family, muPyV and 
SV40. Whereas for Pan troglodyte verus polyomavirus 1a (PtsPyV1a), it is still an 
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evolutionarily close relative of MCV, but not to the same extent as PtsPyV2a and 
GgGPyV1 (Leendertz et al., 2011). On the other hand, raccoon polyomavirus R45 strain 
(RacPyV) (Dela Cruz et al., 2013) is a much more distant relative of MCV than the other 
three non-human primate polyomaviruses (Figure 5.1A). However, these four 
polyomaviruses are all evolutionarily closer to MCV than SV40 and muPyV, which is in 
agreement with other phylogenetic analysis (Figure 5.1A, (Dela Cruz et al., 2013; 
Leendertz et al., 2011; Stevens et al., 2013; Yamaguchi et al., 2013)). Whole genome 
sequences of PtsPyV1a and 2a, GggPyV1 and RacPyV were first subjected to the VMir 
pre-miRNA hairpin prediction algorithm (Grundhoff et al., 2006). Our strategy for 
selecting possible pre-miRNA candidates was based on three parameters. First, the raw 
score for each candidate has to be scored at a VMir cut-off value of at least 125. Second, 
based on all previously discovered polyoma and polyoma-like viral miRNAs (Chen et al., 
2011, 2013; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009), the pre-miRNA 
candidates had to be in the late orientation. Third, since phylogenetic analysis had 
identified the four polyomavirus in this study to be evolutionarily close to MCV (Dela 
Cruz et al., 2013; Leendertz et al., 2011; Stevens et al., 2013), we therefore put our 
emphasis on the pre-miRNA hairpin candidates that are located near the genomic loci at 





Figure 5.1 Selection of polyomaviruses and computational prediction of pre-
miRNA candidates.  
(A) Phylogenetic analysis of polyomavirus encoded large T antigen. Phylogenetic tree 
was constructed using the large T antigen amino acid sequences. The phylogenetic 
analysis was performed by the neighbor-joining method, with the amino acid replacement 
per site indicated along the length of each branch. (B – E) Vmir prediction of pre-miRNA 
candidates for RacPyV (B), PtsPyV1a (C), PtsPyV2a (D) and GggPyV1 (E) pre-miRNAs 
candidates. The pre-miRNA candidates were selected based on RNA secondary structure 
folding and genomic locations. The chosen pre-miRNA candidates are circled.
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To determine if the selected pre-miRNA candidates are indeed processed into 
bona fide miRNAs, approximately 140bp regions encompassing the candidate pre-
miRNAs were synthesized and individually cloned into a heterologous expression vector. 
The expression vectors were then transfected into 293T cells and total RNA was 
harvested at 48 hours post transfection. Northern blot analysis of the RNA clearly 
demonstrates that PtsPyV2a (Figure 5.2C and D), GggPyV1 (Figure 5.2E and F) and 
RacPyV (Figure 5.2G and H) encode miRNAs. For these three polyomaviruses, probes 
that had been designed to recognize the 5p derivative miRNAs resulted in higher 
intensity miRNA bands (Figure 5.2C, E and G, lanes “2”, “G” and “R”, black 
arrowheads) than the probes that recognized the 3p derivative miRNAs (Figure 5.2D, F 
and H, lanes “2”, “G” and “R”, grey arrowheads). Due to high sequence similarity 
between the PtsPyV2a and GggPyV1 5p probes (45 out of 50 nucleotide identity), cross-
reactivity between the PtsPyV2a and GggPyV1 5p miRNAs could be observed (Figure 
5.2C and 2E, lanes “2” and “G”, black arrowheads). Probes that had been designed to 
recognize the loop region of the pre-miRNA hairpin allowed the detection of only the 
higher-molecular-weight pre-miRNA species via Northern blot analysis (data not shown), 
suggesting that the predicted hairpins of PtsPyV2a, GggPyV1 and RacPyV to be bona 
fide pre-miRNAs. Furthermore, neither upstream nor downstream probes that had been 
designed to recognize the 5’ and 3’ regions flanking the pre-miRNA hairpin revealed any 
signals for PtsPyV2a, GggPyV1 and RacPyV (data not shown). This result confirms the 
small RNA signals observed in the Northern blot analysis cannot be accounted for by 
random RNA degradations. The combined Northern blot analysis of PtsPyV2a, GggPyV1 
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and RacPyV indicates that the 5p miRNA derivatives for all three aforementioned 
polyomaviruses are most likely the guide strands (Figure 5.2C to H). However, probes 
that had been designed to recognize the 5p, 3p derivative miRNA regions of the predicted 
pre-miRNA candidate for PtsPyV1a did not result in any detectable small RNA signals 
via Northern blot analysis (Figure 5.2A and B). Additional Northern blot analysis using 
5’, 3’ flanking and the terminal loop probes also failed to reveal any detectable signals 
from the PtsPyV1a pre-miRNA candidate expression vector transfected cells, suggesting 







Figure 5.2 PtsPyV2a, GggPyV1 and RacPyV encode miRNAs.  
Northern blot confirmation of miRNA expression. The selected Vmir predicted pre-
miRNA candidates were cloned into heterologous expression vectors and transfected into 
293T cells. Total RNA from 48 hours post transfected cells were subjected to Northern 
blot analysis. Probes designed to recognize the (A) PtsPyV1a 5p, (B) PtsPyV1a 3p, (C) 
PtsPyV2a 5p, (D) PtsPyV2a 3p, (E) GggPyV1 5p, (F) GggPyV1 3p, (G) RacPyV 5p and 
(H) RacPyV 3p were used. As controls, cells were transfected with either the empty 
pcDNA3.1neo vector (indicated as “N”) or an SV40 miRNA expression vector (indicated 
as “S”). As Northern blot analysis controls, the blot were probed for either the SV40 3p 
miRNA or the cellular miRNA, let-7a. The bands corresponding to the pre-miRNAs 
(white arrowhead), 5p miRNAs (black arrowhead) and 3p miRNAs (grey arrowhead) are 
indicated. As a loading control, ethidium bromide-stained low-molecular-weight RNA is 
shown in the bottom panel for each blot. The identity of each lane is indicated at the top 
of each blot as follows: 1 = PtsPyV1a, 2 = PtsPyV2a, G = GggPyV1 and R = RacPyV.
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To determine if the PtsPyV2a, GggPyV1 and RacPyV miRNAs are biologically active, 
we next engineered 3’ UTR reporter constructs with sequences antisense to each of the 
corresponding pre-miRNA region (Figure 5.3A). Co-transfection of the corresponding 
viral miRNA expression vector resulted in approximately 70%, 60% and 55% reduction 
in the Renilla luciferase signal from the PtsPyV2a, GggPyV1 and RacPyV miRNA 3’ 
UTR reporter constructs, respectively (Figure 5.3B), suggesting that these polyomaviral 
miRNAs are bona fide, functional miRNAs. Co-transfection of the PtsPyV2a miRNA 
expression vector also led to a comparable reduction in the GggPyV1 Renilla luciferase 
signal, which is in congruent with the Northern blot analysis results, that the PtsPyV2a 
and GggPyV 5p derivative miRNAs share sequence similarities (Figure 5.3B). However, 
co-transfection of the PtsPyV1a miRNA expression vector did not result in any 
significant reduction of signal from the corresponding Renilla luciferase reporter 
construct (Figure 5.3B), which is in agreement to the lack of PtsPyV1a miRNA signal as 





Figure 5.3 The PtsPyV2a, GggPyV1 and RacPyV miRNAs can autoregulate the 
early mRNA expression.  
(A) Diagram of a luciferase reporter construct with a miRNA binding site. The miRNA 
binding sites used were: PtsPyV1a, PtsPyV2a, GggPyV1 and RacPyV. (B) The 
PtsPyV2a, GggPyV1 and RacPyV can autoregulate the early mRNA expression. The 
reporters from panel A were cotransfected with firefly luciferase expression vector 
individually into 293T cells, and the Renilla luciferase readings were normalized to the 
readgins from the firefly luciferase (FF. Luc) and plotted on the y axis. The x axis 
indicates the different Renilla luciferase (R. Luc) reporter constructs. The plasmid 
expressing the PtsPyV2a, GggPyV1 or RacPyV miRNAs are indicated by different bars 
as described in the legend. An SV40 miRNA expression vector was used as an irrelevant 
control and indicated as “SV40”. A Renilla luciferase reporter constructs without 
polyomaviral miRNA binding sites cloned in was used as a negative control. 
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5.2.2 The PtsPyV2a, GggPyV1 and RacPyV miRNA biogenesis are Drosha/DGCR8 and 
Dicer dependent.  
To determine if the biogenesis of the PtsPyV2a, GggPyV1 and RacPyV miRNAs 
are Drosha- and Dicer-dependent, we first engineered 3’ UTR reporter constructs with 
the corresponding pre-miRNA region. To test for Drosha-dependency, the pre-miRNA 
hairpins will be cloned into the 3’ UTR of Renilla luciferase. Co-transfection of Drosha 
and DGCR8 expression vectors along with the various pre-miRNA 3’ UTR reporter 
constructs (Lin et al., 2010) will be performed in 293T cells. To test for Dicer-
dependency in miRNA biogenesis, each individual miRNA expression vector will be 
transfected into the colorectal cancer cell lines, DLD-1, with either wild type DLD-1 
(DLD-1WT) or a derivative cell line that is hypomorphic for Dicer (DLD-1Ex5-/-) due to a 
disruption of exon 5 of the Dicer gene loci (Cummins et al., 2006). Total RNA will then 
be harvested at 48 hours post transfection and subjected to Northern blot analysis. Both 
analysis to test for Drosha and Dicer-dependency in miRNA biogenesis are currently in 
progress. However, we do anticipate that upon over-expression of Drosha and DGCR8, 
there will be an increase in the reduction of Renilla luciferase signal from the PtsPyV2a, 
GggPyV1 and RacPyV pre-miRNA 3’ UTR reporter constructs, indicating that the 
biogenesis of these viral miRNAs are indeed Drosha-dependent. We also anticipate that 
upon transfection of the PtsPyV2a, GggPyV1 and RacPyV miRNA expression vectors 
into the Dicer hypomorphic colorectal cancer cell line, DLD-1Ex5-/-, there will be a 
relative decrease in the mature miRNA signal as determined via Northern blot analysis, 
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when compared to the signal observed from transfected wild type DLD-1 cells. This 
result will indicate that the biogenesis of the PtsPyV2a, GggPyV1 and RacPyV miRNAs 
are also Dicer-dependent. Combined, these results will suggest that biogenesis for the 
three aforementioned polyomaviral miRNAs follow the canonical pathway (In progress). 
 
5.2.3 Determination of the sequences of the PtsPyV2a, GggPyV1 and RacPyV mature 
miRNAs.  
To determine the sequences of the mature miRNAs for PtsPyV2a, GggPyV and 
RacPyV, 293T cells were transfected with the corresponding miRNA expression vector. 
Small RNAs (ranging from 10 to 70nt) were then size-fractionated from total RNA at 48 
hours post transfection, followed by cDNA library construction and subsequently 
subjected to next generation small RNA deep sequencing mapping of the miRNAs. The 
deep sequencing result indicates that the majority of the miRNA reads mapped as the 
22nt 5p derivative miRNAs, corresponding to nucleotide position 815 to 836 on the 
RacPyV genome (Figure 5.4, black, thick arrow). In addition, two minor populations of 
the 5p derivative miRNAs are detected as well. The first minor form mapped as a 21nt 
miRNA, shorten by one nucleotide at the 5’ end of the major form of the 5p derivative 
miRNA, corresponding to nucleotide position 815 to 835 (Figure 5.4, black, dashed 
arrow). The second minor form mapped as a different 22nt miRNA, corresponding to 
nucleotide position 816 to 837 (Figure 5.4, black, dotted arrow). Another small minority 
of the reads mapped as the 3p derivative miRNA, corresponding to nucleotide position 
784 to 804 (Figure 5.4, black, thin arrow). This deep sequencing result, in addition to the 
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Northern blot analysis, indicates the RacPyV 5p derivative miRNA as the guide strand 
and the 3p derivative miRNA to be the passenger strand. The deep sequencing mapping 
of the PtsPyV2a and GggPyV1 miRNAs is currently ongoing. However, we do anticipate 
high sequence similarities between the PtsPyV2a and GggPyV1 miRNAs, especially the 
5p derivative miRNA. Furthermore, these two 5p miRNAs can also be expected to share 





Figure 5.4 Small RNA mapping of RacPyV miRNAs.  
Coverage plot of the deep sequencing reads from RacPyV miRNA expression vector 
transfected 293T cells. The number of reads was mapped onto the RacPyV genomic 
region that was cloned into the heterologous expression vector (nucleotide position 738 to 
876, indicated on the x axes) and plotted on the y axes. For better visualization of peak 
separation, an enlarged inset containing the pre-miRNA region (grey dotted lines) is 
shown (top panel). The black bars indicate the start count of each miRNA species and the 
coverage is represented by the grey filled area. RacPyV produces a dominant 5p miRNA 
derivative (indicated by the black, thick arrow) over two less abundant 5p miRNA 
derivatives (indicated by the corresponding black, dotted and dashed arrows) and an even 
less abundant 3p derivative miRNA (indicated by the black, thin arrow). Each miRNA 
sequence is indicated above its corresponding arrow.
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5.2.4 The RacPyV miRNAs are readily detectable in vivo.  
RacPyV has been identified as a candidate etiologic agent of a rare, but high-
grade brain tumors located in the frontal lobes and olfactory tracts in raccoons (Dela Cruz 
et al., 2013). Previous reports have demonstrated that miRNAs encoded by the human 
polyomavirus, JC virus (JCV), and a polyoma-like virus, bandicoot papillomatosis 
carcinomatosis virus 1 (BPCV1), are detectable in the brain tissues of PML patients and 
skin lesion of Western barred Bandicoots, respectively (Chen et al., 2011; Seo et al., 
2008). We next determine if the RacPyV miRNAs can be detected in raccoon brain 
tumors as well. Total RNA was harvested from four different raccoon brain tumor 
samples and one normal raccoon brain sample, followed by Northern blot detection of the 
RacPyV miRNAs. Northern blot analysis revealed that the RacPyV 5p derivative miRNA 
was detectable in all four brain tumor samples (Figure 5.5A, lanes “R1” to “R4”, black 
arrowhead, and from longer exposure indicated by “*”) but not the normal raccoon brain 
sample (Figure 5.5A, lane “N”). The 3p derivative miRNA signal was not detectable via 
Northern blot analysis (Figure 5.5B), which was as expected since the RacPyV 3p 
derivative miRNA has been demonstrated to be the passenger strand from the transfection 
and deep sequencing studies (Figure 5.2H and 4). Probes that had been designed to 
specifically recognize the terminal loop region of the RacPyV pre-miRNA could only 
detect the pre-miRNAs in two of the 4 raccoon brain tumor samples, without additional 
signal around the 22nt size region (Figure 5.5C, lanes “R3” and “R4”, white arrowhead). 
This result, in conjunction with the lack of signal from the probes specific for the 
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RacPyV pre-miRNA 5’ and 3’ flanking region (Figure 5.5D and E), and a probe to detect 
the cellular miRNA let-7a (Figure 5.5F), strongly suggest that non-specific RNA 
degradation fragments in the 22nt size region could not have accounted for the specific 
5p derivative miRNA bands detected in all four raccoon brain tumor samples. To 
determine the full repertoire of RacPyV derivative miRNAs and their sequences, RNA 
was size-fractionated to enrich for the pre-miRNA and mature miRNA derivative size 
classes (ranging from 10 to 70nt) from both transfected 293T cells and two raccoon brain 
tumor samples (Rac#10 and Rac#14). We then generated cDNA libraries from the small-
RNA fraction and performed next generation small RNA deep sequencing. This work is 
currently ongoing, however, we do not anticipate any major deviation in the mature 
RacPyV sequences from the mapping as determined from transfected 293T cells (Figure 





Figure 5.5 The RacPyV 5p miRNA is detected in vivo.  
Northern blot analysis of total RNA from raccoon brain tumor samples. Total RNA was 
harvested from 4 different raccoon brain tumor samples and 1 normal raccoon brain 
sample and subjected to Northern blot analysis. Probes designed to recognize the (A) 
RacPyV 5p, (B) 3p, (C) terminal loop, (D) 5’ flanking region, (E) 3’ flanking region were 
used. As controls, cells were transfected with either the empty pcDNA3.1neo vector 
(indicated as “-”) or the RacPyV miRNA expression vector (indicated as “+”). As 
Northern blot analysis controls, the blot was probed for the cellular miRNA, let-7a (F). 
The bands corresponding to the pre-miRNAs (white arrowhead), 5p miRNAs (black 
arrowhead) and the cellular miRNA, let-7a (grey arrowhead) are indicated. As a loading 
control, ethidium bromide-stained low-molecular-weight RNA is shown in the bottom 
panel for each blot. The identity of each lane is indicated at the top of each blot as 




5.2.5 In vivo miRNA-mediated cleavage of the early transcripts is not detectable via 
5’ RACE.  
Similar to all known polyomaviral miRNAs reported thus far, the RacPyV 
derivative miRNAs are also located antisense, necessarily with perfect sequence 
complementarity to the T antigen transcripts. Polyomaviral miRNA-mediated 
autoregulation of the early viral transcripts is a conserved function for the polyomaviral 
miRNAs, and we have also demonstrated, through a reporter assay, that the RacPyV 
miRNAs are capable of autoregulating the viral early transcripts. We next determine if 
this mode of autoregulation is observable in vivo. A modified protocol of 5’ rapid 
amplification of cDNA ends (5’ RACE) was performed on raccoon brain tumor RNA 
samples that had been pre-enriched for polyadenylated mRNA. If miRNA-mediated 
cleavage of the early transcript happened in vivo, early cleavage fragments mapping 
opposite the 5p derivative miRNA at approximately the 10thh nucleotide position (the 
“scissile phosphate”) should be detectable (Hornstein et al., 2005; Yekta et al., 2004b). 
The expected early transcript cleavage fragment would be expected to map to nucleotide 
position 827 of the RacPyV genome. However, multiple 5’ RACE attempts failed to 
reveal any fragments starting at position 827 of the RacPyV genome. Despite this result, 
a different stable early transcript fragment that started at position 844 of the RacPyV 
genome was readily detectable (data not shown). The mechanism and identity of the 




miRNA-mediated regulation of the T antigen transcripts has been a well-
documented function of the polyomaviral miRNA, via both reporter assay (Chen et al., 
2013; Seo et al., 2008, 2009) and the actual mapping of the early transcript cleavage 
fragments (Chen et al., 2013; Seo et al., 2008; Sullivan et al., 2005, 2009). Regardless of 
their genomic locations, the polyomaviral miRNAs are always found antisense, and 
therefore, with perfect sequence complementarity to the early transcripts. If this 
conserved mode of autoregulation is biologically important in polyomavirus biology, it 
should at least be observed in other members of the family that are evolutionarily close to 
members that are known to encode miRNAs. Furthermore, based on the genomic 
locations of these polyomaviral miRNAs, it is possible that they have evolved 
independently. Therefore, in this study, to address the question whether the miRNAs are 
conserved in polyomaviruses that are divergent from SV40, we inspected four non-
human polyomaviruses that are evolutionarily distant from the prototypic member of the 
family, SV40 and muPyV. We have shown that the capacity to encode for miRNA may 
not be a universal characteristic of the Polyomaviridae. As evident from the Northern blot 
analysis, we were able to confirm the VMir prediction of pre-miRNA hairpin for 
PtsPyV2a, GggPyV and RacPyV, but not PtsPyV1a (Figure 5.1 and 2). Since these 
miRNAs are antisense to the T antigen transcripts, we have also demonstrated, via 
reporter constructs, that the PtsPyV2a, GggPyV1 and RacPyV miRNAs, like all known 
polyomaviral miRNAs, can also autoregulate the early transcripts (Figure 5.3).  
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Since the non-human polyomaviruses in this study are closely related to MCV, one might 
speculate that they would encode miRNAs in a similar genomic location. Therefore, the 
inherent limitations imposed upon by the VMir prediction algorithm and the selective 
verification methodology employed in this study might mean that that the lack of pre-
miRNA and mature miRNA signals could simply be an outcome of PtsPyV1a not 
encoding miRNAs at the particular genomic region inspected. Since SV40, SA12, JCV 
and BKV encode miRNAs at a very different genomic location (antisense to the C-
terminus of the large T antigen(Seo et al., 2008, 2009; Sullivan et al., 2005)), PtsPyV1a 
might still encode miRNA from that location or perhaps, at other locations of the 
genome. However, the Vmir pre-miRNA prediction algorithm, failed to predict good 
candidates near the C-terminus region of the large T antigen, thereby ruling out the 
former possibility. On the other hand, an alternative explanation could be that PtsPyV1a 
might indeed be a miRNA-null polyomavirus, which would not be the first example for 
this virus family. A whole viral genome wide search is required to determine if PtsPyV1a 
is a true miRNA-null member of the polyomavirus family. We have unpublished work to 
demonstrates that more than half of the human polyomaviruses do not encode miRNAs 
(Cox and Sullivan, unpublished). Combined, the discovery that not all polyomaviruses 
encode miRNA will be of great implications to polyomavirus biology. To date, there are 
more than fifty members in the polyomavirus family, but thus far, the capacity to encode 
miRNAs has only been described for nine of the members (Cantalupo et al., 2005; Chen 
et al., 2013; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009), including the three 
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polyomaviruses from this study. This raises the following questions – Do the other 
polyomaviruses encode miRNAs? Are there more miRNA-null members than miRNA-
positive members? Furthermore, if miRNA-mediated autoregulation of the early 
transcripts is a biologically important function in polyomavirus biology, how then would 
the miRNA-null polyomaviruses circumvent the lack of miRNAs? Or is autoregulation of 
the T antigens only relevant to a small subset of polyomaviruses. In order to address these 
questions, it is necessary to screen all known polyomaviruses to identify the miRNA-
positive and the miRNA-null members. 
It has been previously reported that the polyomaviral protein, the large T antigen, 
could be detected within the nuclei of a subset of neoplastic cells in the raccoon brain 
tumors, but not from unaffected region, tissues or normal raccoon brains (Dela Cruz et 
al., 2013). Therefore, this makes our discovery of the RacPyV 5p derivative miRNA in 
all four raccoon brain tumor samples tested a perplexing one. Why would the large T 
antigen, an important driver of tumorigenesis, and the viral miRNA, a regulator of T 
antigen, found in the same raccoon brain tumor? From our reporter assay, we show that 
the RacPyV miRNA can potentially autoregulate the early transcripts (Figure 5.3). 
However, we have failed to detect any miRNA-mediated early transcript cleavage 
fragment from the raccoon brain tumor samples. One possible explanation could be that 
since large T antigens can only be detected in a subset of neoplastic cells, the large T 
antigen transcripts would be expected to be present at a low level. Therefore, the limit of 
detection offered by the 5’ RACE method may not be low enough to detect the even 
lower abundant early cleavage fragments. However, it can be speculated that the identity 
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of the early transcript fragment with a 5’ end mapping to nucleotide position 844 on the 
RacPyV genome to be a stable cleavage fragment that had been derived from the actual 
miRNA-mediated early transcript cleavage fragment. However, the true identity of the 
fragment remains to be determined. 
We have also determined the exact sequence of the RacPyV miRNAs from 
transfection study (Figure 5.4) and are currently mapping the RacPyV miRNAs from the 
actual raccoon tumor samples. However, we do not anticipate any major deviation in the 
in vivo sequencing results from the sequences obtained in the transfection study (In 
progress). Sequence analysis of the RacPyV miRNA has revealed that one of the minor 
species of the 5p derivative miRNA shares partial seed sequence (nucleotide position 2 to 
8) identity with the cellular miR-7-1 5p miRNA, with a GU wobble base pairing at 
nucleotide position 7. It has been previously demonstrated that the murine miR-296 can 
still regulate its target, Nanog, despite a single GU wobble base-pair at nucleotide 
position 3 in the seed sequence (Tay et al., 2008). Therefore, even though a 100 percent 
seed sequence identity is not observable, the minor species of the RacPyV 5p derivative 
miRNA can still be a viral mimic of miR-7-1 5p miRNA. The idea of viral miRNAs 
mimicking cellular oncogenic miRNAs (oncomiRs) is not unprecedented, as evident from 
Bovine Leukemia Virus encoded miRNAs (Kincaid et al., 2012). Various reports have 
been implicated miR-7-1 as tumor suppressor, especially in glioblastoma and 
schwannoma tumors (Kefas et al., 2008; Saydam et al., 2011), at the same time, 
contradictory oncogenic role for miR-7-1 has been suggested as well (Cheng et al., 2005; 
Chou et al., 2010). The potential biological implication of the RacPyV miRNA 
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mimicking the cellular miR-7-1, however, is only speculative at best. In fact, the 5p 
derivative miRNA of the closely related MCV also shares seed sequence identity with 
miR-7-1 (nucleotide position 2 to 7). In addition, the 5p derivative miRNA region of both 
PtsPyV2a and GggPyV1 display high sequence similarity to the MCV 5p derivative 
miRNA, further suggesting that multiple members of the polyomavirus family encode 
miR-7-1 mimics. 
In conclusion, we have shown that the capacity to encode viral miRNAs is not 
conserved among members of the polyomavirus family. To fully decipher the biological 
significance of miRNA-mediated autoregulation of the early transcripts would require a 
screen for miRNAs from all known members of the polyomavirus family. 
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5.4 MATERIALS AND METHODS 
 
5.4.1 Cell culture and RNA isolation.  
Human embryonic kidney 293T cells (HEK293T) were obtained from the 
American Type Culture Collection (Manassa, VA) and maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal bovine serum (Life 
Technologies, Carlsbad, CA). The colorectal cancer cell lines DLD-1WT and DLD-1Ex5-/- 
(Cummins et al., 2006) was maintained in Roswell Park Memorial Institue-1640 medium 
supplemented with 10% fetal bovine serum (Life Technologies). Total RNA was 
harvested using an in-house PIG-B solution as previously described (Chen et al., 2011; 
Lin et al., 2010; Seo et al., 2008; Weber et al., 1998). 
 
5.4.2 Computational prediction and selection of viral pre-miRNA candidates.  
The complete genome sequences for PtsPyV1a (Accession number: 
HQ385746.1), PtsPyV2a (Accession number: HQ385748.1), GggPyV1 (Accession 
number: HQ385752.1) and RacPyV (Accession number: JQ178241.1) were subjected to 
a viral miRNA prediction algorithm, VMir (Grundhoff et al., 2006). A minimum cutoff 
score of 125 was applied to the pre-miRNA prediction for PtsPyV1a and 150 for 
PtsPyV2a, GggPyV1 and RacPyV. A candidate pre-miRNA was only selected for 
verification if it was found in the late orientation and located either in the SV40-like 
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(Sullivan et al., 2005) or the muPyV-like (Sullivan et al., 2009) pre-miRNA locus. The 
pre-miRNA candidate for each polyomavirus was predicted using the mfold RNA folding 
prediction web server (Zuker, 2003). 
 
5.4.3 Construction of polyomavirus large T antigen phylogenetic tree.  
The phylogenetic tree was constructed based on the amino acids sequences of the 
following polyomaviruses: PtsPyV1a, PtsPyV2a, GggPyV1, RacPyV, SV40 (Accession 
number: J02400.1), JCV (Accession number: NC_001699.1), BKV (Accession number: 
JQ713822.1), murine polyomavirus (Accession number: NC_001515.1), SA12 
(Accession number: AY614708.1), Merkel Cell Carcinoma virus, 350 (Accession 
number: JN707599.1). The phylogenetic tree was constructed using the neighbor-joining 
method using the Geneious software (Kearse et al., 2012). 
 
5.4.4 MiRNA expression vector construction, transfection, and Northern blot 
analysis.  
All DNA vector constructs were sequence verified through sequence analysis at 
the Institute of Cellular and Molecular Biology Sequencing Facility at the University of 
Texas at Austin. The primers used in the construction of the pre-miRNA candidates 
expression vectors have been listed in Table 5.1. Briefly, the primers are annealed and 
filled-in using Phusion High-Fidelity DNA polymerase (New England BioLabs, Ipswich, 
MA) according to the manufacturer’s protocol. The PCR products were then cloned into 
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the XhoI/XbaI sites of the pcDNA3.1neo expression vector. 293T cells were plated in 6-
wells plates and transfected with the expression vectors using the Lipofectamine 2000 
transfection reagent (Life Technologies) according to the manufacturer’s instruction. As a 
negative control, cells were transfected with empty pcDNA3.1neo vector. Total RNA was 
harvested at 48 hours post transfection. The total RNA was subjected Northern blot 
analysis as described previously (Sullivan et al., 2005). Briefly, 10 micrograms of total 
RNA was separated on a Tris-borate-EDTA-urea-15% denaturing polyacrylamide gel. 
The RNA was transferred onto a Hybond N+ membrane (GE Healthcare, Pittsburgh, PA). 
The probe sequences used are listed in Table 5.2. 
 
5.4.5 Luciferase assays.  
The miRNA reporter constructs and the viral pre-miRNA hairpin reporters were 
constructed by cloning the pre-miRNA region of each polyomavirus in the early 
orientation (T antigen orientation) and late orientation (pre-miRNA orientation) 
respectively, using the primers listed in Table 5.1. Briefly, the PCR products were 
generated using Phusion High-Fidelity DNA polymerase (New England BioLabs) 
according to the manufacturer’s protocol, and cloned into the XhoI/XbaI sites of the 
pcDNA3.1dsRluc vector, which expressed a destabilized version of the Renilla 
luciferase. 293T cells were plated in 24-wells plates and transfected using the TurboFect 
transfection reagent (Thermo Scientific, Waltham, MA). For the miRNA reporter 
luciferase assay, 293T cells were co-transfected with the corresponding viral miRNA 
expression vector. As negative controls, the SV40 miRNA expression vector (Chen et al., 
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2013) and the empty Renilla luciferase reporter construct were used. For the viral pre-
miRNA hairpin reporter luciferase assay, 293T cells were co-transfected with pCK-
Drosha-FLAG and pcDNA-DGCR8-FLAG (Han et al., 2004) at a ratio of 1:1. As a 
negative control, the empty Renilla luciferase reporter construct was used. The luciferase 
signal from microprocessor overexpressed 293T cells was compared to 293T cells co-
transfected with the empty pcDNA3.1puro vector. The pcDNA3.1luc2CP vector, which 
expressed a destabilized version of the firefly luciferase, was also co-transfected in both 
assays to normalize for transfection efficiency. The transfected cells were collected at 24 
hours post transfection and analyzed with the Dual-luciferase reporter assay system 
(Promega, Fitchburg, WI) according to the manufacturer’s instruction. The luciferase 
readings were collected using a Luminoskan Ascent microplate luminometer (Thermo 
Scientific). The readings from the Renilla luciferase were normalized to the readings 
from the firefly luciferase, with the ratios plotted as a bar graph relative to the empty 
Renilla luciferase vector control. 
 
5.4.6 Dicer dependence assay.  
DLD-1WT and DLD-1Ex5-/- cells were seeded in 6-wells plates. The cells were 
transfected with the polyomaviral miRNA expression vectors using the TurboFect 
transfection reagent (Thermo Scientific) at approximately 50% confluence. Total RNA 
was harvested at 48 hours post transfection using the PIG-B solution (Weber et al., 1998) 
followed by Northern blot analysis as described in the “Northern blot analysis” section. 
The probes used were listed in Table 5.2 as well. The SV40 miRNA expression vector 
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and an empty pcDNA3.1neo vector were used as the positive and negative controls, 
respectively.  
 
5.4.7 Small RNA library and computational analysis of sequencing reads.  
293T cells were seeded in 10cm tissue culture dishes and transfected with the 
PtsPyV2a, GggPyV1 or the RacPyV miRNA expression vector using the Lipofectamine 
2000 transfection reagent (Life Technologies). Total RNA was harvested at 48 hours post 
transfection. Two raccoon brain tumor tissue samples (Rac#12 and Rac#14) were 
homogenized in Lysing Matrix A tubes (MP Biomedicals, Solon, OH), each containing 
one milliliter of TRIzol RNA isolation reagents (Life Technologies), using a Mini-
Beadbeater-24 (Bartlesville, OK) at the fastest setting for one minute followed by cooling 
on ice for one minute. The process of homogenization and cooling was repeated for two 
additional times. The lysate was then centrifuged at 100G for one minute to pellet the 
beads. The supernatant was then transferred into four milliliters of TRIzol and subjected 
to RNA isolation according to the manufacturer’s protocol. The small RNA fraction from 
the transfected 293T cells and the brain tumor tissue samples was gel fractionated as 
previously described (Chen et al., 2013; Lin et al., 2010). The small RNA cDNA library 
was generated using the NEBNext Multiplex Small RNA library prep set for Illumina kit 
(New England BioLabs) according to the manufacturer’s instructions. The resulting 
cDNA library was then subjected to paired-end sequencing on the Illumina HiSeq 
(Illumina, San Diego, CA). 
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Table 5.1 List of primers for the constructions of miRNA expression vectors, miRNA reporter constructs and 3’ UTR 
hairpin reporter constructs. 
 





























Construction of miRNA reporter constructs 
PtsPyV1a 
Forward ATCGCTCGAGAGTCTGCAGAATCCACCGCATC 
PtsPyV1a Reverse ATCGTCTAGAGGACTCATCGCAGTAGAGATCATC 
PtsPyV2a 
Forward ATCGCTCGAGCAATACTCTGATGACACCTCCG 





RacPyV Forward ATCGCTCGAGGGATTCCTCTCGGGATCATGG 
RacPyV Reverse ATCGTCTAGAGGAATTATCTCCGTGTAGATTGGC 
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Table 5.1, cont. 














































Table 5.2 List of probes used in the Northern blot analysis. 
 
Northern blot probes 
PtsPyV1a 5p arm probe GAGCCAGTGTACCTGGAAGTTCTTCCAGGAGC 
PtsPyV1a 3p arm probe ACCGATTCCAGAAGAGAATCCAGCACACCCTG 
PtsPyV1a 5' flanking probe GTTCTTCCAGGAGCAGTAGCACCTGGGATGATCTCTACTGCGATGAGTCC 
PtsPyV1a 3' flanking probe AGTCTGCAGAATCCACCGCATCCACTTCAGCCGAGACCACCGATTCCAGA 
PtsPyV1a loop probe GCACACCCTGCGGAGCCAGT 
PtsPyV2a 5p arm probe GAACCAGTGTACCTAGAGGTTCTTCCAGAAGT 
PtsPyV2a 3p arm probe CAATTCAGGAAGAGAATCCAGCACACAACACG 
PtsPyV2a 5' flanking probe TCTTCCAGAAGTGATGGCACCTGGGATGATTTGTTCTGTGACGAGTCGAT 
PtsPyV2a 3' flanking probe CATACTCTGATGACACCTCCGATGCAACAGAGACCACCAATTCAGGAAGA 
PtsPyV2a loop probe CACAACACGGAACCAGTGTA 
GggPyV1 5p arm probe GAACCAGTGTACCTGGAAGTTCTTCCAGGAGC 
GggPyV1 3p arm probe ACCGATTCCAGAAGAGAATCCAGCACACCCTG 
GggPyV1 5' flanking probe CTTCCAGAAGTGATGGCACCTGGGATGATCTGTTCTGTGATGAATCCATT 
GggPyV1 3' flanking probe AACACTCTGCAGAGACTTCCGATGGAACCGAGACCACCAGTCCAAGAAGA 
GggPyV1 loop probe CACAGCCAAGAACCAGTGTA 
RacPyV 5p arm probe AAAGTCAAGTACCTCTATGCCTTCCCACAGACCCCACTCCTCAGCCAATCTACACG 
RacPyV 3p arm probe CATGGAGAATTCGCCGGAGGCGAGGGGTCCAGCGGGAGGGACAGGGTACATACCTC 
RacPyV 5' flanking probe TCCTCAGCCAATCTACACGGAGATAATTCCGAGGACCCAC 
RacPyV 3' flanking probe GATGGGATTCCTCTCGGGATCATGGAGAATTCGCCGGAG 
RacPyV loop probe AGGGTACATACCTCAAAGTCAAGTACCT 
 204 
CHAPTER 6 Establishment of Laboratory SV40 Persistently 




Polyomaviruses establish life-long, persistent infections in their natural hosts, but 
the underlying mechanism remains poorly understood. Rhesus macaques are exposed to 
SV40 infections early in their lives, followed by the establishment of persistent infections 
in the kidney and lymphoid tissues. Throughout the lifetime of the host, periodic episodes 
of transient viremia and viruria are readily observable (Ashkenazi and Melnick, 1962). 
Subsequent in vivo studies of SV40 persistent infections conducted in SIV-infected 
immunocompromised monkeys reveal that under the context of natural infection, SV40 
can be detected in multiple organ tissues, including the kidney, central nervous system, 
lymph nodes, liver and spleen (Lednicky et al., 1998; Newman et al., 1998; Simon et al., 
1999). A recent in vivo study of SV40 persistent infection was conducted in the Syrian 
golden hamsters, a widely used model for studying SV40 infections and oncogenesis 
(Butel et al., 1972; Cicala et al., 1993; Diamandopoulos, 1973; McNees et al., 2009; Patel 
et al., 2009; Sroller et al., 2008; Swain et al., 2012; Vilchez et al., 2004). In that study, 
Zhang et al. has shown that following the initial acute SV40 infections in the liver, 
kidney, spleen, lung and brain of the infected animal, the kidney becomes the preferred 
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site of SV40 persistent infection, with the organ harboring the main reservoir of persistent 
infections (Zhang et al., 2014). 
In the cell culture setting, the earliest SV40 persistence cell line was established 
using the Rhesus macaque monkey kidney epithelial cells (LLC-MK2). Upon de novo 
infection of SV40, these cells transition into a “stable carrier state” characterized by 
extensive viral replication without obvious development of cytopathic effect (CPE), 
persisting for as long as eleven weeks post infection (Norkin, 1976, 1977). Additional 
reports have also demonstrated SV40’s ability to establish persistent infections in vastly 
different human cell lines such as the human glioblastoma, immortalized human 
fibroblast cell lines, lymphoblastoid B-cell lines and mesothelial cells (Dolcetti et al., 
2003; Fahrbach et al., 2008; Morelli et al., 2004; Norkin et al., 1985). Despite these 
studies on SV40 infections of Rhesus macaque, under both the whole animal and cell 
culture settings, our understanding of the underlying mechanism for the establishment of 
SV40 persistent infections remains rudimentary.  
Several members of the polyomavirus, including SV40, have been shown to 
express miRNAs (Cantalupo et al., 2005; Seo et al., 2008, 2009; Sullivan et al., 2005, 
2009). The polyomaviral miRNAs are located antisense to the T antigen transcripts, and 
thus, maintain perfect sequence complementarity and mediate endonucleolytic cleavages 
of these early transcripts (Chen et al., 2013; Sullivan et al., 2005, 2009). Since the T 
antigens, especially the large T antigen, play essential roles in multiple stages of the 
polyomaviral lifecycle (An et al., 2012; Sullivan and Pipas, 2002), the miRNA-mediated 
autoregulation of the early transcripts has been suggested as a possible driver in the 
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establishment of persistent infections for SV40 and BKV, a human member of the 
polyomavirus family (Broekema and Imperiale, 2013; Sullivan et al., 2005).  
In this study, we set out to address the question whether the SV40 miRNAs can limit the 
lytic replication of SV40 and its potential role in the establishment of persistent SV40 
infections. Using a cell culture approach, we first generated stable African green monkey 
cells that pre-expressed the SV40 miRNAs followed by studying their effect on lytic 
SV40 replication. Surprisingly, we observed rare cases of cells that survived the initial de 
novo infection went on to become persistently infected. Here, we characterize these 
persistently infected cell lines and discuss the potential implications in our understanding 





6.2.1 Effects of pre-expression of the 776 miRNAs on lytic replication of SV40. 
Polyomaviral miRNA-mediated autoregulation of the early transcripts has been 
well documented for several members of the family (Seo et al., 2008, 2009; Sullivan et 
al., 2005, 2009). The biological implications of the polyomaviral miRNAs in immune 
evasion and control of replication have been further demonstrated for the SV40 and BKV 
miRNAs respectively (Broekema and Imperiale, 2013; Sullivan et al., 2005). These 
reports combined to suggest a potential role of polyomaviral miRNAs in the 
establishment of persistent infections. In light of this model, we first constructed an 
African green monkey kidney epithelial cell line (BSC-40) that stably expressed the 
SV40 776 miRNA (Chen et al., 2013; Sullivan et al., 2005). Northern blot analysis was 
then conducted on the derived monoclonal stable cell line and the clone with the highest 
expression of 776 miRNA was used throughout the rest of the study and was named “B7” 
(data not shown). A control stable BSC-40 cell line that did not express the 776 miRNA 
was constructed using the same methods. One of the clonal derivative was used and was 
named “BN”. To determine the effect of 776 miRNA pre-expression on the lytic 
replication of SV40, the stable cell lines were infected with six different permutations of 
the SV40 virus – miRNA expressing virus (WT) or miRNA-null mutant (SM) under three 
different genetic background of nonarchetype, protoarchetype or archetype. To assay for 
the effect of 776 miRNA pre-expression, plaque assay was conducted to track the lytic 
spread of virus infection. The results of the plaque assay did not reveal any robust 
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difference in the plaque sizes between the B7 stable cell and the parental BSC-40 cells, 
suggesting no significant effect on the lytic replication of SV40 when the 776 miRNA 
was pre-expressed in the cells (Figure 6.1). However, infections of the BN stable cell line 
resulted in plaques that are larger in size when compared to the plaques from the infected 
B7 stable cell line and the infected parental BSC-40 cells (Figure 6.1). This result 
suggests that during the construction of the BN and B7 stable cell lines, the act of 
selection using G418 sulfate may have selected for cells that are more susceptible to 






Figure 6.1 Plaque assay analysis of SV40 infections on BSC-40 pre-expressing the 776 miRNA.  
Parental BSC-40 and two stable cell lines, one expressing the 776 miRNA (indicated as “B7”) and the other not expressing the 
viral miRNAs (indicated as “BN”) were infected at an MOI of 0.01. The viruses were miRNA expressing SV40 (indicated as 
“WT”) and miRNA-null mutant SV40 (indicated as “SM”) in three different genetic background (indicated as “nonarchetype”, 
“protoarchetype” and “archetype”). Plaques were stained using neutral red at 15 days post infection. 
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6.2.2 Derivation of cell lines that survived the protoarchetype-SM infections.  
SV40 is known to undergo lytic replication in permissive cell lines such as the 
African green monkey cells, as evident from the cytopathic effect (CPE) characterized by 
vacuoles formation in the cytoplasm, swelling of the nucleus and eventual lysis of the 
infected cells (Diderholm, 1963; Miyamura, 1976; Miyamura and Kitahara, 1975). 
Surprisingly, colonies that survived the initial protoarchetype-SM infections of the BN 
and B7 stable cell lines are observable even after more than 30 days post infection. To 
characterize these surviving cell lines, individual colonies were selected and amplified, 
with the leftover cells pooled and amplified as well. Three different survivor cell lines 
were selected for the subsequent studies – a pooled survivor derived from the B7 stable 
cell line, named B7-PSMp and two clonal lines of survivor derived from the BN and B7 
stable cell lines, named BN-PSM1 and B7-PSM1 respectively. To characterize these 
surviving cell lines, they were first subjected to Western blot analysis for SV40 proteins, 
large T antigen and VP1. The Western blot analysis of 5 days old cultures indicates that 
all three surviving cell lines express the large T antigen (Figure 6.2A, “Large T antigen” 
panel). Comparing the large T antigen expression levels in the surviving cell lines to the 
levels obtained from the BN and B7 cell lines that had been de novo infected with 
protoarchetype-SM demonstrates that the large T antigen expressed by the B7 derived 
surviving cell lines migrate similarly to the de novo infection controls (Figure 6.2A, lanes 
“B7-PSMp” and “B7-PSM1”). However, the BN derived surviving cell line expresses an 
altered form of large T antigen that migrate differently than the other two survivor cell 
lines (compare lane “BN-PSM1” to lanes “B7-PSMp” and “B7-PSM1”, indicated by 
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“*”). Further Western blot analysis of BN-PSM1 lysate on lower percentage 
polyacrylamide gel reveals that there are two different species of large T antigen, both 
with faster migrations than the large T antigen observed in de novo infections and the B7 
derived surviving cell lines (Figure 6.2B, lane “BN-PSM1”). In addition, larger 
molecular weight bands from the large T antigen Western blot analysis, indicative of the 
multimeric form of the viral protein (Montenarh et al., 1984; Schürmann et al., 1985), is 
only observable in the B7 derived survivors as well (Figure 6.2, indicated by “**”). This 
observation further suggests that the large T antigen expressed in BN-PSM1 is different 
from the wild type large T antigen. Western blot analysis for the viral capsid protein, VP1 
indicates that VP1 expression could only be detected for the two B7 derived cell lines 
(Figure 6.2, “VP1” panel, lanes “B7-PSMp “ and “B7-PSM1”). This result suggests that 
either BN-PSM1 does not express VP1 at all, or the expression level was too low to be 
detectable via Western blot analysis. 
As an initial attempt to determine the effect of cellular stress on the expression of 
large T antigen in the three surviving cell lines, they were treated with sodium butyrate 
(NaB) at 0.01M for 24 hours prior to Western blot analysis for the large T antigen. NaB 
has multiple effects on mammalian cell cultures including alteration of gene expression 
and inhibition of proliferation (Candido et al., 1978; Davie, 2003). At 24 hours post NaB 
treatment, lower expression level for large T antigen is observed for both B7-PSMp and 
B7-PSM1 (Figure 6.2B, lanes “B7-PSMp” and “B7-PSM1”). This result is not surprising 
due to previous reports of NaB being an inducer of apoptosis (Chopin et al., 2002; 
Soldatenkov et al., 1998; Wang et al., 2002, 2006). Interestingly, NaB treatment of BN-
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PSM1 cells resulted in the switch in expression level between the slower migrating and 
the faster migrating large T antigens (Figure 6.2B, lane “BN-PSM1”). However, at this 






Figure 6.2 Western blot analysis of lytic infection surviving cell lines.  
(A) Western was performed on the three 5 days old cultures of protoarchetype-SM 
infection surviving cell lines for large T antigen and VP1. (B) Effects of sodium butyrate 
treatment on the surviving cell lines. The surviving cells were treated with sodium 
butyrate at 0.01M (indicated as “0.01M NaB”) for 24 hours. As negative controls, 
surviving cells were left untreated for 24 hours. As positive controls, the BN and B7 
stable cell lines were either de novo infected with the protoarchetype-WT or SM viruses 
(indicated as “WT” and “SM”), and total protein from 47 hours post infection was 
included in the analysis. Uninfected BN and B7 cell lines were included as negative 
controls and indicated as “Mock”. The monomeric and multimeric form of large T 
antigens are indicated by “*” and “**” respectively.  
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6.2.3 Differential large T antigen expression pattern among the surviving cell lines. 
Western blot analysis is a sampling of the overall population of cells, and is 
therefore, not reflective of protein expression at the level of individual cell. To address 
the question if large T antigen is expression in every cells or only a subpopulation of 
cells, immunofluorescence for large T antigen was conducted on all three surviving cell 
lines. The results indicate that only a subpopulation of the cells in the B7-PSMp and B7-
PSM1 survivor cell lines expresses large T antigen but is evident in every BN-PSM1 cell 
(Figure 6.3). However, the large T antigen expression level in both the B7-PSMp and B7-
PSM1 cell lines were higher than expression level observed in the BN-PSM1 cell line 
(Figure 6.3). This result suggests that the higher expression of large T antigen in a 
subpopulation of B7-PSMp and B7-PSM1 cells as determined by immunofluorescence 
can account for the Western blot signal observed, resulting in an overall expression level 





Figure 6.3 Different large T antigen expression pattern across whole 
populations of the surviving cell lines.  
Immunofluorescence was conducted on 3 days old culture of the B7-PSMp, BN-PSM1 
and B7-PSM1 cell lines. The anti-mouse IgG conjugated with AlexaFluor 594 was to 
visualize the cells. Hoechst 33342 was used to stain the nucleus. Signal from the large T 
antigen (red) was overlayed onto the signal from the nucleus (blue).  
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6.2.4 The survivor cell lines release progeny virions.  
Western blot detection of the capsid protein, VP1, suggests the potential ability of 
these survivor cell lines to produce progeny virions. CPE is an obvious characteristic of 
African green monkey kidney cells undergoing lytic SV40 replication, however, CPE is 
not observable in these cell lines (data not shown), despite the robust expression of large 
T antigen in all three cell lines, and VP1 in two of the cell lines (Figures 6.2, 6.3). The 
combined results suggest that even if these surviving cells were capable of producing 
progeny virions, it would have to be through a route that is not characterized by the lysis 
of the cells. To determine if these surviving cells do indeed release progeny virions, 
culture supernatant was harvested from all three cell lines at 5 days post culture. The 
supernatant was then used to infect parent BSC-40 cell, followed by immunofluorescence 
for VP1. The immunofluorescence results suggest that all three cell lines do indeed 
release progeny virions into the culture supernatant, as indicated by the expression of 
VP1 in the infected parent BSC-40 cells (Figure 6.4). The greater number of VP1 positive 
cells from B7-PSMp and B7-PSM1 supernatant infection than BN-PSM1 supernatant 
indicated that the amount of virion release is higher for the two B7 derived surviving cell 
lines (Figure 6.4). The result is in agreement with the VP1 Western blot analysis, 
indicating the VP1 expression level in BN-PSM1 was too low to be detected via Western 
blot analysis (Figure 6.2). The combined immunofluorescence and Western blot analysis 
results indicate that these three surviving cell lines are capable of releasing progeny 





Figure 6.4 Production of progeny virions from all three surviving cell lines.  
Culture supernatant was obtained from 5 days old cultures of B7-PSMp, BN-PSM1 and 
B7-PSM1. Supernatant was used to infect parent BSC-40. The infected cells were stained 
for VP1, and visualized using an anti-rabbit IgG conjugated with AlexaFluor488. DAPI 




6.2.5 Episomal protoarchetype-SM genomes are detected in B7-PSMp, BN-PSM1 and 
B7-PSM1.  
It has been previously demonstrated that SV40 persistent infection can be 
established in A172 human glioblastoma cells (Norkin et al., 1985). Furthermore, the 
SV40 DNA was found to persist in an episomal state. To determine the state of the 
protoarchetype-SM genome in the three surviving cell lines, total genomic DNA was 
harvested and linearized via restriction digestion, followed by Southern blot analysis. The 
result demonstrates that the when compared to a positive control restriction digestion of 
protarchetype-SM genome isolated from de novo infection (Figurer 6.5, lane “+”), the 
majority of the protoarchetype-SM genomes in the surviving cell lines are in the episomal 
state (Figure 6.5, lanes “B7-PSMp”, “BN-PSM1” and “B7-PSM1”, indicated by “*”). 
However, apart from the episomal genomic DNA band, other smaller bands are observed 
as well. The radioactive probe was designed to recognize the mutant pre-miRNA region 
of the protoarchetype-SM genome, therefore, suggesting that one of the smaller bands 
that is only visible in B7-PSMp and B7-PSM1 could be the stably integrated 776 miRNA 
expression loci that cross-reacted with the probe (Figure 6.5, lanes “B7-PSMp” and “B7-
PSM1”). However, the identities of the other remaining bands remain to be determined. 
At this time, we cannot rule out possible occurrence of integration events of the 
protoarchetype-SM genome into the cellular genome. Interestingly, the genomic DNA 
used in the Southern blot analysis was obtained from cells that had been successively 
passaged in cell culture for at least ten times, spanning over a period of 30 days, 
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indicating possible segregation of the viral genome to the daughter cells during each cell 
division. The combined results suggest that the protoarchetype-SM genome persists in all 





Figure 6.5 Majority of the protoarchetype-SM genomes persist in an episomal 
state in the surviving cell lines.  
Genomic DNA was harvested from the surviving cell lines after 10 successive passages 
in cell culture over the span of 30 days. The genomic DNA was linearized using either 
the AgeI or the BamHI restriction enzyme. An approximately 300bp region spanning the 
mutant pre-miRNA region of protoarcehtype-SM was used to generate the radioactive 
probe. Genomic DNA from the BN and B7 stable cell lines were included as negative 
control. 10ng of protoarchetype-SM genome obtained from lytic replication was included 
as a positive control (indicated as “+”). The band representing the linearized 
protoarchetype-SM genome is indicated by “*”. The band representing stably integrated 




Persistent infection is a poorly understood area of polyomavirus biology. Despite 
prior studies of SV40 persistent infections in Rhesus macaque cell cultures (Norkin, 
1976, 1977), our understanding remains rudimentary. In this study, we describe the 
establishment of African green monkey kidney epithelial cell lines that are persistently 
infected with protoarchetype-SM, a miRNA-null mutant of SV40. A recent study by 
Broekema and Imperiale has demonstrated the effect of the BKV miRNAs in limiting the 
replication of BKV, indicating a potential role for the polyomaviral miRNAs in the 
establishment of persistent infections (Broekema and Imperiale, 2013). However, for 
SV40, we have shown that pre-expression of the 776 miRNA in African green monkey 
kidney epithelial cells does not significantly alter the lytic replications of both SV40 and 
SM, regardless of their genetic background (Figure 6.1). Yet, it is important to point out 
that the plaque assays was performed in stable cell lines that were constructed under 
G418 selection. Therefore, it can be speculated that during the selection process, a cell 
line that is more susceptible to SV40 infection may have arose. Therefore, the lack of 
effect on SV40 and SM lytic replication by the pre-expressed miRNAs observed is only 
limited to this specific result, and we cannot formally rule out that the 776 miRNAs do 
not have an effect at all. Broekema and Imperiale had used primary human renal 
proximal tubule epithelial (RPTE) cells, the natural host for BKV whereas in this study, 
infection of African green monkey cells was used, which supports lytic replication of 
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SV40. Therefore, the fact that a cell type from a non-natural host of SV40 was used can 
explain the lack of effect on SV40 replication from the 776 miRNAs. 
The surprising outcome of this study is the establishment of African green monkey 
kidney cells that are persistently infected with protoarchetype-SM, in both BSC-40 cells 
with or without the stable expression of the 776 miRNAs. By the tenth passage in cell 
culture, corresponding to over 30 days in culture, the majority of the protoarchetype-SM 
genomes are still maintained as episomes in all three persistent cell lines. Maintenance of 
episomal viral genome is a well-known characteristic for some members of the 
herpesvirus and the papillomavirus family (Hammerschmidt and Sugden, 2013; 
Lieberman, 2013; McBride, 2013; You, 2010). For Epstein-Barr virus (EBV) and 
Kaposi’s sarcoma-associated herpesvirus (KSHV), tethering of the viral episome to the 
host chromatin is mediated by the viral proteins EBNA-1 and LANA, respectively 
(Ballestas and Kaye, 2011; Frappier, 2012). For the papillomavirus family, the viral 
protein E2 facilitates the retention, maintenance and partition of the viral genome 
(McBride, 2013). However, there are no known reports of such polyomaviral protein 
mediated maintenance of the polyomaviral episomes. However, previous studies have 
demonstrated the potential for the SV40 large T antigen to associate with cellular 
chromatin (Schirmbeck and Deppert, 1987; Vassetzky et al., 1999), therefore, it might be 
formal possibility for the large T antigen to serve as a viral “tetherin” to maintain the 
episomal SV40 genomes.  
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Previous work by Chittenden et al. has demonstrated that SV40-origin containing 
plasmid can be maintained in stably transfected African green monkey cells, COS7 
(Chittenden et al., 1991). In those stable cell lines, the plasmid can be maintained for at 
least 2 months in culture. In addition, the plasmids are maintained at 100 to 1000 copies 
per cell and is paralleled to cellular DNA replication, replicating once per round of cell 
cycle (Chittenden et al., 1991). The persistent infection system established in this study 
shares striking similarities with the aforementioned persistent plasmid system. First, 
crude quantification of the protoarchetype-SM genome in the persistent cell lines resulted 
in copy numbers in the thousands range. (data not shown) Second, majority of the viral 
genomes exist as episomes and are maintained even after over 30 days in culture (Figure 
6.5). Third, the SV40 large T antigen is present at a lower level than lytic replication 
(Figure 6.2). Fourth, G418 was used during the selection process of the BN and B7 cell 
lines, from which the persistent cell lines were derived from. However, at this time, it 
remains unclear if large T antigen is involved in the maintenance of the viral episomes, or 
if the act of stable clones selection using G418 had also inadvertently selected for cells 
that are more conducive to the establishment of persistent infections. Since COS7 is a cell 
line that stably expresses the SV40 large T antigen, determining if large T antigen plays 
any role in the persistent infection cell lines could be one of the first step towards a 
greater understanding of SV40 persistence. 
The inherent differences in viral progeny release and large T antigen expression 
pattern between the persistently infected cell lines point to at least two different 
variations of persistent infections (Figure 6.2, 6.3, 6.4). Yet, the mechanism behind these 
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variations remains to be determined. A slight hint however, may have been provided by 
the expression of large T antigen with different mobility as determined by Western blot 
analysis (Figure 6.2). Several studies have previously demonstrated that phosphorylation 
of the SV40 large T antigen can alter its migration during Western blot analysis (Grässer 
and König, 1992; Grässer et al., 1988). Therefore, it can be speculated that the large T 
antigens expressed by BN-PSMp are hyperphosphorylated when compared to the large T 
antigens expressed by B7-PSMp and B7-PSM1. How can phosphorylation of large T 
antigen contribute to the establishment of SV40 persistent infection? It has been 
previously demonstrated that phosphorylation of large T antigen can inhibit the 
unwinding of the origin of replication and the subsequent DNA replication (Cegielska 
and Virshup, 1993; Cegielska et al., 1994). If the large T antigens expressed by BN-
PSM1 are indeed in the hyperphosphorylated form, it may explain the low yield of virus 
progeny produced by this cell line. Yet at this time, we cannot formally rule out that the 
large T antigens expressed by BN-PSM1 are not truncated. 
Here, we have derived an SV40 persistent infection system from African green 
monkey kidney cells, BSC-40.  
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6.4 Future Directions 
The conserved nature of miRNA-mediated autoregulation of the early transcripts 
implies biological importance (Broekema and Imperiale, 2013; Seo et al., 2008, 2009; 
Sullivan et al., 2005, 2009). Yet, pre-expression of the 776 miRNA did not alter lytic 
replication of all six viruses tested in this study. However, the assays were performed on 
clonal derivatives of the BN and B7 stable cell lines. To ensure that the result observed 
was not due to clonal artifact from the stable cell lines, plaque assays will next be 
conducted on the pooled BN and B7 stable cell lines. 
Even though the capacity to release progeny virions has been demonstrated for all 
three persistent cell lines in this study, one of the most important next step is to sequence 
their corresponding genome, to ensure that the identity of the protoarchetype-SM has 
been preserved during the establishment of these persistently infected cell lines. Next, in 
situ hybridization will be performed to confirm that the viral genomes do indeed 
persistent as episomes in these cell lines. Furthermore, in situ hybridization will also 
reveal the specific nuclear localization of the viral genome, whether they exist as free 
episomes or are tethered to the cellular chromatin. 
To better understand the underlying difference between the persistently infected 
cell lines, it is necessary to first determine the molecular contribution to the aberrant 
migrating form of large T antigen observed in the BN-PSM1 cell line. Phosphatase 
treatment of the cell lysate will be performed prior to Western blot analysis to determine 
if it is a phosphorylation mutant. Sequencing of the genome will allow us to know if it is 
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a truncated form of large T antigen. Large T antigen can be overexpressed in these 




6.5 Materials and Methods 
 
6.5.1 Cell culture.  
African green monkey kidney epithelial cells BSC-40 were obtained from the 
American Type Culture Collection (Manassas, VA). The BSC-40 cell culture was 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) (Life Technologies, Carlsbad, CA). 
 
6.5.2 Stable cell line construction.  
All DNA vector constructs were sequence verified through the sequence analysis 
at the Institute of Cellular and Molecular Biology Sequencing Facility at the University 
of Texas at Austin. The two vectors used in the construction of stable BSC-40 cell lines 
were pcDNA3.1neo and pcDNA3.1neo-776miR (Chen et al., 2013). Briefly, BSC-40 
cells were first seeded in 10cm tissue culture dishes. The cells were then transfected with 
either pcDNA3.1neo or pcDNA3.1neo-776miR using the Lipofectamine 2000 
transfection reagent (Life Technologies) according to the manufacturer’s instruction. At 
24 hours post transfection, the transfected BSC-40 cells were sub-cultured at a 1:3, 1:5 
and 1:10 ratio intp 10cm tissue culture dishes. Stable cell lines were selected for using 
G418 sulfate at a concentration of 600μg/mL (EMD Millipore, Darmstadt, Germany). 
Individual colonies were selected and amplified into clonal cell lines. The remaining 
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leftover cells were collected as a pool and amplified as well. The derivative stable cell 
line were maintained in DMEM supplemented with 10% FBS and 600μg/mL G418 and 
the culture media was refreshed every three days.  
 
6.5.3 Construction of chimeric SV40 viruses.  
To generate the SV40 and SV40 miRNA mutant virus (SM) (Sullivan et al., 2005) 
under the protoarchetype and archetype genetic background, K661 (protoarchetype) and 
SVCPC (archetype) genomes were first digested with BstXI and KpnI (New Engladn 
BioLabs, Ipswich, MA) to excise the non-coding regulatory region (NCCR). The vectors 
carrying the wild type SV40 or SM (pSVB3 and pSVB3-SM, both of nonarchetype 
genetic background) were also digested with BstXI and KpnI to remove their NCCR. The 
protoarchetype or the archetype were sub-cloned into the BstXI/KpnI sites in the vector 
to generate the protoarchetype-WT, –SM , archetype-WT and –SM vectors. The 
corresponding chimeric viruses were produced as described (Kraus and Mertz, 2001). 
Briefly, the viral vectors were digested with BamHI (New England BioLabs), followed 
by intramolecular ligation of the excised viral DNA. The ligation reaction was then 
transfected into BSC-40 and further amplified. 
 
6.5.4 SV40 infections.  
BSC-40 cells (parent), stable BSC-40 without SV40 miRNA expression (BN) and 
with SV40 776 miRNA expression (B7) were seeded in 6-wells plates. The cells were 
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infected with nonarchetype, protoarchetype or archetype WT, or SM virues at an MOI of 
10. 500 microliters of viral inoculum was used for each well after aspiration of the culture 
media. The plates were rocked back-and-forth every 15 minutes for 2 hours at 37°C 
(Tremblay et al., 2001). The viral inoculum was replaced with DMEM supplemented 
with 2% FBS, without G418 sulfate. 
 
6.5.5 Derivation of the persistent cell lines.  
Both the BN and B7 stable BSC-40 cell lines were infected with protoarchetype-
SM at an MOI of 0.01 as described in the “SV40 infections” section. The media was 
replaced with DMEM supplemented with 2% FBS every 3 days until complete 
destruction of the cell monolayer. The media replacement continued until individual 
surviving colonies were observable. Individual colonies were selected and amplified into 
clonal cell lines. The remaining leftover cells were collected as a pool and amplified as 
well. The cell lines were maintained in DMEM supplemented with 10% FBS, without 
G418.  
 
6.5.6 RNA isolation and Northern blot analysis.  
Total RNA was harvested from the cells using an in-house PIG-B solution as 
described previously (Chen et al., 2011; Lin et al., 2010; Seo et al., 2008; Weber et al., 
1998). The total RNA were then subjected to Northern blot analysis as described 
(Sullivan et al., 2005). Briefly, 10 micrograms of total RNA was separated on a Tris-
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borate-EDTA-Urea-15% denaturing polyacrylamide gel. The RNA was transferred onto a 
Hybond N+ membrane (GE Healthcare, Pittsburgh, PA). The membrane was probed for 
overnight at 38.5°C in the ExpressHyb hybridization solution (Clontech, Mountain View, 
CA). The SV40 3p miRNA probe sequence is: CTCAGGGCATGAAACAGGC. 
 
6.5.7 Plaque assay.  
The BN and B7 stable BSC-40 cell lines were seeded in 6-wells plate and infected 
as described in the section “SV40 infections”. The viral inoculum was replaced with a 
2mL 1:1 mixture of Minimal Essential Medium (MEM) supplemented with 10% FBS and 
twice the amount of Penicillin (200 I.U/mL) and Streptomycin (200 μg/mL), and 1.8% 
Bacto-agar (BD Biosciences, San Jose, CA). The same mixture was re-fed to the existing 
layer every 3 days until 15 days post infection (dpi). The plaques were visualized by 
adding neutral red dissolved in the media-agar mixture at 100 μg/mL at the last re-fed. 
The dye was allowed to diffuse through the layer for one day prior to plaque 
visualization.  
 
6.5.8 Protein isolation and western blot analysis.  
The uninfected and 47 hours post infected BN and B7 stable BSC-40 cells, and 5 
days old cultures of the surviving cell lines were lysed in RIPA buffer (150mM sodium 
chloride [Avantor Performance Materials, Center Valley, PA], 10mM Tris, pH 7.2 
[Fisher Scientific], 0.1% sodium dodecyl sulfate [Avantor Performance Materials], 1% 
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Triton X-100 [Fisher Scientific], 1% sodium deoxycholate [Alfa Aesar, Ward Hill, MA], 
5mM EDTA [Fisher Scientific] and 1 tablet of complete mini, EDTA-free protease 
inhibitor (Roche, Indianapolis, IN) per 10mL of RIPA buffer). For sodium butyrate 
treatment, the surviving cell lines were treated with sodium butyrate at 0.01M for 24 
hours prior to total protein harvest using RIPA buffer. 50 micrograms of total protein 
were heated at 95°C for 5 minutes in SDS sample buffer with β-mercaptoethanol 
(375mM Tris-HCL, pH6.8 [Fisher Scientific], 6% (w/v) sodium dodecyl sulfate [Avantor 
Performance Materials], 48% (v/v) glycerol [Sigma-Aldrich], and 0.03% (w/v) 
bromophenol blue [Fisher Scientific]) and subjected to electrophoresis using a 10% 
denaturing acrylamide gel (Bio-Rad). Proteins were transferred onto Immobilon-FL 
PVDF membrane (Millipore, Billerica, MA) using the Bio-Rad Mini Trans-Blot 
electrophoretic transfer cell (Bio-Rad, Hercules, CA).  The membrane was blocked in 5% 
(w/v) skim milk powder (HEB, San Antonio, TX) in Tris-buffered saline with 0.1% (v/v) 
Tween-20 (TBST, Fisher Scientific) for 1 hours at room temperature. Membrane was 
probed using a mouse antibody against the large T antigen, pAB416 (1:200, a gift from 
Dr. James Pipas) or a mixture of two rabbit antibody against the BC and DE loop of VP1, 
respectively (1:2000 each, gifts from Dr. Robert Garcea), overnight at 4°C. After 
overnight incubation, the membrane was washed with TBST, 4 times, 15 minutes each, 
followed by incubation with either anti-mouse or anti-rabbit secondary antibody IgG 
conjugated to HRP (1:5000, Bio-Rad) for 1 hours at room temperature. The membrane 
was washed 4 times with TBST, 15 minutes each. The West Dura chemilumimnescent 
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substrate (Thermo Scientific, Rockford, IL) was used to generate the signal for 
visualization on the Blue Ultra Autorad film (BioExpress, Kaysville, UT).  
 
6.5.9 Immunofluorescence detection of large T antigen in the persistent cell lines. 
The protoarchetype-SM infection surviving BN and B7 stable BSC-40 cells were 
seeded in 6-wells plates. The 3 days old cell culture was stained for large T antigen and 
visualized via immunofluorescence. Briefly, the cells were washed with phosphate buffer 
saline (PBS) (Life Technologies) and fixed using 4% paraformaldehyde in PBS 
(Affymetrix, Cleveland, OH) at 37°C for 30 minutes. The cells were permeabilized with 
0.1% Triton X-100 (Thermo Scientific) in 3% bovine serum albumin (BSA) – PBS. The 
cells were then blocked with 3% BSA – PBS for 1 hour at room temperature. The cell 
were stained for large T antigen using pAb416 (1:200), overnight at 4°C. After staining, 
the cells were washed four times using PBS, 10 minutes each. The cells were then 
incubated with anti-mouse IgG conjugated with AlexaFluor488 (1:1000, Life 
Technologies) for 1 hour at room temperature. Following secondary antibody staining, 
the cells were washed four times with PBS, with DAPI included in the final wash at 
1μg/mL. The cell were kept in PBS and imaged using a Nikon Eclipse TS100 




6.5.10 Immunofluorescence detection of VP1.  
The protoarchetype-SM infection surviving BN and B7 stable BSC-40 cells were 
seeded in 6-wells plates. Supernatant was collected from 5 days old cell culture. BSC-40 
cells were seeded in 6-wells plates and infected with the supernatant as described in the 
“SV40 infections” section. Cells were stained as describe in the “Immunofluorescence 
detection of large T antigen in the persistent cell lines” section at 43 hours post infection. 
VP1 was stained using the mixture of two rabbit antibodies against the BC and DE loop 
of VP1 (1:2000 each). The anti-rabbit IgG conjugated with AlexaFluor594 (1:1000, Life 
Technologies) was used. Hoechst 33342 was used at a concentration of 1μg/mL. 
 
6.5.11 Southern blot analysis of persistent cell lines.  
Genomic DNA was harvested from the persistent cell lines as described (Strauss, 
2001). 10 μg of genomic DNA was digested with either BamHI or AgeI (New England 
BioLabs). The digested DNA was purified using phenol-chloroform extraction followed 
by ethanol precipitation. The samples were separated on a 1% agarose-TAE gel at 4°C, 
overnight at 70V. The gel was transferred onto an Amerisham Hybond-XL membrane 
(GE Healthcare) according to the manufacturer’s instructions. Radioactive probes was 
generated using the Amersham Rediprime II Random Prime Labelling System (GE 
Healthcare). The membrane was probed overnight at 55°C in ExpressHyb hybridization 
solution (Clontech). The template for the random priming reaction was generated by PCR 
amplification of a 301bp region of the SM pre-miRNA mutant region (nucleotide position 
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2663 to 2963) using the following pair of primers: SV40 ATTAAA-F, 




CHAPTER 7 Detection of Extracellular JCV miRNAs as a Non-




 There are currently four known human polyomaviruses associated with human 
pathologies – JC virus (JCV), BK virus (BKV), Merkel cell carcinoma virus (MCV) and 
trichodysplasia spinulosa virus (TSV) (Feng et al., 2008; Gardner et al., 1971; van der 
Meijden et al., 2010; Padgett et al., 1971). JCV is the etiological agent of Progressive 
Multifocal Leukoencephalopathy (PML), a rare, neurodegenerative disease caused by the 
lytic reactivation of JCV in the brain of immunocompromised patients (Astrom et al., 
1958; Padgett et al., 1971). From a historical perspective, PML is mostly associated with 
patients with acquired immunodeficiency syndrome (AIDS), as a study in the United 
States between 1998 and 2005 showed that 82% of PML patients also had AIDS (Molloy 
and Calabrese, 2009). However, in recent years, an entirely new group of patients 
undergoing immunomodulatory drug regime were found to be at risk of developing PML. 
Current diagnostics for PML involve detection of JCV DNA via the polymerase 
chain reaction (PCR) from cerebrospinal fluid (CSF) or a direct brain biopsy (Brew et al., 
2010; Major, 2010). Both of these assays are invasive and impractical for routine 
sampling. Other PML biomarker approaches have attempted to utilize PCR for JCV DNA 
from isolated blood/serum or detection of immunoreactive antibodies against JCV. Both 
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of these approaches fall short as biomarkers for PML since many healthy non-PML 
patients have been previously exposed to JCV and will periodically have JCV viremia. In 
fact, approximately 50 to 80% of the human population is seropositive for JCV antibodies 
as JCV is found to persistently infect the kidney and perhaps other non-neural tissues 
such as lymphocytes (Brew et al, 2010). Thus, being seropositive for JCV-reactive 
antibodies or even having viral DNA detected in bodily fluids via PCR is not predictive 
of the neural disease PML. 
 In patients with PML, magnetic resonance imaging (MRI) can sometimes be used 
to reveal changes in local brain features characteristic of this condition. However, this 
methodology misses many cases of PML and is not amenable as an early diagnostic of 
PML. Furthermore, other neurological disorders can cause white matter abnormalities 
such as multiple sclerosis and systemic lupus erythematosus (Brew et al., 2010). 
Therefore, at present, a definitive diagnosis for PML can only be confirmed by the 
detection of JCV DNA in the CSF or in brain biopsy, which is too invasive to be 
routinely performed as a prognostic diagnostic for rare incidences of PML associated 
with various drug regimens. 
Several potentially important immunomodulatory drugs that could benefit patients 
includes: Natalizumab (trade name Tysabri) for multiple sclerosis, efalizumab (trade 
name Raptiva) for psoriasis and rituximab (trade name Rituxan) for arthritis are 
associated with rare occurrences of PML. The gold standard for the diagnosis of PML is 
through a brain biopsy, in combination with the detection of JCV DNA in the CSF via 
PCR. Both methodologies are invasive in nature.  Thus, there is a need in the art for non-
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invasive and accurate methods for detecting JCV infections.  This study therefore 
addresses these and other needs in the art. This study addresses the need to find an 
alternate, non-invasive diagnostic for PML. 
Exosomes are small, membrane vesicles of approximately 40 to 100nm in 
diameter. Exosomes are secreted by a various cell types, in particular, neuronal cells such 
as oligodendrocytes, microglial cells and astrocytes (Frühbeis et al., 2012). Exosomes 
originate from the invagination and budding from the membrane of late endosomal-
derived structures known as the multivesicular bodies (MVBs). Exosomes are then 
released into the extracellular environment as a result of a fusion event between the 
MVBs with the plasma membrane. Since exosomes can be found to in various body 
fluids such as breast milk, saliva, plasma and urine (Lässer et al., 2011a; Pisitkun et al., 
2004; Skog et al., 2008) makes them a novel non-invasive, alternative for the diagnostics 
of diseases. Recently, it has been demonstrated that in addition to proteins, exosomes also 
carry nucleic acids such as mRNA and miRNAs (Skog et al., 2008). The profile of 
exosomal contents, therefore, are useful indications of the content of the exosomes 
secreting cells. 
miRNAs are eukaryotic, small, regulatory molecules (approximately 22nt in 
length) that controls the expression of their target mRNAs by binding to them, resulting 
in translational repression or degradation (Bartel, 2009). Several virus families, such as 
herpesviruses and polyomaviruses, encodes miRNAs (Grundhoff et al., 2006; Pfeffer et 
al., 2004; Seo et al., 2008, 2009; Sullivan et al., 2005, 2009). It has recently been reported 
that both Epstein-Barr virus (EBV), a member of the herpesvirus family, proteins and 
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miRNAs are detected in exosomes released by EBV infected cells (Meckes et al., 2010, 
2013; Pegtel et al., 2010). Along these findings, we have previously shown that JCV also 
encodes miRNA and are detected via Northern blot analysis of brain samples obtained 
from patients suffering from PML (Seo et al., 2008). Here, we address the question 
whether JCV miRNAs can be detected in exosomes secreted by astrocytes where JCV 
lytic replication is occurring, therefore, serving as a non-invasive, alternate diagnostics 




7.2.1 JCV miRNAs are detected in exosomes secreted by JCV infected astroglial cells.  
We have previously demonstrated that the JCV 5p derivative miRNAs were 
detectable in brain samples obtained from patients suffering from PML (Seo et al., 2008). 
To determine if JCV miRNAs are detectable in the exosomes, we first established a cell 
culture system for the isolation and characterization of exosomes secreted from JCV 
infected cells. SV40-transformed human astroglial cells, SVGA (Major et al., 1985), were 
first infected with the Mad-1 strain of JCV. Exosomes from 3 days post infected (dpi) 
infected SVGA cell culture supernatant were isolated via differential ultracentrifugation. 
The first step in determining the identity of the exosomal pellet obtained from the 
ultracentrifugation procedure, TEM was performed on an aliquot of the pellet. The TEM 
image showed that vesicular structures between 40 to 100nm were visible in the 
ultracentrifugation purified exosomal samples with “saucer-like” morphology (Figure 
7.1A and B), consistent with the observed size and morphology from previously reported 
structural analysis of exosomes preparations (Raposo et al., 1996). As a second, 
independent method to confirm the identity of the exosomes preparation obtained via 
ultracentrifugation, western blot detection of CD63, a member of the tetraspanin family 
that has been previously reported to be present at high abundance in exosomes (Pols and 
Klumperman, 2009), was performed. The western blot result indicated that exosomes 
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were indeed isolated via ultracentrifugation of cell culture supernatant from JCV infected 






Figure 7.1 TEM and western blot analysis confirmed the identity of exosomes isolated via ultracentrifugation.  
Exosomes were isolated from JCV infected SVGA cell culture supernatant at 3dpi, via ultracentrifugation. (A and B) TEM 
images of exosomes secreted by JCV infected SVGA at 3dpi. The exosomes are indicated by the red arrows. The size scale 
is indicated at the bottom of each panel. (C) Western blot analysis for CD63 from total cell lysate and exosomes under non-
reducing condition. Enrichment of CD63 signal was observable in 1 microgram of exosomal samples obtained via 
ultracentrifugation but not in 1 microgram to total cell lysate. 
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To determine if the JCV miRNAs were detectable in the exosomes, RNA was 
harvested from exosomes obtained from JCV infected SVGA, followed by Northern blot 
analysis for the JCV 5p derivative miRNA. The result however, did not reveal any signals 
from the JCV 5p derivative miRNAs (Figure 7.2A). A second Northern blot analysis for 
the abundant miRNA, let7-a, demonstrated that the cellular miRNA was not detectable in 
the exosomal RNA sample as well (figure 7.2B). These results suggested that either JCV 
miRNAs were not encapsulated by the exosomes, or that the amount of JCV miRNAs 
present was too low to be detectable via Northern blot analysis. The stem-loop RT PCR 
analysis was next performed to increase the detection sensitivity for the JCV 5p 
derivative miRNA (Chen et al., 2005; Kramer, 2011). Reverse transcription reaction was 
performed on exosomal RNA obtained from both uninfected and JCV infected SVGA. 
The total RNA was either left untreated or treated with DNase to reduce the amount of 
contaminating viral DNA during the reverse transcription reaction. Using a modified 
stem-loop primer designed to specifically recognize the last 9 nucleotides of the JCV 5p 
derivative miRNA, followed by end-point PCR identification. The RT-PCR results 
demonstrated that the JCV 5p derivative miRNA was detectable in the exosomal RNA 
preparation obtained from the cell culture supernatant of SVGA cells undergoing lytic 
JCV replication (Figure 7.2C). This end-point RT PCR assay, however, did not 
demonstrate high enough sensitivity and specificity. Without DNase treatment of the total 
RNA sample, amplified signal was also observed in total RNA from JCV infected 
SVGA, suggesting non-specific amplification of JCV DNA. Furthermore, RT PCR signal 
from exosomal samples was observable only after 45 cycles of amplification, suggesting 
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Figure 7.2 Detection of JCV 5p derivative miRNA via Northern blot analysis and 
end-point stem-loop RT PCR.  
(A, B) Northern blot analysis of total and exosomal RNA. Exosomes from 3dpi SVGA 
was isolated via ultracentrifugation. Total and exosomal RNAs were subjected to 
Northern blot analysis for the JCV 5p derivative miRNA (A) and a control cellular 
miRNA, let7-a (B). The JCV pre-miRNA signal is indicated by a white arrowhead, the 
JCV 5p derivative miRNA signal is indicated by a black arrowhead whereas the let7-a 
miRNA is indicated by a grey arrowhead. As a loading control, ethidium bromide-stained 
low-molecular-weight RNA is shown in the bottom panel for each blot. (C) End-point 
stem-loop RT PCR detection of JCV 5p derivative miRNA from exosomal RNA. Total 
(indicated as “Total”) and exosomal (indicated as “Exo”) RNA from 3dpi SVGA 
(uninfected, “M” and JCV infected, “J”) were either left untreated or subjected to DNase 
elimination of contaminating DNA prior to end-point stem-loop RT PCR designed to 
recognized the last 9nt of the JCV 5p derivative miRNA. PCR bands corresponding to the 
JCV 5p derivative miRNA were detected after 45 cycles of PCR amplification only from 
the JCV infected samples. The row “DNase” indicates whether the RNA samples had 
been treated with DNase prior to the RT reaction and the row “RT” indicates whether the 
reverse transcriptase enzyme had been added to the reaction. The red “*” indicates 




7.2.2 Confirmation of exosomal JCV 5p derivative miRNA via TaqMan-based stem-
loop RT PCR.  
The end-point PCR method for detecting the JCV 5p derivative miRNA consisted 
of 45 cycles of amplification steps. To increase the sensitivity of this assay and improve 
the limit of detection, a TaqMan-based stem-loop RT PCR was performed. SVGA cells 
were first infected with the Mad-1 strain of JCV and total RNA was harvested from the 
infected cells at 1, 3, 5 and 7dpi infection. To better improve efficiency and streamline 
the exosomes isolation process, a commercial exosomes precipitation solution, 
ExoQuick-TC (Taylor et al., 2011; Yamada et al., 2012) was used isolate exosomes from 
SVGA culture supernatant at 1, 3, 5 and 7dpi. Prior to detection of the JCV 5p derivative 
miRNA, the purity of the exosomes were first determined. Total cellular protein and 
exosomal protein were subjected to western blot analysis for Tsg101 and Calnexin. 
Tsg101 is an essential protein in exosomes biogenesis and are enriched in exosomes 
whereas Calnexin is an endoplasmic reticulum marker and are absent in exosomes 
(Lässer et al., 2011b; Urbanelli et al., 2013). Western blot analysis of exosomes isolated 
using the ExoQuick-TC exosomes precipitation solution indeed displayed enrichment of 
Tsg101 and an absence of Calnexin (Figure 7.3). RNA from the precipitated exosomes 
and the infected cells were then harvested and subjected to the TaqMan-based stem-loop 
RT PCR that specifically recognized the JCV 5p derivative miRNA. The quantitative 
PCR result demonstrated that the JCV 5p derivative miRNA was readily detectable in 
both the total and exosomal RNA from the JCV infected Mad-1 cells at all time points 
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but not from uninfected SVGA cells (Table 7.1), suggesting that the viral miRNAs were 
indeed detectable in exosomes secreted by JCV infected cells. However, detection of the 
viral miRNA signals from the total RNA samples registered at least 2.7 Ct cycles (3dpi) 
to 3.13 Ct cycles (7dpi) earlier than their exosomal counterparts, suggesting the need for 
further enrichment of neuronal exosomes prior to detection of the viral miRNAs via the 





Figure 7.3 Western blot confirmation of exosomes isolated via ExoQuick-TC 
exosomes precipitation solution.  
Exosomes were isolated from uninfected (indicated as “Mock”) and JCV infected 
(indicated as “JCV”) SVGA at 1, 3, 5 and 7dpi using the ExoQuick-TC exosomes 
precipitation solution. 50 micrograms of total protein and exosomal protein were 
subjected to Western blot analysis for Tsg101, an exosomes marker, and Calnexin, an 
endoplasmic reticulum marker absent in exosomes. “DPI” indicates the days post 
infection of each sample.
 249 
 
Table 7.1 TaqMan stem-loop RT PCR detection of JCV 5p derivative miRNA from 
exosomes secreted by JCV infected SVGA.  
Commercial TaqMan stem-loop RT PCR kit was used to detect the JCV 5p derivative 
miRNA from both total and exosomal RNA samples derived from 1, 3, 5 and 7dpi 
SVGA. Each data is represented as an average and standard deviation of Ct cycle number 
in triplicate. Uninfected SVGA is indicated by “Mock” and JCV infected SVGA is 





Mock JCV Mock JCV 
1dpi N.D. 25.78 ± 0.04 39.63 ± 0.65 30.49 ± 0.24 
3dpi 39.07 ± 0.82 27.29 ± 0.02 N.D. 30.00 ± 0.04 
5dpi 39.54 ± 0.79 26.04 ± 0.03 39.21 ± 0.77 30.14 ± 0.09 
7dpi 39.55 ± 0.78 24.81 ± 0.02 39.86 ± 0.24 30.41 ± 0.12 
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7.2.3 Enrichment of neuronal exosomes via PLP-mediated Immunoaffinity capture. 
Since the cells were cultured in media containing regular fetal bovine serum 
(FBS), the exosomal preparations from the virus infected cells would therefore, contain 
exosomes from the serum itself. The presence of exosomes would be expected to increase 
the background signal when detecting the JCV 5p derivative miRNA. Previous reports 
have demonstrated successful isolation of exosomes of specific cellular origin via 
immunoaffinity capture, through targeting of membrane proteins that are unique to the 
exosomes of interest (Clayton et al., 2001; Koga et al., 2005; Mathivanan et al., 2010; 
Tauro et al., 2012). Proteomic profiling of oligodendroglial exosomes revealed the 
presence of unique myelin proteins such as proteolipid protein (PLP), 2’, 3’-cyclic 
nucleotide 3’ phosphodiesterase (CNP), myeline-associated glycoprotein (MAG) and 
myelin oligodendrocyte glycoprotein (MOG) (Krämer-Albers et al., 2007). Western blot 
analysis demonstrated that PLP was readily detectable in SVGA cells under both 
uninfected and JCV infected conditions (data not shown), therefore, PLP was selected as 
the target protein for isolation of SVGA exosomes via immunoaffinity capture. Exosomes 
were first isolated from JCV infected SVGA supernatant at 3dpi, using the ExoQuick-TC 
exosomes precipitation solution. Four different antibodies against PLP were used 
individually to immunoaffinity capture SVGA secreted exosomes, following by 
harvesting of exosomal RNA. As a control for exosomes immunoaffinity capture, an 
antibody against CD63 was used. TaqMan stem-loop RT PCR was next performed on the 
exosomal RNA for the JCV 5p derivative miRNA. The result, however, did not reveal 
any enrichment of the viral miRNA signal over the input total exosomes as the Ct cycle 
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number observed for each immunoaffinity capture sample was greater than the Ct cycle 
number for the total exosomes sample (Table 7.2), indicating the failure to enrich for 
neuronal exosomes via PLP-mediated immunoaffinity capture. In addition, the lack of 
signal from CD63-mediated immunoaffinity capturing of exosomes (Ct cycle number of 
37.90) further suggesting the general inefficiency or lack of complete capturing of 
exosomes through this methodology. 
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Table 7.2 No enrichment of SVGA secreted exosomes via PLP-mediated 
immunoaffinity capture.  
Exosomes from 5dpi uninfected (“Mock”) and JCV infected SVGA were isolated via 
ExoQuick-TC exosomes precipitation solution. Four different antibodies against PLP 
were used in the immunoaffinity capture of SVGA exosomes. An antibody against CD63 
was used as a control. RNA from immunoaffinity captured exosomes were harvested and 
subjected to TaqMan stem-loop RT PCR to detect the JCV 5p derivative miRNA. The 
result suggests none of the tested antibodies displayed enrichment of SVGA exosomes. 
Each data is represented as an average and standard deviation of Ct cycle number in 
triplicate. Uninfected SVGA is indicated by “Mock” and JCV infected SVGA is 
indicated by “JCV”. “N.D.” represents not detectable due to Ct cycle number greater than 
40. 
 Mock JCV 
CD63 N.D. 37.90 ± 1.85 
PLP (O10) 39.70 ± 0.32 30.38 ± 0.09 
PLP (9001) N.D. 37.66 ± 2.10 
PLP (2D7) 38.99 ± 1.57 39.25 ± 1.30 
PLP (G-17) N.D. 39.38 ± 1.07 
ExoQuick-TC 39.36 ± 1.10 30.25 ± 0.06 




In the early 1980s, despite being a rare disease in the general population, before the 
era of highly active anti-retroviral drug therapies, PML was as one of the top disease 
affecting patients suffering from AIDS (Collazos, 2003). More recently, the introduction 
of monoclonal antibodies as therapeutic agents against autoimmune disease, PML is a 
clinical problem of rising interest and economic importance to several 
biotechnology/pharmaceutical companies. The lack of antiviral drug against JCV 
replication calls for closer monitoring of patients under these therapeutic regimes for lytic 
JCV replication in the brain. However, the current gold standard of PML diagnosis 
involves detection of JCV genome in the CSF via PCR or by brain biopsy are too 
invasive to be implemented for routine surveillance of patients under the monoclonal 
antibodies treatment regime. Until the availability of effective treatment against active 
JCV replication in the brain, the development of a non-invasive diagnostic for PML is of 
the utmost importance. Here, we describe a methodology for detecting JCV miRNA in 
exosomes secreted by neuronal cells as a potential non-invasive diagnostic for PML. We 
first demonstrate that cultured astroglial cells, SVGA, release exosomes into the culture 
supernatant. TEM visualization of the exosomal morphology and western blot analysis 
for exosomal protein, CD63 confirm successful isolation of exosomes from JCV infected 
SVGA cells (Figure 7.1). Via end-point stem-loop RT PCR, we are able to detect the JCV 
5p derivative miRNA from exosomes secreted by JCV infected SVGA cells (Figure 7.2). 
However, the end-point stem-loop RT PCR detection method was not as sensitive and 
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specific as anticipated, we therefore turn to the TaqMan-based stem-loop RT PCR using 
commercially designed RT primers for detection of the JCV 5p miRNA derivative from 
the exosomes and indeed able to detect the viral miRNA from both total and exosomal 
RNAs. These assays, however, were performed under the condition of contaminating 
bovine exosomes introduced by the supplemented FBS in the cell culture media, thereby 
potentially reducing the signal-to-noise ratio in the detection of viral miRNAs from 
exosomal RNA. Indeed, we are not able to observe enrichment of viral miRNA signal in 
the exosomal RNA sample over the total RNA sample. 
To circumvent this issue, two alternatives are available. First, exosomes depleted 
FBS can be used in the cell culture media, thereby eliminating the contaminating bovine 
exosomes. Second, a second enrichment step can be perform to selectively harvest 
exosomes of neuronal origin. For the development of a new diagnostic, the former 
alternative is less desirable due to the fact that exosomes are secreted by multiple tissue 
types (Simpson et al., 2012), thus, having contaminating bovine exosomes in the cell 
culture media is a better mimic of human samples. To enrich for exosomes secreted by 
the SVGA cells, we target one of the neuronal specific membrane protein, PLP, for the 
immunaffinity capture of exosomes after pre-concentrating the total exosomes via 
ExoQuick-TC exosomes precipitation solution. However, the lack of signal-to-noise ratio 
improvement indicate an unsuccessful enrichment of SVGA secreted exosomes via 
immunoaffinity capture. The PLP protein is a member of the tetraspanin with only two 
extracellular loop regions found at the extracellular surface (Dhaunchak and Nave, 2007; 
Greer et al., 1996; Krämer-Albers et al., 2007). Therefore, inability for the chosen 
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antibodies to recognize either of the extracellular motifs could explain the lack of 
enrichment of SVGA exosomes. Greer et al. had successfully generated two antibodies, 
3F4 and 3G9, which were raised to specifically recognize each of the two extracellular 
loops (Greer et al., 1996). Therefore, utilizing these two antibodies can be a better option 
over the four antibodies tested in this study. Since JCV specifically establishes lytic 
replication in oligodendrocytes, the myelin producing cells of the central nervous system 
(Krämer-Albers et al., 2007; Major et al., 1992; Zu Rhein, 1969; Zurhein and Chou, 
1965), aside from PLP, other oligodendrocyte membrane proteins that are present in 
oligodendrocytes-derived exosomes, namely CNP, MAG and MOG (Fitzner et al., 2011; 
Krämer-Albers et al., 2007), can also be targeted in immunoaffinity capture of the 
exosomes.  
The isolation of oligodendrocytes-derived exosomes from human body fluid 
samples such as serum and urine hinges on one important factor – crossing of the blood-
brain-barrier. Indeed, a previous report by Skog et al. has clearly demonstrated the 
isolation of exosomes secreted by glioblastoma tumors from the serum of glioblastoma 
patients. Furthermore, mRNA and miRNAs characteristics of glioma were detected in 
those exosomes as well. Therefore, the overall schematic of the non-invasive diagnostic 
for PML proposed in this study will first require routine blood draws and/or collection of 
urine samples from patients undergoing monoclonal antibodies treatment regime. Total 
exosomes will then be harvested from the body fluid via ultracentrifugation or direct 
precipitation using commercial solutions. Exosomes of neuronal origin, or specifically, 
oligodendrocyte-derived, can be enriched via immunoaffinity capture through the 
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targeting of membrane surface protein that are uniquely expressed in oligodendrocytes. 
Finally, TaqMan-based stem-loop RT PCR will be conducted to determine if the JCV 
miRNAs can be detected in the exosomes. 
 
7.4 Future Directions 
 
Since PML is characterized by a progressive spread of JCV lytic infection of 
oligodendrocytes (Gheuens et al., 2013). Therefore, one might predict that at the earliest 
onset of PML, only a small population of oligodendrocytes will be displaying JCV lytic 
replication. Therefore, the subpopulation of exosomes isolated from the patient serum 
samples that are positive for the JCV miRNAs will be flooded by exosomes of various 
other cellular origin. Therefore, to sample exosomes from the brain, in particular, 
secreted by oligodendrocytes will definitely require an additional enrichment step, via 
immunoaffinity capture. Despite not being able to capture SVGA exosomes using four 
different antibodies against PLP, the idea of immunoaffinityt capture is not without merit. 
Several biotechnology companies such as Systems Biosciences and Life Technologies are 
offering magnetic beads with conjugated antibodies against exosomal membrane protein 
such as CD63. To specifically enrich for exosomes secreted by oligodendrocytes, it is 
necessary to target oligodendrocytes-specific membrane proteins. As discussed, Greer et 
al. has two published antibodies against extracellular loop regions of PLP that can be 
tested in the immunoaffinity capturing of oligodendrocytes-derived exosomes. There are 
also additional oligodendrocytes specific membrane protein such as MAG and MOG, 
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which are also enriched in exosomes (Krämer-Albers et al., 2007), that can serve as target 
for immunoaffinity capturing of the exosomes.   
 
7.5 Materials and methods 
 
7.5.1 Cell culture and preparation of culture medium for exosomes isolation.  
SVGA cells (SV40 transformed astroglial cells, kindly provided by Walter 
Atwood, Brown University, Providence, RI) were maintained in Minimal Essential 
Medium Eagle with Earle’s salts and L-glutamine (MEM, Cellgro, Manassa, VA) 
supplemented with 10% heat inactivated fetal bovine serum (FBS, Sigma-Aldrich, St. 
Louis, MO), penicillin (100IU/mL) and streptomycin (100μg/mL) (Cellgro).  
 
7.5.2 JCV infection of SVGA cells.  
SVGA cells were seeded in T175 tissue culture flasks. The cells were infected 
with JCV (Mad1 strain, kindly provided by Walter Atwood) in MEM containing 2% heat 
inactivated FBS at 37°C for 1 hour. The plates were gently rocked every 15 minutes. The 
virus inoculum was replaced with 30mL of regular MEM containing 10% heat 
inactivated FBS.  
 
 258 
7.5.3 Ultracentrifugation isolation of exosomes.  
Exosomes were isolated from either mock infected or JCV infected SVGA cell 
culture medium by first centrifugation at 300g for 10 minutes at 4°C (Avanti J-E 
centrifuge with JS 5.3 swinging bucket rotor, Beckman Coulter, Brea, CA). The 
supernatant was collected and centrifuge at 2000g for 20 minutes at 4°C (Avanti J-E 
centrifuge with a JS 5.3 swinging bucket rotor, Beckman Coulter). The supernatant was 
transferred to a 75mL polycarbonate bottles (ThermoFisher Scientific, Asheville, NC). 
The supernatant was centrifuged at 10,000g for 30 minutes at 4°C (Sorvall Ultra Pro 80 
with a T-647.5 fixed angle rotor, ThermoFisher Scientific). The supernatant is transferred 
using a pipet to a fresh 75mL polycarbonate bottle and centrifuged at 100,000g for 2 
hours and 30 minutes at 4°C. The supernatant was discarded by decanting. The pellet was 
washed with phosphate-buffered saline (PBS, Cellgro) and centrifuged at 100,000g for 2 
hours and 30 minutes at 4°C. The supernatant was discarded by decanting. To remove the 
supernatant as completely as possible, the bottle was kept upside down and the remaining 
liquid on the side of the mouth of the bottle was removed with an aspirator. The pellet is 
suspended in 200μL of PBS and divided into 50μL aliquots and stored at -80°C. 
 
7.5.4 Pre-enrichment of exosomes from cell culture media.  
Prior to isolation of the neuronal exosomes via proteolipid protein (PLP) specific 
immunoaffinity capture, supernatant from SVGA cell cultures (mock or JCV Mad1 strain 
infected) were subjected to ExoQuick-TC Exosome Precipitation (System Biosciences, 
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Mountain View, CA), according to the manufacturer’s protocol. Briefly, SVGA cell 
culture supernatant was centrifuged at 3000g for 15 minutes at 4°C. 10mL of the 
centrifuged SVGA cell culture supernatant was then mixed with 2mL of ExoQuick-TC 
Exosome Precipitation Solution. The mixture was placed at 4°C for overnight. After 
overnight incubation, the mixture was centrifuged at 1500g for 30 minutes at 4°C. The 
resulting supernatant was aspirated. Another centrifugation step of 1500g at 4°C was 
done for an additional 5 minutes. The remaining trace of supernatant was aspirated. The 
exosomes pellet was dissolved in 200μL of PBS and stored at -80°C. For subsequent 
Western blot analysis, the exosomes pellet was resuspended in RIPA lysis buffer. For 
subsequent Northern blot analysis, the exosomes pellet was resuspended in PIG-B 
solution.  
 
7.5.5 RNA isolation and end-point stem-loop Reverse Transcription (RT) PCR 
detection of JCV 5p derivative miRNA.  
Total RNA from mock or JCV infected SVGA cells were harvested using an in-
house PIG-B solution (2M guanidinium thiocyanate [EMD, Billerica, MA], 20mM citrate 
buffer, pH4.5, 5mM EDTA [Fisher Scientific, Pittsburg, PA], 0.25% Sarkosyl [Sigma 
Aldrich], 48% saturated phenol, pH4.5 [Amresco, Solon, OH], 2.1% isoamyl alcohol 
[Fisher Scientific], 0.5% β-mercaptoethanol [Sigma Aldrich], 0.1% 8-hydroxyquinoline 
[EMD], and 0.0025% Coomassie blue [EMD]) as described previously (1, 2, 3). RNA 
from mock infected or JCV infected SVGA exosomes were isolated using the same 
protocol as above. Prior to reverse transcription, total RNA was either left untreated or 
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treated with TURBO DNase (Ambion, Austin, TX) according to the manufacturer’s 
protocols. Reverse transcription was done using SuperScript III reverse transcriptase 
(Invitrogen, Grand Island, NY) using the stem-loop RT parameters of 16°C for 30 
minutes followed by 60 cycles of 30°C for 30 seconds, 42°C for 30 seconds and 50°C for 
1 second, ending with 85°C for 5 minutes. PCR was done on the reverse transcription 
product using Taq DNA polymerase (New England BioLabs, Ipswich, MA). The primers 
used were as follows: JCV 5p miRNA stem-loop RT primer, 
GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACATGCTTTTC
, JCV 5p miRNA PCR forward, GGCCTCGTTCTGAGACCTGG, and stem-loop PCR 
reverse, GTGCAGGGTCCGAGGT. The PCR program used was a touchdown PCR 
protocol with the annealing temperature starting at 62°C for 30 seconds, decreasing by 
0.5°C every cycles for 20 cycles. PCR was continued for another 25 cycles at an 
annealing temperature of 52°C. The extension step was performed at 68°C for 30 seconds 
for each cycle. The PCR product was analyzed in a 3% agarose Lithium Borate gel 
(BioExpress, Kaysville, UT). The agarose gel was stained by ethidium bromide (Fisher 
Scientific) and visualized using a Bio-Rad Universal Hood II gel imager (Bio-Rad, 
Hercules, CA). 
 
7.5.6 TaqMan-based stem-loop RT PCR for detection of JCV 5p derivative miRNA. 
Total or exosomal RNA was subjected to RT using the RT mix provided by the TaqMan 
MicroRNA Assay (Life Technologies, Grand Island, NY), using the parameters as 
described in for the end-point RT PCR. Quantitative PCR was performed using the 
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primer mix provide by the TaqMan MicroRNA Assay and the TaqMan Universal PCR 
Master Mix, No AmpErase UNG (Life Technologies) on a ViiA 7 Real-Time PCR 
system under the default settings for TaqMan-based real time PCR.  
 
7.5.7 Northern blot analysis.  
Briefly, 10 micrograms of total RNA was or equal volume of exosomal RNA was 
separated on a Tris-borate-EDTA-Urea-15% denaturing polyacrylamided gel. The RNA 
was transferred onto a Hybond N+ membrane (GE Healthcare, Pittsburgh, PA) as 
previously described (Sullivan et al., 2005). The sequence of the probe to detect the JCV 
5p derivative miRNA was: CAATCACAATGCTTTTCCCAGGTCTCAGAAGCCTCT. 
 
7.5.8 Protein isolation and western blot analysis.  
Mock or JCV infected SVGA cells were lysed in RIPA buffer (150mM sodium 
chloride [Avantor Performance Materials, Center Valley, PA], 10mM Tris, pH 7.2 
[Fisher Scientific], 0.1% sodium dodecyl sulfate [Avantor Performance Materials], 1% 
Triton X-100 [Fisher Scientific], 1% sodium deoxycholate [Alfa Aesar, Ward Hill, MA], 
5mM EDTA [Fisher Scientific] and 1 tablet of complete mini, EDTA-free protease 
inhibitor (Roche, Indianapolis, IN) per 10mL of RIPA buffer. 1μg of exosomes samples 
and 50μg of mock or JCV infected SVGA total protein were heated at 70°C for 10 
minutes in SDS sample buffer without β-mercaptoethanol (375mM Tris-HCL, pH6.8 
[Fisher Scientific], 6% (w/v) sodium dodecyl sulfate [Avantor Performance Materials], 
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48% (v/v) glycerol [Sigma-Aldrich], and 0.03% (w/v) bromophenol blue [Fisher 
Scientific]) and subjected to electrophoresis using a 10% denaturing acrylamide gel (Bio-
Rad). Proteins were transferred onto Immobilon-FL PVDF membrane (Millipore, 
Billerica, MA) using the Bio-Rad Mini Trans-Blot electrophoretic transfer cell (Bio-Rad).  
The membrane was blocked in 5% (w/v) skim milk powder (HEB, San Antonio, TX) in 
Tris-buffered saline with 0.1% (v/v) Tween-20 (TBST, Fisher Scientific) for 1 hours at 
room temperature. Membrane was probed using a mouse monoclonal antibody against 
CD63 (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA), a rabbit monoclonal 
antibody against Tsg101 (1:1000, EMD Millipore, Billerica, MA) or a rabbit monoclonal 
antibody against Calnexin (1:1000, Cell Signaling Technology, Danvers, MA), overnight 
at 4°C. After overnight incubation, the membrane was washed with TBST, 4 times, 15 
minutes each, followed by incubation with anti-mouse secondary antibody IgG 
conjugated to HRP (1:5000, Invitrogen) for 1 hour at room temperature. The membrane 
was washed 4 times with TBST, 15 minutes each. The West Dura chemiluminescent 
substrate (Thermo Scientific) was used to generate the light signal for visualization on the 
Blue Ultra Autorad film (BioExpress).  
 
7.5.9 Transmission Electron Microscopy (TEM).  
Transmission electron microscopy imaging of exosomes preparations was 
performed as described (4), with slight modifications. Briefly, 10μL of the exosomes 
preparation was mixed with 10μL of 4% paraformaldehyde (PFA) solution in PBS (USB 
Corporation, Cleveland, OH) to achieve a final concentration of 2% PFA. A drop of the 
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sample was spotted on a piece of parafilm (Pechiney Plastic Packaging, Menasha, WI) 
and a Formvar Carbon Film on 300 square mesh Nickel Grid (Electron Microscopy 
Sciences, Hatfield, PA) was floated on top of the sample. The excess liquid was blotted 
off and allowed to dry for 20 minutes at room temperature. The grids were washed 8 
times with deionized water prior to staining, using the floating method as described 
above. To stain the samples, a drop of uranyl-acetate solution, pH4.2 – 4.5 (kindly 
provided by the Institute of Cellular and Molecular Biology Microscopy Facility, The 
University of Texas at Austin, Austin, TX) was spotted onto a piece of parafilm and the 
grid was floated on the drop for 5 minutes, followed by blotting off the excess uranyl-
acetate solution. The grids were washed one time as described above. Imaging was 
performed using a Tecnai Spirit BioTwin transmission electron microscope (FEI, 
Hillsboro, OR) at 80kV. 
 
7.5.10 Immunoaffinity capture of exosomes from ExoQuick-TC enriched exosomes. 
200μL of either EcoMagTM Protein L Magnetic Beads (Bioclone Inc., San Diego, CA) or 
Dynabeads® Protein G beads (Invitrogen, Grand Island, NY) were washed twice with 
PBS+0.1% Tween 20 (ThermoFisher Scientific, Asheville, NC). 10mg of the following 
PLP antibodies were added to 200μL of the beads in a total volume of 400μL of 
PBS+0.1% Tween 20 for conjugations to the beads, overnight, at 4°C, with rotation on a 
Labquake Shaker Rotisserie (ThermoFisher Scientific). The following antibodies against 
PLP were used: Monoclonal Mouse IgM Clone#O10 Human PLP Antibody (R&D 
Systems, Inc., Minneapolis, MN). Monoclonal Mouse IgG2a kappa Myelin PLP 
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Antibody (2D7) (Novus Biologicals, Littleton, CO). Polyclonal Goat PLP Antibody (G-
17) (Santa Cruz Biotechnology). Monoclonal Rat Myelin PLP (Human, #9001) Antibody 
(ImmunoDiagnostics, Inc., Woburn, MA). After overnight antibody conjugation onto the 
magnetic beads, the beads were washed twice with PBS+0.1%BSA (Sigma-Aldrich, St. 
Louis, MO). 50μL of the ExoQuick-TC enriched exosomes and 50μL of PBS+0.1%BSA 
were added to the antibody-conjugated magnetic beads. Immunoaffinity capturing of the 
neuronal exosomes was done overnight, at 4°C, with rotation as above. After overnight 
capturing of the neuronal exosomes, the magnetic beads were washed three times with 
PBS+0.1%BSA. The exosomes-captured magnetic beads are subjected to RNA isolation 
for stem-loop RT PCR detection of JCV microRNA or western blot analysis. 
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CHAPTER 8  Thesis Significance and Future Work 
 
 Polyomaviruses are a fascinating family of DNA viruses. Ever since the discovery 
of the first polyomavirus in 1953, our understanding of fundamental molecular biology 
and tumor biology has grown by leaps and bounds. However, we have not yet fully 
uncover everything about these viruses, best demonstrated by the discovery of the 
polyomaviral miRNAs, first described in 2005. More importantly, several members of the 
polyomaviruses are associated with human pathologies – MCV is the first human 
polyomavirus known to cause cancer, Merkel cell carcinoma; JCV is the causative agent 
of PML, a rare neurodegenerative disease that has recently received more attention since 
the introduction of immunomodulatory therapies; BKV causes nephropathy is transplant 
patient and is one of the leading cause of organ rejection; TSV is the etiological agent of 
a skin disease known as trichodysplasia spinulosa. With the recent boom in discovery of 
new human polyomaviruses comes a need to better understand these viruses and how 
they contribute to human pathologies, to the ultimate goal of preventing or even treating 
polyomavirus-associated diseases. This work is a small piece of this puzzle, addressing 
the functions of polyomaviral miRNAs. 
 There are currently more than fifty polyomaviruses, yet only a small subset has 
been inspected for the capacity to encode miRNAs. It is therefore a worthwhile endeavor 
to screen all known polyomaviruses and differentiate the miRNA-positive from the 
miRNA-null members. This will perhaps allow us to draw important correlation between 
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the polyomaviral miRNAs, their natural host cell types and the pathologies that they 
cause. One conserved function of the polyomaviral miRNAs is the autoregulation of the 
early transcripts and the biological relevance to polyomavirus biology is one of the main 
theme covered in this work. However, it is of the utmost importance to extend this work 
beyond tissue culture. The fact that SV40 undergoes lytic infection in the laboratory 
setting calls for the need to better understand the relevance of miRNA-mediated 
autoregulation during natural polyomavirus infection. For SV40, the next step is to study 
the miRNAs in the more relevant host type, the Rhesus macaques. A good starting point 
would be to determine the effect of the SV40 miRNAs between the wild type virus and 
the miRNA-null mutant in primary rhesus macaque kidney epithelial cells.  
 The biggest mystery in the polyomavirus field, however, is the establishment of 
polyomaviral persistent infections in their natural hosts. By fully characterizing the 
laboratory persistent infection systems established in this work, we can perhaps better 
understand the underlying mechanism of polyomaviral persistent infections. The 
evidence described in this work points to the large T antigen as the most important player 
in persistent infections, yet, we cannot formally rule that the miRNAs are not involved at 
any point. Therefore, one of the first step would be to establish the same laboratory 
infection system using a miRNA-expressing virus (for example, protoarchetype-WT) and 
determine if additional expression of the SV40 miRNAs would alter the establishment of 
laboratory persistent infections. 
 It can be speculated that the polyomaviral-miRNA mediated autoregulation of the 
early transcripts is a way for the polyomaviruses to evade the immune response. Without 
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high levels of large T antigen, active lytic replication cannot be supported. We speculate 
that the polyomaviral miRNAs to play an important role in the establishment of persistent 
infections, by preventing the expression of the T antigens. Yet, may not be the only 
requirement. Additional contributions may come from alterations of the functionalities of 
the large T antigen or even targeting of other cellular transcripts by the polyomaviral 
miRNAs, both suggested by this work.  
 The field of polyomaviral miRNAs is going to marvel us with how a small virus 
such as the polyomavirus with limited genomic space had evolved to tap into the power 
of miRNAs. Yet at the same time, it is baffling as to why not all polyomaviruses encode 
miRNAs. Understanding how these miRNA-null polyomaviruses cope with the 
challenges faced by the miRNA-positive polyomaviruses will definitely amaze us even 
more. 
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CHAPTER 9  Conclusions 
 
 The field of viral miRNAs is relatively young, despite the discovery of more than 
300 known viral miRNAs, from both DNA and RNA viruses, only a few of them have 
well-defined functions. From a virus standpoint, miRNAs can be the difference between 
elimination and survival. The relatively small genome sizes have put extreme constraints 
on many virus families and the gene repertoire that they can have. Since miRNAs are 
small molecules that do not occupy significant genomic space, they are the perfect genes 
that can still fit within the limitations imparted upon these viruses by their small genome 
sizes. Unlike viral proteins, the fact that miRNAs are non-immuogenic makes them the 
perfect viral regulatory gene. In addition, miRNAs are capable of targeting a wide array 
of targets. Since a single seed sequence (nucleotide position 2 to 8) can potentially target 
16384 unique transcripts, the plasticity offered by miRNAs again, alleviates the genomic 
limitations that most viruses suffer from.  
 My work focuses on the discovery and determining the functions of polyomaviral 
miRNAs. At the start of this dissertation work, only SV40, muPyV, JCV and BKV have 
been shown to encode miRNAs. Since then, I have shown that several other non-human 
polyomaviruses also encode miRNA. More importantly, through a collaborative effort 
with Dr. Gil Ju Seo, we have demonstrated that MCV, the first human polyomavirus 
known to cause cancer, encodes miRNAs as well. All known polyomaviral miRNAs are 
located antisense to the early transcripts and can be further categorized into two groups 
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based on their genomic locations, at the C-terminus or closer to the N-terminus of large T 
antigen. Despite the differences in their genomic locations, previous studies and my work 
have demonstrated that all polyomaviruses that are known to encode miRNAs also 
preserved the function of autoregulating the early transcripts. The fact that miRNAs are 
highly conserved among different strains of the same virus, in particular, SV40, JCV and 
BKV, further emphasizes the importance of miRNA-mediated autoregulation of the early 
transcripts. In addition, through this work, I have also demonstrated that this mode of 
autoregulation is conserved in a diverse virus family, the Bandicoot Papillomatosis 
Carcinomatosis Viruses (BPCV). Despite not located directly antisense to the early 
transcripts, the BPCV miRNAs can still autoregulate the early transcripts, further 
emphasizing the importance of miRNA-mediated autoregulation of the early transcripts.  
What is the biological significance of this conserved miRNA-mediated 
autoregulation of the early transcripts? Several research groups, including our own, have 
implicated a role for the miRNA-autoregulation of the early transcripts in immune 
evasion and establishment of persistent infections. This implication should not come as a 
surprise to anyone since polyomaviruses establish persistent infections in their natural 
hosts, and polyomaviral miRNAs can control the expression of the T antigens, which are 
required at multiple stages of the virus life cycle. However, from my work, there was no 
significant difference in lytic replication between K661 and K661-776miR, suggesting 
that at least in the laboratory setting, the SV40 miRNAs play a minimal role. A major 
drawback from my work is the fact that the studies were performed in African green 
monkey cells, in which SV40 will undergo lytic replication, an obvious deviation from 
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persistent infection of its natural host, the Rhesus macaque. Therefore, one ongoing work 
in our lab revolves around studying the potential effects that the SV40 miRNAs will have 
on infections of primary Rhesus macaque kidney epithelial cells. 
This work, together with other works from our lab, has indicated that not all 
polyomaviruses encode miRNA. This raises two very interesting questions – First, are 
there more miRNA-encoding polymaviruses than miRNA-null polyomaviruses, or it is 
vice versa? Second, if the autoregulation of T antigen is indeed important, how do 
miRNA-null polyomaviruses achieve the same regulatory goal? To address this question, 
future experiments will require us to inspect all polyomaviruses for their potential to 
encode miRNAs. The result should offer insights as to why some polyomaviruses do not 
encode miRNAs and how that can be related to the host cell types that those 
polyomaviruses naturally infect.  
Even though the autoregulation of the early transcripts is one conserved function 
of the polyomaviral miRNAs, it is highly unlikely for these viral miRNAs to not target 
host transcripts as well. In fact, ULPB3, a natural killer cell activating ligand, has been 
implicated as a host target for the JCV 3p derivative miRNA. Therefore, besides 
autoregulation of the early transcripts, our lab is also aiming to determine the possible 
host targets for polyomaviral miRNAs. We have preliminary work to suggest that the 
MCV 5p miRNA shares the same minimal seed sequence as the cellular miR-7 
(nucleotide position 2 to 7), potentially allowing the MCV 5p miRNA to target a selected 
set of host transcripts. Since an oncogenic role has been implicated for miR-7, we are 
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currently focusing on determining the possible cellular targets of the MCV 5p miRNA 
and how these targets are related to the MCV biology and Merkel cell carcinoma.  
One of the most intriguing question in polyomavirus biology is how these viruses 
establish persistent infections. In this work, I have only just begun to address this 
important question through the establishment of two different laboratory SV40 persistent 
infection systems. However, this work is only at its infant stage, and more efforts are 
necessary to fully characterize these persistently infected cell lines before we can even 
begin to unravel the biggest mystery of polyomavirus biology – persistence. Since one of 
the major differences between these two persistently infected cell lines is the presence of 
the SV40 miRNAs, it is possible for the SV40 viral miRNAs to play an important role in 
the establishment of persistent infections.  
Finally, how can we translate our scientific advancement from beyond the 
laboratory to potentially helping this world? I have started this endeavor by first 
demonstrating that the detection of JCV miRNAs in exosomes can serve as a non-
invasive alternative diagnostic of PML. This idea, at this point however, has only been 
demonstrated under the cell culture setting. The next step will require the actual 
enrichment of neuronal exosomes from biological fluid samples and the subsequent 
detection of the JCV 5p miRNA. If this diagnostic does indeed work in the clinical 
setting, it can potentially benefit a lot of patients who are undergoing immunomodulatory 
treatment regime and at risk of developing PML. 
 
 272 
This work was aimed at the discovery of polyomaviral miRNAs and determining 
their functions. But for every miRNA discovered, more questions were raised. 
Polyomaviruses have been well studied, especially for SV40 and muPyV; yet, we are 
only scrapping the tip of an iceberg. I hope that the work that I have done has contributed 
to not just a better fundamental understanding of this virus family, but also towards the 
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